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ABSTRACT 
Skin is the largest organ in the human body and acts as a protective barrier against 
exterior chemical and pathogenic agents. Because of the large surface area and easy 
accessibility, drug delivery through skin has numerous potential applications. The 
stratum corneum, SC (the outermost layer of the skin), forms the main barrier to 
diffusion of permeants through the skin; circumventing this barrier is challenging and it 
is difficult to deliver “large” molecules such as proteins and peptides across the skin. 
The physicochemical properties of a permeant affect its transport into and through the 
skin and well characterised diffusional determinants include the octanol/water partition 
coefficient, molecular weight, solubility and hydrogen bonding groups of a drug. Less 
well understood is the role of chirality. The enantioselectivity of the skin during 
epidermal permeation has been poorly researched with few investigations focussing on 
the effect of drug chirality. 
In this project, three libraries of unnatural amino acids were synthesised in their racemic 
and enantiomerically pure forms; a saturated series, an unsaturated series and a 
hydroxylated series of -amino acids. The monomers were assembled into peptides of 
different dimensions, specifically dimers, tetramers and in some cases hexamers and 
octamers. This library was used to probe and seek to understand the effects of 
increasing molecular weight and chirality on permeant uptake into stratum corneum 
membranes. In addition, the ability of these materials to hold water, and so act as 
potential moisturising agents in dry skin conditions was explored. 
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To meet these objectives, the physical properties of these materials were measured and 
assessed ranging from analytical characterisation (Nuclear Magnetic Resonance - NMR, 
Mass Spectrometry - MS, Infra-Red - IR) to water uptake assays (Thermal Gravimeric 
Analysis - TGA, Dynamic Sorption Vapou - DVS). The materials tended to form 
intramolecular hydrogen bonds as the peptide length increased. Thus, their foldameric 
structures were also explored using circular dichroism and for some materials with 
unusual properties X-ray diffraction was performed. Selected compounds were applied 
to isolated sheets of stratum corneum to assess their uptake. The influence of chirality, 
molecular weight, chemical composition (saturated, unsaturated and hydroxylated), 
water holding capacity and secondary structure on the uptake of the material into the 
tissue were explored and the results illustrated that complex relationships existed 
between structure and uptake but chiral selectivity of drug uptake into the stratum 
corneum was demonstrated. 
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1. INTRODUCTION 
Human skin is an impressive physical, immunological, and sensory barrier to the 
surrounding environment. It has long been used as a portal for drug delivery and it is a 
formidable barrier that usually requires appropriate technology for successful delivery. 
It is also a heterogeneous organ, with several delivery routes and sites that could be 
targeted for desirable pharmacological and immune responses. While the skin acts as a 
barrier, it is not a complete barrier. Many chemicals do penetrate the skin, either 
intentionally or unintentionally, and cutaneous metabolism does occur. Because of its 
large surface area, the skin may be a major route of entry into the body for drug 
administration. This may require the design of a specific chemical or physical delivery 
system to enhance the permeation of an active substance. In this chapter, a brief 
overview of the structure and function of the skin is presented along with aspects 
regarding physical chemistry and drug delivery that are of relevance to the present 
study. 
1.1 SKIN STRUCTURE AND FUNCTION 
Skin is a tegument that wraps human tissues, organs and fluids. Its thickness, colour, 
presence of hair, glands and nails varies depending on the body region. Despite these 
variations, all types of skin possess the same basic structure. It is the largest organ in the 
human body and provides a sturdy, flexible and self-repairing barrier to the exterior 
environment, protecting the internal organs and fluids from external influences. It 
prevents loss of endogenous water (humans are approximately 70% water) and 
nutrients, and protects against many unwanted toxic substances and pathogenic 
___________________________________________________________Introduction 
 
 
 
3 
 
 
microorganisms. The skin also responds to mechanical forces (elasticity and 
cushioning). It is organized in three distinct layers
1
 (Figure 1.1): the epidermis, the 
dermis and the hypodermis. The external surface, epidermis, is stratified and its 
thickness varies depending on function and hydration. Thicker skin is mainly found in 
palmar areas such as hands and feet, where mechanical resistance is needed. 
 
 
Figure 1.1 Schematic overview of the skin layers, appendages, blood and lymphatic vessels.
1
 
 
1.1.1 HYPODERMIS 
The hypodermis, or subcutaneous fat tissue, is the superficial membrane of the 
macroscopic anatomy of the skin from the inside to the outside. It is a relatively thick 
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layer (millimetre magnitude) in most areas but it is not present at all body sites (e.g., 
absent in the eyelids).
2
 Its limits are difficult to define because it merges with the dermis 
and its principal function is to insulate the body and protect it against physical shock. Its 
adipose tissue is an important energy reservoir, mainly as triglycerides. 
1.1.2 DERMIS 
The dermis, or corium, composed of connective tissues as collagen fibrils, elastic tissue 
and a few reticular fibres; is the largest of the layers. It supports blood and lymphatic 
vessels, nerve endings, hair follicles and sebaceous and sweat glands. The vascular 
system and sweat glands are essential for the body’s thermoregulation; skin’s resting 
blood flow increases in response to an increase in temperature gradient between skin 
and core temperatures, caused by water elimination through sweat glands. The 
vasculature is also important for wound repair and removal of toxins; small molecules 
are removed from near the dermo-epidermal layer. The lymphatic flow has been shown 
to have an influence in the clearance of molecules with higher molecular weights.
3
 
Typically 3-5 mm thick, the dermis provides nutritional support for the avascular 
epidermis and comprises a fibrous protein matrix, mainly collagen, elastin, and 
reticulum, embedded in an amorphous colloidal polysaccharide gel. The physical 
behaviour of the dermis, including elasticity and support, is determined by the fibre 
bundles and the colloidal gel. The dermis provides flexibility with strength, serves as a 
barrier to infection, and functions as a water storage organ.
4
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1.1.3 EPIDERMIS 
The epidermis is divided into two strata, the non-viable epidermis (stratum corneum, 
SC) and the viable epidermis. The viable epidermis is itself, a stratified layer (Figure 
1.2) and its thickness varies from around 0.06 mm on the eyelids to around 0.8 mm on 
the palms of the hands and soles of the feet.
2
 The epidermis of the soles and palms is 
thicker even in the embryo, the more prominent curvature lines are recognisable in 
twelve week old human embryo.
5
 Over a period of 2-3 weeks, the SC is regenerated by 
keratinised cells that migrate from the stratum basale. 
 
a)      b) 
Figure 1.2 a) Histological preparation of human epidermis,
6
 stratum corneum (C), stratum lucidum (L), 
stratum granulosum (G), stratum spinosum (S), stratum basale (B). b) Schematic representation of human 
epidermal cell differentiation.
2
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1.1.3.1 Stratum Basale 
Also identified as stratum germinativum or, more commonly, the basal layer, its cells 
are similar to those of other tissues in the human body. The cells in the basal layer are 
cubic and form a unique layer separated from the dermis by a very thin membrane 
(basement membrane) by hemidesmosomes (involving one cytoplasmic plaque). Within 
the stratum basale and the stratum spinosum there are keratinocytes linked through 
desmosomes (involving two cytoplasmic plaques). Keratinocytes are the only cells 
within the epidermis that can divide via mitosis. After replication, one of the cells 
migrates towards the skin surface and the other remains in the basal layer; the cellular 
division happens, on average, once every 200 to 400 h.
2
 The stratum basale also 
contains other specialised cell types such as melanocytes; these synthesise the pigment 
melanin (eumelanin and phaeomelanin – less common) from tyrosine via tyrosine 
hydroxylase enzymatic activity. The ratio between keratinocytes and melanocytes varies 
from 5:1 to 20:1 according to body site and it appears that melanocytes presence is light 
exposure inducible.
2
 Melanin absorbs ultra violet (UV) radiation and is a free-radical 
scavenger. Melanocytes are in contact with keratinocytes by dendritic connections as 
well as the Langerhans cells, also found within the stratum basale. Langerhans cells 
derive from bone marrow and take up and process microbial antigens, they play an 
important role in some skin conditions. Merkel cells are also found in the basal layer, 
these cells are related to nerve endings having a role in cutaneous sensation and are 
found in large number in the lips and fingertips. 
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1.1.3.2 Stratum Spinosum 
The stratum spinosum together with the stratum basale are often termed the Malpighian 
layer. The spinous cells from this layer are relatively large keratinocytes that change 
morphology from columnar to polygonal.
2
 The keratinocytes are also connected to 
adjacent cells by desmosomes derived from the condensation of the synthetic product of 
cellular differentiation (keratins). Keratins agglomerate to form tonofilaments, these are 
also found, in small number, in the cells of the stratum basale. 
1.1.3.3 Stratum Granulosum 
The stratum granulosum (or granular layer) is the last layer of the viable epidermis. Its 
name is related to the fact that cells are characterised by numerous dense cytoplasmic 
granules. The chemical nature of these keratohyalin granules is distinct from that of the 
tonofilaments. It is believed that the keratinisation process involves a combination of 
tonofilaments and keratohyalin to form the mature keratin complex.
6
 It is at the granular 
layer that the terminal cell differentiation process starts and cells undergo a number of 
structural and composition changes. The keratinocytes lose their organelles via 
enzymatic degradation and become corneocytes – chemical and physical resistant cells.7 
Membrane-coating granules are also synthesised in the Golgi complex (an organelle 
found in eukaryotic cells) and they contain the responsible precursors for the 
intercellular lipid lamellae found in the stratum corneum.
2
 These granules are extruded 
into the intercellular spaces as they approach the stratum lucidum. The stratum lucidum 
is a transition layer between the stratum granulosum and the stratum corneum, well 
observed in thicker skin (as in palms and soles). Some dermatologists disagree on the 
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real existence of this layer claiming that it could be a tissue preparation artefact and 
thus, is often described as part of the stratum corneum. 
1.1.3.4 Stratum Corneum 
The stratum corneum, the outermost layer of the skin, is the result of the dynamic cell 
differentiation migrating process from the stratum basale to the upper stratum 
granulosum, a journey that takes approximately 14 days.
2
 It is composed of dead, 
keratin-rich cells (corneocytes) embedded in a complex intercellular lipid mixture, 
particularly rich in ceramides, fatty acids, cholesterol and cholesterol sulphate, 
organised in bilayer arrays. The barrier function of the mammalian skin is mainly due to 
the SC, which is also responsible for the poor penetration of drugs into the skin.
8
 It 
contains no blood vessels and therefore diffusion is the physical process that governs 
molecule transport into and out of the human body.
9
 The SC has the ability to swell 
from a thickness of 10-15 m (when dry)10,11 up to a thickness of about 40 m (when 
hydrated).
12
 Though it is an epidermal layer, about 50 years ago the SC was not 
considered to be important in the permeability barrier;
13
 nowadays it is often studied as 
a separate membrane in topical and transdermal drug delivery. It is often represented as 
a “brick and mortar” model (Figure 1.3), its keratinocytes are polygonal, elongated and 
relatively flat, approximately 0.2 to 1.5 m thick with a diameter of 34 to 46 m.2 
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Figure 1.3 A representation of the "brick and mortar" model of human stratum corneum.
2
 
 
At the deeper side of this layer, the cornified cells maintain desmosomic connections 
and intracellular keratin possesses an ordered pattern. Near the surface, the desmosomes 
and internal structure of the cells are destroyed in a process leading to desquamation. 
Together, this organised structure provides mechanical resistance and insulation to 
prevent water loss from the body. This barrier nature is due to its constituents, 75-80% 
is protein of which, about 70% is -keratin and 10% is -keratin and a proteinaceous 
cell envelope.
2
 Corneocytes are surrounded by a monolayer of -OH-ceramides that 
form the corneocyte lipid envelope (CLE).
14
 The cell envelope is a thick layer ( 10nm) 
of highly cross-linked ceramides and fatty acids covalently bound to glutamate residues 
in the involucrum of the corneocytes. The CLE role in the SC barrier function can be 
Stratum corneum 
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viewed as a scaffold for the organisation of the extracellular lamellar bilayers which are 
a mixture of the lipid matrix, fatty acids, cholesterol and cholesterol sulphate. 
Exhaustive lipid solvent extractions induce the collapse of the corneocytes and so the 
CLE has also been suggested to contribute to the cohesion of the SC.
14
 Finally, the CLE 
can also function as a semi-permeable membrane that can allow the passage of water 
while restricting the loss of larger hygroscopic molecules, such as filaggrin (filament 
aggregation protein) breakdown products (smaller peptides and free amino acids), out of 
the corneocyte. Filaggrin is a crucial component of the keratinocyte mesh in the outer 
layer of epidermis; it helps keratin filaments to aggregate and it is synthesised initially 
as profilaggrin, an approximately 500 KDa highly phosphorylated, histidine-rich 
polypeptide.
15
 
1.1.4 NATURAL MOISTURISING FACTOR 
The SC barrier is continually disturbed by both external forces (UV, low relative 
humidity (RH), cold temperatures, and surfactants), and internal factors (cutaneous 
disease, psychological stress, and diabetic complications) which can lead to conditions 
such as dry skin and decreased performance of the barrier. In order to maintain its 
flexibility, integrity, and critical catabolic activity the SC must remain hydrated, and in 
healthy skin the tissue contains greater than 10% water. In the absence of water, the SC 
is an intrinsically fragile structure, which readily becomes cracked, brittle and rigid. 
Water plays a key role in maintaining the SC barrier integrity. This water would easily 
evaporate without the presence of inherent skin moisturising agents, leaving the skin dry 
and tight. Water supply from the innermost skin layers and normal sweating maintain 
the skin moisture level which mediates the activity of some hydrolytic enzymes, for 
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example those involved in the degradation of filaggrin that generate the Natural 
Moisturising Factor (NMF). Filaggrin, within the keratinocytes is a cohesive protein 
that integrates the keratin mesh; its degradation releases a number of amino acids which 
are partially metabolised into hygroscopic molecules. An analysis of the chemical 
composition of the SC
16
 led to the conclusion that, the NMF components (Table 1.1) 
were breakdown products from the proteolysis of the filaggrin protein (Figure 1.4). 
NMF is a natural skin protector against dehydration and has also been referred to as 
“naturally occurring humectants” or “hygroscopic water soluble substances”.17 
Table 1.1 Chemical composition of NMF.
18
 
Compound % 
Free amino acids and urocanic acid 40.0 
Pyrrolidone carboxylic acid 12.0 
Lactate 12.0 
Sugars, organic acids, peptides, unidentified materials 8.5 
Urea 7.0 
Chlorine 6.0 
Sodium 5.0 
Potassium 4.0 
Ammonia, uric acid, glucosamine, creatine 1.5 
Calcium 1.5 
Magnesium 1.5 
Phosphate, citrate, formate 1.0 
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The presence of sugars in the SC represents primarily the activity of the enzyme D-
glucocerebrosidase as it catalyses the removal of glucose from glucosylceramides to 
initiate lipid lamellae organization in the deep SC. In addition, the degradation of 
corneodesmosomes also releases sugars from these glycosylated proteins. Historically 
the main focus of interest has been the origin of the free amino acids (FAA) and their 
derivatives within the SC, which together represent over 50% of the NMF. 
 
Being a complex mixture of low molecular weight water-soluble compounds, which is 
present within the corneocytes, the NMF components have the ability to bind water 
against the desiccating action of the environment and thereby maintain tissue hydration. 
This ability is mainly due to pyrrolidone carboxylic acid (PCA) and lactic acid salts; 
they absorb atmospheric water and dissolve in their own water of hydration, thereby 
acting as very efficient humectants. In essence, the amount of NMF in the SC 
determines how much water it can hold for any given relative humidity and the highly 
structured intercellular lipid lamellae is responsible for preventing the NMF 
components “escaping” from the surface layers of the skin.19 
 
The contributions of the individual components of the NMF have been studied 
extensively, but their synergistic behaviour to the overall properties of the SC remains 
relatively poorly researched. 
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Figure 1.4 Schematic representation of profilaggrin transdermal differentiation. 
 
Recently, the potent water biding molecule hyaluronic acid has been shown to be 
naturally present in the SC,
20
 and the importance of glycerol, present at low 
concentrations, has been emphasised by the studies of Verkman and co-workers,
21
 
Previously, these two molecules have been ignored and the NMF composition and 
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function has focused on four major intrinsic components: lactate, free amino acids 
(FAA), PCA, and urea. PCA is produced in the skin through the arginine-citruline-
ornitine-glutamic pathway, the free amino acid is not hygroscopic; however, the sodium 
salts of this acid are more hygroscopic than glycerine. The proportion of urea/other 
NMF component is 7%; it comes from the degradation of arginine or from sebaceous 
glands. This substance is a major skin hygroscopic agent and, because of its small size, 
urea penetrates to the deepest layers of the SC, where it breaks keratin hydrogen bonds 
and retains water molecules because of its osmotic properties.
18
 
The chemical structure of -hydroxy-acids (AHA) has an alcohol group on the alpha 
position (the carbon adjacent to the acid group); it is this proximity between functional 
groups that gives these molecules their ability for higher water retention and absorption. 
Thus, these highly hygroscopic compounds boost skin moisturising and strengthen the 
skin barrier function. AHAs have regulatory properties on keratinisation. The sodium 
salts of these acids are also highly hygroscopic and enhance the SC layer flexibility.
18
 
A recent study reports the potential use of unnatural amino acid derivatives with 
enhanced ability of water retention as replacement NMF constituents.
22
 Within this 
current project, two of those amino acids were also synthesised (see Appendix A1), 
namely N-hydroxyglycine and N-hydroxyserine. 
The NMF is essential for the normal functioning of the SC. In combination with the SC 
lipids, this pool of low molecular weight compounds assists in the retention of water 
within the corneocytes, a capability that is vital for the integrity of this barrier, and its 
mechanical properties. Hydration of the SC is also essential for the normal functioning 
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of numerous enzymatic processes that are essential, not only for desquamation, but also 
for the generation of the NMF itself. 
1.1.5 METABOLIC FUNCTION OF THE SKIN 
Although one of the skin’s functions is to prevent the entry of xenobiotics - a chemical 
substance that is not naturally produced, the barrier may be overcome to become an 
entry point. It is commonly believed that skin is an inert tissue but in reality, it is a 
living organ with its own biological system where chemical reactions (e.g. oxidation, 
reductions, hydrolysis and methylation) occur. The extent of cutaneous metabolism is 
modest compared to other organs such as the liver, the kidney, the lung and the 
intestine. Though modest, drug metabolism can be significant considering the large 
surface area of the skin.
2
 There is growing evidence that most common drug-
metabolising enzymes are expressed in the skin.
23
 In 2007, Oesch and co-workers 
summarise the knowledge on drug metabolising enzymes in the skin of human, rat and 
pig
24
 (often used as a model for human skin because of its similarities) and factors 
influencing the metabolic activity of skin enzymes have been studied by Zhang and co-
workers.
25
 In many case studies, the keratinocytes were shown to be the major site of 
drug metabolism in the skin.
26,27
 An example of the occurrence of drug metabolism was 
reported by Nacht et al. where topically applied benzoyl peroxide was recovered on the 
dermal side as benzoic acid.
28
 Another interesting study is reported by Slominski et al., 
where the authors report the metabolism of melatonin in skin.
29
 In addition to inherent 
drug metabolising enzymes, microorganisms present on the skin surface, such as 
Staphylococcus epidermidis, may also metabolise topically applied drugs.
2
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1.2 PERMEATION PROCESS THROUGH THE SKIN 
There is a long tradition of delivering drugs through skin; records of the husk of castor 
oil plant in water being placed on an aching head date from the 16
th
 century BC. From 
ointments, pastes and poultices, more sophisticated dosage forms have become 
significant commercial successes following the launch of the first transdermal patch, for 
scopolamine,
30
 in 1979. Transdermal drug delivery (TDD) through the skin is controlled 
by a physical process – diffusion. Due to its characteristics, the SC is the main obstacle 
for this process to occur and there are essentially three pathways (not mutually 
exclusive) by which a molecule can traverse the SC (Figure 1.5): the shunt routes, the 
transcellular routes and the intercellular lipid domains. The individual contribution of 
each potential pathway is a function of the nature of the permeant (molecular species 
that moves through or into the tissue).
2
 
 
Figure 1.5 A representation of the principal mechanisms and pathways operating during transdermal and 
topical drug delivery.
2
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1.2.1 TRANSAPPENDAGEAL ROUTE 
Representing a bypass through the SC barrier, the appendages (hair follicles, sweat 
ducts) account for about 0.1% of the total surface of the skin.
12
 Although their 
contribution is generally neglected it should not be considered insignificant. Studies 
have demonstrated that the shunt routes can be either significant
31
 or minor 
contributors
32
 to the permeation/penetration of a drug. This behaviour is largely 
dependent on the nature of the permeant and the experimental design. For example, as 
described above, water can have a significant effect on the SC; full hydration of the 
tissue leads to skin swelling and so the shunt routes openings are likely to close down. 
On the other hand, the shunt routes may be a quicker access to a drug in contrast to the 
longer path to traverse via other routes. The typical example of a clove of garlic rubbed 
on the soles of the feet and rapidly tasted in the mouth can be explained by penetration 
through the shunt routes avoiding the bulk of the SC. It also becomes of relevance in the 
transport of larger polar molecules and ions that would have lower affinity to traverse 
the bulk of the SC. The importance of the shunt routes has also been highlighted for the 
delivery of vesicular structures, as they offer lower resistance than the SC bulk.
2
 
1.2.2 TRANSCELLULAR ROUTE 
This route offers a highly hydrated moiety and one can conclude that the essentially 
aqueous environment is an optimum media for hydrophilic molecules. However, the 
polar route is essentially hydrated keratin-filled cells bound to the CLE and thus, a 
molecule crossing the SC encounters repeated obstacles. In other words, the path is 
complex; first the partitioning into the keratinocyte, then diffusion through the hydrated 
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keratin, followed by partition into the bilayer lipids and finally diffusing across the lipid 
bilayer to start the same path across the next keratinocyte. In addition there are between 
4 and 20 layers of hydrophobic chains and hydrophilic head groups of the lipid domains 
between each keratinocyte.
2
 Heisig et al.
33
 demonstrated that the transcellular route 
should not be ignored and Sznitowska and co-workers showed that this route is the main 
barrier to a hydrophilic zwitterion (baclofen);
34
 clearly the nature of the permeant 
influences the “chosen” path to traverse the SC. 
1.2.3 INTERCELLULAR ROUTE 
Representing 1% of the SC diffusional area,
2
 the intercellular route may be considered 
the only continuous phase within the SC and it provides the path by which most small, 
uncharged molecules traverse the SC.
35
 
A mosaic model domain was proposed by Forslind
36
 for the SC lipids taking in account 
the lipid packing heterogeneity. This arrangement allows for water loss regulation 
whilst permitting sufficient water to enter the tissue to maintain keratinocyte hydration; 
inferring that fluid liquid crystalline domains could provide the pathway by which 
permeants traverse the SC. This model does not exclude the possibility of preferential 
paths, meaning that there would be alternative routes of lower resistance to permeation. 
More tortuous than the transcellular route, a molecule travels through the continuous 
150 to 500 m thick2 lipid domains in between the keratinocytes, dependent on their 
physico-chemical properties. The real path dimension that molecules have to cross is 
unknown and thus various permeation parameters must be taken in account including 
pathlength, permeability and diffusion coefficients. 
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Though the skin is a complex biological system, a mathematical model can be applied 
to describe the behaviour of a molecule traveling through the skin. Fick’s first law 
(Equations 1) has successfully been applied to analyse experimental data. This relatively 
simple mathematical model allows insight to the path of a drug traversing the skin, 
considering simple diffusion in a pseudo-steady-state.
2
 The applicability of Fick’s law, 
post excision low permeability of the skin and strong evidence that the diffusional 
resistance is in the SC, represent the three reasons that lead to believe that the 
movement of molecules across the skin is by passive diffusion.
37
 
𝐽 = −𝐷
𝑑𝑐
𝑑𝑥
            Equation 1.1 
Where, 𝐽 is the flux of the permeant defining the amount of material that passes through 
a unit area per unit time, 𝐷 is the diffusion coefficient of the permeant and 
𝑑𝑐
𝑑𝑥
 is the 
concentration gradient (𝑐 is the concentration and 𝑥 is the space coordinate measured 
normal to the section). Fick’s second law (Equation 2) is derived from equation 1. 
𝜕𝑐
𝜕𝑡
= 𝐷
𝜕2𝑐
𝜕𝑥2
            Equation 1.2 
Where, 𝑡 is time. The solution of this equation (with the appropriate geometry, initial 
and boundary conditions) gives the permeation profile of a drug through skin. 
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1.2.4 PROPERTIES OF PERMEANTS AND UPTAKE 
From the above, one can infer that the permeation pathways are not mutually exclusive, 
and that the nature of the permeant has great influence in the permeation process. It is 
well known that the physicochemical properties of a permeant affect its transport into 
and through the skin, including its octanol/water partition coefficient, molecular weight 
and hydrogen bonding groups. The partition coefficient may be the rate-limiting step as, 
in a very simplified fashion, a hydrophilic molecule will partition preferentially into 
hydrated keratinocytes (intracellular route) and a more lipophilic molecule will prefer 
the lipid bilayers. In 1992, Moriguchi and co-workers
38
 developed a mathematical 
method to predict the octanol/water partition coefficient that involves several variables 
including number of carbon, nitrogen and oxygen atoms, their proximity, number of 
intramolecular hydrogen bonds, among other parameters. The size and shape of a 
molecule, in an isotropic medium, influences the diffusion coefficient; the bulkier the 
molecules the smaller its diffusivity. Despite this not so unexpected relationship, large 
and bulky molecules (aptamers) have recently been reported to traverse the skin as 
shown by Lenn et al.
39
 
Normal ambient temperature and atmospheric pressure are the typical conditions for 
TDD. At these conditions, most organic molecules have low aqueous solubility and 
hence, the solubility/melting point is another parameter to take into account when 
predicting the permeability of a candidate through skin. Lipophilic molecules would 
naturally permeate at a higher rate than hydrophilic molecules, but it is also necessary 
that a candidate would exhibit some hydrophilic characteristics. Computational methods 
have been employed to estimate the solubility and permeability of drugs.
40
 In addition 
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to its solubility, ionisation is another property that may influence the permeation 
process. The ionised form of a drug permeates through the lipid barrier at lower rates 
than the unionised drug. 
Less well understood is the role of chirality. The enantioselectivity of the skin during 
epidermal permeation has been subject of study in some cases, for example nicorandil,
41
 
flurbiprofen,
42
 and propranolol.
43
 To date, however, only a few investigations have 
focused on the effect of chirality with respect to binding or metabolism in the skin, and 
their transdermal delivery.
44
 
1.3 PERMEANT SELECTIVITY AND CHIRALITY 
Biologists have been looking back through the evolutionary chain to understand what 
early life forms all species are descended from – since the publication of Charles 
Darwin’s book “On the Origin of Species” in 1859. There are many questions yet to be 
answered about the origin of life and one of them is: why is it that the building blocks of 
life are all homochiral - that is, why are their molecules all structured in the same way, 
and not a mixture of the different possible ways? The answer remains unclear, but 
almost all amino acids are L-type and sugars are D-type. Researchers exploring the 
origin of life are keen to answer this question, and why the particular forms we see 
today – L-amino acids and D-sugars – were favoured, rather than their stereoisomers. 
Many of the molecules that organisms produce exhibit a specific handedness. This is 
important because the response of an organism to a particular molecule often depends 
on how that molecule fits a particular site on a receptor molecule. Therefore, in 
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designing pharmaceuticals, chemists must be concerned about which enantiomer is the 
active one. Ideally, the pharmaceutical should consist of the pure active isomer. 
The importance of stereochemistry in drug research and development as well as 
pharmacotherapy is well acknowledged. This is mainly due to a collective 
understanding that stereochemically pure drugs may provide safer and more efficient 
alternatives to racemates. Many chiral drugs are used as their racemic mixtures in 
clinical practice. In fact, two decades ago, 25% of therapeutic agents were 
commercialised as racemic mixtures.
45
 Two enantiomers of a chiral drug generally 
differ in pharmacodynamic and/or pharmacokinetic properties as a consequence of the 
stereoselective interaction with optically active biological macromolecules. 
Stereoselective metabolism of drugs is most commonly the major contributing factor to 
stereoselectivity in pharmacokinetics.
46
 Chiral substances possess a unique architecture 
such that, despite sharing identical molecular formulas, atom-to-atom linkages, and 
bonding distances, they cannot be superimposed. Thus, in the environment of living 
systems, where specific structure-activity relationships may be required for effect (e.g., 
enzymes, receptors, transporters, and DNA), the physiochemical and biochemical 
properties of racemic mixtures and individual stereoisomers can differ significantly. In 
drug development, enantiomeric selection to maximize clinical effects or mitigate drug 
toxicity has yielded both success and failure.
47
 
The SC, the rate-limiting barrier in transdermal drug delivery is chiral in nature and 
enantiomers behave differently with respect to their transport across the skin. The role 
of the skin as a portal of entry for chiral molecules is becoming an increasingly active 
and exciting field of research. To date, however, only a few investigations have focused 
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on the effect of enantiomeric differences of chiral drugs with respect to binding or 
metabolism in the skin on their transdermal delivery. 
Physicochemical properties of a racemate may be drastically different from the 
enantiomers. Chirality may also influence drug delivery because a single enantiomer or 
a non-racemic blend may have improved solubility, dissolution, and stability. In 
addition, many pharmaceutical excipients (e.g. cellulose and its derivatives) either 
naturally occur as single enantiomers or are derivatives. 
Similar to the solid dosage forms containing chiral excipients, biological membranes 
may provide chiral environments. Most drugs cross the gastrointestinal membrane 
through passive diffusion; thus, no stereoselectivity in the process is expected. It 
appears, however, that stratum corneum possesses chiral discrimination properties. A 
mathematical model has been reported as being able to predict enantioselective 
permeation of chiral drugs across human skin, based on the interdependence of certain 
physicochemical characteristics.
48
 Indeed, Kommuru et al. reported that in vitro data 
indicate significant stereoselectivity in skin penetration of ketoprofen
49
 (Figure 1.6 a). 
Suedee et al. proposed a transdermal patch for selective controlled drug delivery of the 
active S-enantiomer from racemic propranolol.
50
 The same author had previously 
reported a formulation containing a chiral cellulose derivative excipient for the 
enantioselective delivery of propranolol
51
 (Figure 1.6 b). Heard and co-workers, in 
1995, discussed the stratum corneum as a potential source of chiral discrimination that 
could result in differential diffusion rates of propranolol.
52
 Their findings did not lead to 
the hypothesis of chiral discrimination during diffusion; they stated that definitive 
evidence for intrinsic stereoselectivity in skin permeation has yet to be obtained. 
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Figure 1.6 Chemical structures of a) ketoprofen and b) propranolol. 
 
A majority of the chiral excipients in pharmaceutical dosage forms are from natural 
sources and therefore exist in the optically pure form. A selected list of commonly used 
excipients along with their major applications is shown in table 1.2. 
The interaction of chiral excipients with drugs and their influence on the therapeutic 
outcomes have not been thoroughly investigated. This may be due to the misconception 
that excipients are “inactive” materials and are not expected to affect the performance of 
dosage forms.
44
 
The rational development of products for transdermal drug delivery requires a thorough 
understanding of both the biological composition of the skin barrier and the 
physicochemical properties of drug molecules. For chiral drugs, whose biological 
activity is associated with one enantiomer, enantioselective permeation would affect the 
pharmacodynamics profile of the racemate. In such cases, development of a transdermal 
delivery system based on a single enantiomer, rather than racemate, could reduce the 
therapeutic dose required to achieve the desired pharmacological effect, which in turn 
can minimize or eliminate the adverse effects associated with chiral drugs. 
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Table 1.2 Examples of chiral excipients and their pharmaceutical applications.
44
 
Excipients Major applications 
Celluloses Disintegrants, suspending agents, stabilizers, 
coating agents, binders, viscosity builders, film 
formers, dissolution modifiers, enteric coating 
agents, taste masking, diluents. 
Starch, Sugars and Derivatives Binders, disintegrants, viscosity builders, 
sustained release matrix, suspending agents, 
diluents, sweeteners, dissolution enhancer 
binders, bulking agents for lyophilized 
products. 
Cyclodextrins Complexing agents, dissolution enhancers, 
stabilizers 
Acids Antioxidants, acidifying agents, acidulants, 
flavours, buffering agents, effervescent agents, 
diluents. 
Amino acids, peptides and Derivatives Stabilizers, sweeteners, solubility enhancers 
Fats, Oils, Essential Oils Emulsifying agents, suspending agents in 
emulsion systems, absorption enhancers, 
dissolution modifiers, flavours, penetration 
enhancers, antioxidants. 
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Physicochemical properties of chiral ibuprofen were evaluated and considered 
significant in the permeation process by Yuan et al.
53
 The pure enantiomers of 
ibuprofen have lower melting points than racemic ibuprofen, and therefore have higher 
solubility in skin lipids and greater percutaneous absorption. In this study, the eutectic 
emulsion showed the highest permeation rates among all test preparations. 
High melting points mean that the forces holding the molecule are strong hence low 
solubility
54
 and a clear relationship was established between melting point and passive 
transport of poorly soluble drugs.
55
 
Krishnaiah et al. investigated enantioselective penetration enhancing effect of carvone 
on the permeation of nicorandil
41
 (Figure 1.7). Their findings showed that R-carvone 
exhibited a higher penetration enhancing activity when compared with S-carvone and 
RS-carvone. 
 
Figure 1.7 Chemical structures of carvone a) R, b) S and c) nicorandil. 
 
A study conducted by Zeng et al. evaluated the possible relationship between the 
physical properties and the permeation of S-amlodipine and RS-amlodipine as well as 
the possible enantioselectivity of permeation of amlodipine in the presence and absence 
of enhancers, such as terpene enhancers and ethanol
56
. S-amlodipine was found to have 
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a higher flux than RS-amlodipine in the transdermal permeation study in vitro. 
However, the difference of amlodipine enantiomers in permeation was not found in the 
absence and presence of enhancers, such as linalool, (-)-menthol, (-)-limonene, and 
ethanol (Figure 1.8), and indicated that there was no enantioselectivity in the permeation 
of amlodipine across rat skin. 
 
Figure 1.8 Chemical structure of a) amlodipine, b) (-) menthol, c) (-) limonene d) linalool and e) ethanol. 
 
Another beta blocker (metoprolol, Figure 1.9) was evaluated by Kommuru et al. as well 
as the influence of chiral permeation enhancers. Kommuru found that the use of 
permeation enhancers was significant to the flux values when the formulation contains 
only one of the enantiomers.57 
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Figure 1.9 Chemical structure of metoprolol. 
 
Flurbiprofen (Figure 1.10) is a chiral anti-inflammatory drug, Valentova et al. observed 
marked differences in the permeation profiles of enantiomers (R)- and (S)-flurbiprofen 
from a donor solution containing racemic (RS)-flurbiprofen.
42
 Cilurzo et al.
58
 found 
that, depending on the vehicle and the use of racemate or enantiomer, the ibuprofen 
fluxes followed the rank order: S-IB vehicled in a saturated solution > S-IB vehicled in a 
plaster  RS-IB vehicled in a plaster > RS-IB vehicled in a saturated solution. 
 
Figure 1.10 Chemical structures of a) flurbiprofen and b) ibuprofen. 
 
A different approach was used by Suedee et al.,
59
 to deliver S-omeprazole (Figure 1.11). 
They developed a pH-responsive drug delivery system for enantioselective delivery of 
racemic drugs. 
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Figure 1.11 Chemical structure of omeprazole (a) S and (b) R, sold under the brand names of Prilosec and 
Losec. 
 
All the above specified structures are molecules with low molecular weight (<500 Da), 
no more than five hydrogen bond donors, no more than ten hydrogen bond acceptors 
and calculated lipophilicity lower than five. That means that these compounds obey to 
the Lipinski’s rule of 5 (note that lipophilicity lower than five is an assumption from 
oral drug delivery observations). Though generally successful, deviations do occur but 
the rule of 5 does identify key physicochemical parameters that are important for 
passive diffusion. 
Whilst the above considers drug molecules, in light of the discussion of NMF, it is of 
interest to explore chirality and delivery of amino acids and their assembly into 
peptides. They initially comply with Lipinski’s rule but, as the size of the peptide 
increases so does the molecular weight and number of hydrogen bond donor/acceptors; 
also, the side chain motifs may add extra properties and finally, naturally occurring 
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amino acids and peptides have an extra feature to their structure in that they are all 
chiral. 
1.4 AMINO ACIDS AND PEPTIDES 
A molecule is termed “chiral” when its mirror image is non-superimposable. Nature has 
a distinct preference for one of these mirror images. Amino acids, for example – the 
building blocks of proteins – are all of the same configuration, with very few 
exceptions. The chemical connection between two amino acids (-CONH-) is called the 
amide or peptide bond, and is generally represented as a single bond yet, it possesses 
characteristics that resemble a double bond due to an electronic resonance effect due to 
the atoms involved being in the same plane. This mesomeric effect is responsible for the 
high stability of the amide bond. The intermediate character “single-double” bond 
results in a shorter bonding length than the one observed in a single bond and 
consequently a significant reduction on the ability to rotate. Rotation is permitted about 
the N-Cα and the Cα-C bonds (Figure 1.12). 
 
Figure 1.12 Illustration of a dipeptide and its dihedral angles. Adapted from Nelson et al.
60
 
 
 
___________________________________________________________Introduction 
 
 
 
31 
 
 
The backbone of a polypeptide chain can be pictured as a series of rigid planes with 
consecutive planes sharing a common point of rotation at Cα. These rigid peptide bonds 
limit the range of conformations that can be assumed by a polypeptide chain. The 
mesomeric effect enables the oxygen and nitrogen atoms to participate in hydrogen 
bonds and this property makes a remarkable contribution to the three-dimensional 
structure of peptides and proteins. By convention, the bond angles resulting from 
rotation at Cα are labelled  for the N-Cα bond and  for the Cα-C bond. 
The specific sequence of amino acids is known as the primary structure of a protein 
(Figure 1.13), and the term secondary structure refers to the local conformation of some 
part of a polypeptide commonly as a sequence of hydrogen bonding between non-
adjacent amino acids. One of the most common secondary structures found in proteins 
is the α-helix because this conformation makes optimal use of internal hydrogen bonds. 
Helices are right or left-handed and so it is usual to refer to chirality of helices in terms 
of P (plus) or M (minus) if the axial chirality is right or left-handed, respectively. 
 
Figure 1.13 Levels of structure in proteins, showing the primary, secondary, tertiary and quaternary 
structures.
60
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The remarkable diversity of protein structure has inspired chemists to design their own 
oligomers which have unique secondary structures. The word “foldamer” was 
introduced in the scientific community in 1998 by Gellman
61
 to describe these 
structures and ever since, it gained an important role in research. 
1.5 DRUG DELIVERY 
In 2008, Prausnitz
62
 elaborated a list of the Food & Drug Administration (FDA) 
approved drugs for passive transdermal delivery and six years later (2014) Guy
63
 
updated that list with two more actives. A total of 17 drugs reflect the difficulty in 
compromising between skin permeability and pharmacological potency.  
Numerous strategies have been explored to overcome the barrier of the SC and expand 
the administration of drugs through the skin including active and passive methods. The 
development of chemical enhancers is broadly reported in the literature and is 
increasingly being refined.
64,65 
In recent years, studies have been conducted reporting 
the use of amino acid derivatives as carriers,
66,67
 as transdermal permeation enhancers,
68
 
and as cell-penetrating peptides (CPP) to enhance topical delivery of proteins and 
peptides.
69,70
 When applied to transdermal systems the common designation of CPP 
becomes SPP (skin-penetrating peptides). In 2006 Chen et al.,
71
 described the delivery 
of insulin through skin using a peptide (11 residues) as facilitator. Kummar et al.,
72
 
identified a 6 residue peptide that altered the lipid organisation of the skin and enhanced 
the delivery of 5-fluoruracil. The same authors showed that peptides can enhance the 
delivery of cyclosporine,
73
 through the skin and also provided some insight on the 
mechanism of action of 5 different peptides as mediators between cyclosporine and 
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keratin. In 2016 Menegatti et al.
74
 developed a computational process for screening 
libraries of peptides to identify SPPs capable of enhancing transdermal delivery of 
cyclosporine. Cyclosporine is a cyclic peptide with a molecular weight over 1200 Da – 
i.e. significantly larger than the upper limit of 500 Da often cited. Gennari and co-
workers,
75
 delivered UFH (unfractioned heparin, Mw 12000-15000 Da), an 
anticoagulant and antithrombotic drug through human skin. The permeability of UFH 
increased about 30-fold after conjugation with a peptide. The molecular weight 
challenge was taken further by Gautam et al.,
76
 they reported the delivery of GFP (green 
fluorescent protein, Mw 26.9 KDa) using a peptide as carrier. 
The field is in expansion and Lipinski’s rule of 5 seems not applicable when 
considering large biomolecules such as peptides, proteins or aptamers. 
1.6 HYPOTHESIS TO BE TESTED. AIMS, OBJECTIVES AND WORK PLAN 
From the above it is clear that further work is merited in terms of disruption of the 
skin’s barrier for drug delivery. A specific aspect that has not received a lot of attention 
is the role of chirality in the permeation process. This project has the ambition of 
making a contribution in this field, by analysing the influence of the physical properties 
of enantiomerically pure compounds and establishing structure-activity relationships. 
The ultimate desire of this study is to obtain foldamers to use as peptidomimetics within 
the realm of therapeutics and even catalysis.
77,78
 
Previous studies in our research group demonstrated that an unnatural five membered 
ring amino acid had high water holding capacity. This observation drove the design of a 
synthetic route to fulfil the premise stated above and the following objectives were set: 
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1. To synthesise a racemic and enantiomerically pure unnatural  amino acid; 
2. Make structural changes to the synthesised  amino acid (derivatising into a 
saturated and a doubly hydroxylated  amino acid) and evaluate the effects of 
these changes; 
3. Build on the molecular weight of the unnatural amino acid into peptic dimers, 
tetramers and hexamers and evaluate the effects of those changes; 
4. To observe if the synthesised oligomers form a helix as a secondary structure; 
5. To characterise all new compounds (structure and physical properties including 
hygroscopicity) and test them for skin uptake. 
 
In order to fulfil the proposed objectives a route to the unnatural amino acid (MMU) 
was designed, as illustrated in Figure 1.14. 
 
Figure 1.14 Synthetic route to achieve the desired unnatural amino acid. 
 
Once the unnatural cyclic unsaturated amino acid was obtained and derivatised into the 
saturated and hydroxylated five membered ring amino acid, three series of peptides 
were generated following the synthetic route shown in Figure 1.15. 
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Figure 1.15 Synthetic route to achieve the desired starting materials to access foldamers. 
 
The resulting dipeptides (4a, 5a and 7a) provided the starting materials to obtain the 
desired oligomers with a repetition of once, twice, three or even four times the dipeptide 
structure. 
The following chapters describe the materials and general methods employed (Chapter 
2), whilst Chapter 3, 4 and 5 provide experimental details, results and discussion of the 
synthesis, characterisation and water uptake of the unnatural amino acids (Chapter 3), 
dipeptides (Chapter 4) and peptides with higher molecular weights (Chapter 5) in their 
racemic and enantiomerically pure forms. Chapter 6 is dedicated to the analysis of the 
water and compound uptake regarding chirality and Chapter 7 includes a general 
discussion of the results obtained. 
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2. MATERIALS AND METHODS 
In this chapter an overview of the equipment, materials and methods used throughout 
this project is provided. Specific details about each method can be found in chapters 3, 4 
and 5. 
2.1 CHEMICALS 
All chemicals were purchased from Sigma Aldrich and Fisher Scientific. A table of all 
chemicals used along this project with batch number, manufacturers, catalogue number 
and purity can be found in Appendix A2. Multiple orders of the same compound were 
made over the time course of this project; where the batch numbers were the same, the 
compound was entered only once. 
2.2 SYNTHESIS 
Classical methods of synthesis were used to obtain the desired compounds. The main 
reactions involved were a [2+2] cycloaddition to assess the main precursor, classic 
peptide chemistry (protection, deprotection and coupling) and an enzymatic resolution 
to assess enantiomerically pure compounds. The synthesis details are discussed in 
chapters 3, 4 and 5. 
2.3 NUCLEAR MAGNETIC RESONANCE (NMR) 
1
H NMR and 
13
C NMR spectra were recorded on a Bruker Nanobay 400 (at 400 MHz 
or 100 MHz) spectrometer in the deuterated solvent stated or a Bruker DPX 400 (at 
400MHz or 100 MHz), 
1
H-
1
H COSY, 
1
H-
13
C HQSC and 
1
H-
13
C HMBC spectra were 
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used for the assignment of the chemical shifts when necessary. A Bruker Avance III 500 
MHz, or on a Bruker Avance III 700 MHz was used to record NOESY, ROESY and 
TOCSY spectra. The field was locked by referencing to the relevant deuteron resonance 
and all characteristic peaks are reported in parts per million (ppm) using the following 
abbreviation for splitting patterns: s (singlet), brs (broad singlet), d (doublet), dd 
(doublet of doublets), ddd (doublet of doublet of doublets), t (triplet), dt (doublet of 
triplets), ddt (doublet of doublet of triplets), q (quartet); m (multiplet). Coupling 
constants (J) are quoted in Hz. 
2.4 INFRA-RED SPECTROSCOPY (IR) 
IR spectra were recorded on a Thermo Scientific Nicolet iS5 FT-IR spectrophotometer 
equipped with a Thermo Scientific iD5 ATR Accessory. A small amount of sample 
(<10 mg) was placed as a solid and the spectra were typically collected between 400 
and 4000 cm
-1
 with a mean of 16 scans recorded at a resolution of 4 cm
-1
. All 
characteristic peaks are reported in wavenumbers (cm
-1
). 
2.5 MASS SPECTROMETRY (MS) 
Mass spectra were recorded on a Thermo Scientific LQT-Orbitrap-XL at 100K 
resolution equipped with a Thermo Scientific Accela LC, with a 2.1x50 mm C18 
column, particle size 1.9 m, pore size 175 Å. The buffers used were typically 
water:acetonitrile (9:1, v/v) both with 0.1% formic acid. Samples were dissolved in 
water or methanol as appropriate and diluted to a final concentration of 30 g/mL and a 
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5 L injection was run. When that failed to deliver results a direct infusion into the 
Orbitrap in positive and negative mode was run. 
2.6 MELTING POINT (MP) 
Melting points were measured on a Stuart SMP10 digital melting point apparatus and 
are compared to literature values when available. 
2.7 CHROMATOGRAPHY (THIN LAYER AND COLUMN) 
Reactions were monitored by thin layer chromatography (TLC) on silica gel pre-coated 
aluminium sheets (TLC Silica Gel 60 F254, Merck). Visualisation, when possible, was 
accomplished by irradiation by UV light at 254 nm and potassium permanganate stain. 
Column chromatography was performed on Merck silica gel (60 Å, 230 - 400 mesh, 40 
- 63 µm). 
2.8 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
An Agilent Technologies 1200 Series HPLC was used, with a ratio of HPLC grade 
hexane:propan-1-ol (95:5, v:v) as eluent, a Chiralpak AD-H column (0.46 cm x 25 cm), 
an injection volume of 5 L at 1 mL/min, 30 min runs and UV detection at 210 nm. 
2.9 X-RAY 
Single-crystal X-ray diffraction data were collected for compounds 2b, MCUH, DCUH 
and DCDH, on an Oxford Diffraction Gemini diffractometer, using Cu K𝛼 incident 
radiation, with the crystal held at a temperature of 150 K using an Oxford Instruments 
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Cryojet device. The crystal structure was solved
79
 and refined
80
 using the Olex2
81
 
system and crystal data are summarised in Tables 1, to 4 respectively (Appendix A3). 
Powder X-ray diffraction data were collected for N-hydroxyglycine on a Bruker D8 
Advance (Cu Kα1, λ = 1.54056 Å) in capillary mode. The data collected was performed 
at room temperature (ca. 293 K) in the rage 3 - 65° 2Θ for a total of 15 minutes. 
DICVOL06
82
 as implemented in DASH
83
 was utilised to index the data to a monoclinic 
cell and the simulated annealing procedure in DASH was employed to solve the crystal 
structure. 
The unit cell and structure solution parameters are given in Tables 5 and 6 (Appendix 
A3). 
2.10 POLARIMETRY 
Specific optical rotations were obtained using a Perkin Elmer Polarimeter 341 with 
reference to the sodium D line (=589 nm) in HPLC grade water or chloroform. The 
results are shown as [𝛼]𝐷
𝑇  in deg.dm
-1
.g
-1
.mL, given by equation 2.1 
[𝛼]
𝑇 =
𝛼
𝑙×𝑐
            Equation 2.1 
Where,  is the measured rotation, l is the path length in dm, 𝑇 is the temperature in ºC 
and c is the concentration in g.mL
-1
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2.11 DYNAMIC VAPOUR SORPTION (DVS) 
The DVS experiments were outsourced to M2M facilities. 
The experiment was carried out using ca. 10-20 mg of material loaded into a DVS 
Advantage System (Surface Measurement Systems, UK) held at 25  0.1°C. The sample 
was then subjected to a step profile from 0% RH to 90% RH
a
 (P/Po, whereby P = Partial 
pressure of water vapour and Po = Equilibrium vapour pressure of water) at 10% RH 
increments; followed by desorption from 90% RH to 0% RH at 10% RH decrements 
maintaining the sample at drying step at 25°C. The weight change during the sorption 
cycle was then monitored, allowing for the hygroscopic nature of the sample to be 
determined. The % RH was maintained by a mixture of DI water and nitrogen (flow rate 
of 200 sccm
b
) which acted as a wet purge and dry purge respectively. The percentage of 
mass change per minute (dm/dt) was set as 0.002 with a dm/dt window set as 5 minutes, 
minimum stability for 10 minutes and maximum stage time was 240 minutes at each % 
RH. The experiment was set with a sampling rate of 1 sec and save data set at 1 min. 
                                                          
 
 
a
 The RH is normally expressed as a percentage; a higher percentage means that the gas (nitrogen)-water 
mixture is more humid. 
b
 Standard cubic centimetres per minute. 
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2.12 CIRCULAR DICHROISM (CD) 
CD spectra were recorded using a Chirascan spectropolarimeter (Applied Photophysics, 
UK). Spectra are presented with absorbance (A) < 2 at any measured point with a 0.5 
nm step, 1 nm bandwidth, and a 1 s collection time per step. The CD signal from the 
background was subtracted from the CD signal of the sample solution. The sample 
solutions were measured using a 0.1 mm quartz plate sample holder with water as the 
background. All CD spectra were measured at 20 ºC, which was controlled by an 
external temperature controller and water reservoir. Results are presented in molar 
ellipticity and it was calculated according to equation 2.2. 
𝜀 =
𝑆𝑎𝑚𝑝𝑙𝑒−𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑
10×𝑐×𝑙
          Equation 2.2 
Where,  is molar ellipticity in deg.cm2.dmol-1, c is concentration in mol.L-1 and l is the 
pathlength in cm. 
2.13 WATER UPTAKE DETERMINATION 
Water uptake was determined using thermogravimetric analysis (TGA) on a TGA Q50 
instrument from TA instruments, UK, with nitrogen purge. The experiments were 
conducted as follows: approximately 10 mg of each compound were kept under a 
controlled environment of 100% RH at 32ºC, over one week. The 100% RH was 
achieved using a desiccator containing water, equipped with a thermo-hygrometer and 
sealed (Figure 2.1). Each experiment was run in triplicate and the results are shown as 
mean  SD. The samples were then heated at a constant rate of 5ºC/min from room 
temperature to 250-300ºC. 
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a)                                     b)            c) 
Figure 2.1 a) Desiccator equipped with a thermo-hygrometer in an incubator at 32ºC. b) Samples at time 
0h. c) Samples with one week exposure to 100% RH. 
 
The curves obtained allowed discrimination between surface water (up to about 100ºC) 
and crystallization water. The weight loss was measured between temperatures varying 
from 110-160ºC (each compound has its interval of temperature for water loss). The 
number of waters, 𝑁𝑤, that bind to the compound is calculated according to the 
following equation: 
𝑁𝑤 =
𝑛𝑤
𝑛𝑐
            Equation 2.3 
Where, 𝑛𝑤 is the number of moles of water and 𝑛𝑐 is the number of moles of 
compound. 
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2.14 SATURATED COMPOUND SOLUTIONS PREPARATION 
Small amounts of compound were added to 1 mL of water. After each addition the 
solution was left stirring at room temperature until complete dissolution of solute. The 
addition was stopped once a visible suspension of the solute was observed. Each 
solution was then filtered and used in the compound uptake studies. The solubility was 
determined using method B described in Section 2.16. 
2.15 STRATUM CORNEUM PREPARATION 
SC was isolated following the classical procedure by Kligman and Christophers.
84
 Pig 
skin samples from the flank were kindly donated by Pirbright Institute and stored at -20 
ºC. When needed, the skin was defrosted and left to equilibrate at room temperature for 
about 2 hours, the bristles were shaved with a razor and the samples were then dipped in 
water at 60ºC for 1 min to allow the separation of the viable epidermis (Figure 2.2) by 
rolling it over itself (or by gentle pushing). The samples were then placed, viable 
epidermis down, in a Petri dish equipped with a bed of filter paper (six filter papers) 
embedded in 0.0001% (w/v) solution of trypsin in 0.5% (w/v) aqueous solution of 
sodium bicarbonate and left to digest overnight in an incubator at 37ºC. The digested 
viable epidermis was gently swabbed with a cotton tip embedded in water. The isolated 
SC was then rinsed with water several times and placed in a desiccator to dry. Once 
dried, the membrane was cut into approximately 2 cm
2
 pieces and used in the compound 
uptake experiments. 
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Figure 2.2 Illustration of the procedure for the SC isolation. 
 
2.16 COMPOUND UPTAKE 
A sample of dried SC was weighed (3-6 mg), dipped into a saturated solution of each 
compound and left at 32ºC, over a 24 hours period. The tissue was then removed, 
blotted dry on a filter paper and dipped into 1 mL of water for 24 hours, at room 
temperature to extract the water soluble compound. A second wash (1 mL of water) was 
done to evaluate residual compound within the SC. The SC was then removed and left 
to dry. 
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2.16.1 ASSESSMENT OF COMPOUND UPTAKE 
Method A - TNBSA 
The resulting solution was freeze dried for 48 h and the solid obtained was dissolved in 
1mL of NaHCO3/Na2CO3 buffer (pH 9.3). Standard solutions of the compound to be 
assessed were prepared ranging from 1.5-100 M in buffer, with increments of 5 M 
for 10-100 M and 0.5 M for 1.5-10 M. 25 L of 0.03 M TNBSA (2,4,6-
trinitrobenzene sulfonic acid) in buffer solution were added to the sample solution, to 
the blank solution (buffer) and to each standard solution. The samples were left reacting 
for 30 minutes and their absorbance was read ( = 420 nm) using a Jenway 7315 
spectrophotometer. The concentration of the sample was determined using the 
calibration curve. 
Method B - LC/MS 
Standard solutions of the compound to were prepared ranging from 3-100 g/mL in 
water. The resulting solutions were analysed by LC/MS (mass spectra were recorded on 
a Bruker micrOTOF-QII with electrospray ionisation (ESI) in positive mode, equipped 
with an Agilent 1100 Series LC with a 150x2.1 mm ACE 5 C18 column, particle size 5 
m, pore size 100 Å. The buffers used were water:acetonitrile (95:5, v/v) both with 
0.1% formic acid for all compounds except TCUU, TCUS and HCUS which was 
water:acetonitrile (90:10, v/v) and OCUS with a ratio of 85:15 (v/v). Samples were run 
with a 10 L injection at 200 L/min) and the concentration of compound determined 
using a calibration curve of the same compound. Each experiment was repeated in 
triplicate and each analysis was run three times. The results are shown as a mean  SD. 
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2.17 MOLECULAR MODELLING 
The dimeric structures were energy minimised using Chemdraw’s Chem3D package. 
The structure that generated the lowest energy was used for the addition of water 
molecules (10 or more water molecules were added to each dimer). Molecular dynamics 
was then performed at 300 K until equilibrium was reached and then the energy 
minimised. 
 
 
 48 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
 
 
 
 
 
 
 
_______________________Synthesis and Water Uptake of Unnatural Amino Acids 
 
 
 
49 
 
 
3. SYNTHESIS AND WATER UPTAKE OF UNNATURAL AMINO ACIDS 
3.1 INTRODUCTION 
This chapter is divided in four sections. The current section gives an overview of the 
final compounds synthesised and their synthetic routes whilst Section 3.2 describes, in 
detail, the synthetic procedures involved in obtaining and confirming the library of 
unnatural amino acids, termed “monomers” herein (Figure 3.1), and their 
characterisation. In this section, the procedures are described for library a (racemic 
library). Section 3.3 discusses the synthetic approaches and the results obtained when 
assessing the water uptake ability of the monomers and finally, Section 3.4 provides 
conclusions and the context for the work described in Chapter 4. Spectral data for the 
described compounds can be found in Appendix A4. 
Schemes 3.1 and 3.2 provide a summary of the structures and synthetic strategies used 
to assess the desired compounds. The structural changes to the  amino acid (reduction 
and hydroxylation) have an impact on the molecule’s lipophilicity/hydrophilicity and it 
is expected that this will have an influence on the properties of the synthesised 
compounds. 
For ease of discussion throughout this thesis, compounds have been coded with a three 
or four letter code (chemical names for each compound are given below, section 3.2.9, 
where the compounds are confirmed through spectroscopic methods) according to the 
following: 
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First letter (for 3 and 4 letters code) – here M – refers to Monomer. In subsequent 
chapters, a Dimer will be denoted as D, Tetramer as T, Hexamer as H and Octamer as 
O. 
Second letter (for 3 letters code) – refers to the number of isomers, therefor M denotes a 
Mixture of the possible isomers; 
Second and third letters (for 4 letters code) – refer to the stereochemistry of the amino 
and acid groups with respect to one another, therefor CD and CU denote the 
stereochemistry of the amine and acid groups (Cis Down and Cis Up). 
Third/fourth letter (3 letters/4 letters code) – refers to the derivatisation on the five 
membered ring. Therefor U denotes Unsaturation (double bond), S denotes Saturation 
(single bonds) and H denotes the presence of Hydroxyl groups (–OH). 
 
Figure 3.1 Summary of the synthesised monomeric structures. 
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For clarity with schemes, the letter “a” refers to mixtures (full and dash bonds, relative 
stereochemistry), the letter “b” denotes enantiomerically pure compound going to the 
back of the plane (dash bonds) and the letter “c” denotes enantiomerically pure 
compound going up the plane (full bonds). The series of compounds a, is drawn using 
relative stereochemistry; they should always be interpreted as a mixture of the possible 
isomers. 
 
 
Scheme 3.1 Synthetic route to obtain monomers MMU, MCUU and MCDU. i) Cycloaddition: CSI, Et2O, 
-20ºC; ii) Lactam ring opening: 10% HCl, r.t.; iii) Ion exchange: Dowex, 2M NH4OH; iv) Enzymatic 
resolution: Lipase, H2O, MTBE. 
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Scheme 3.2 Synthetic route to obtain monomers MMS, MCDS, MCUS, MMH, MCDH and MCUH. i) 
Protection of the amino group: Boc2O, Dioxane, Water, 0ºC; ii) Protection of the acid group: BnOH, 
PyBop, DIPEA, DCM, r.t.; iii) Hydroxylation: OsO4, NMO, Acetone, r.t.; iv) Hydrogenation: H2, Pd/C, 
MeOH; v) Amino group deprotection: TFA, DCM, r.t.; vi) Ion exchange: Dowex, 2M NH4OH, H2O. 
 
Note: In addition to the above depicted compounds, L-Alanine is also included in 
section 3.2 due to its use in Chapter 4 as part of the compounds therein prepared. 
 
3.2 EXPERIMENTAL 
3.2.1 CYCLOADDITION 
Procedure to synthesise 2a. A solution of chlorosulfonyl isocyanate (CSI) (6.46 mL, 
74.0 mmol) in diethyl ether (Et2O) was added dropwise to a solution of freshly doubly 
distilled 1,3-cyclopentadiene (CPD, 1) (8.74 mL, 104 mmol) in dry Et2O (150 mL) at -
20ºC (methanol (MeOH) bath cooled with a cryocooler). After complete addition, the 
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mixture was left stirring for 40 min. The mixture was then slowly poured into a cold 
solution (0ºC, ice bath) of Na2SO3 (7.60 g, 60.8 mmol) in water (100 mL) and 20% 
KOH (100mL). After stirring for 45 min at 0ºC, the organic layer was separated, and the 
aqueous layer extracted with ethyl acetate (EtOAc) (4×150 mL). The combined organic 
layers were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The 
residue was purified by column chromatography (n-hexane: EtOAc, 1:3, Rf = 0.25) to 
afford 7.66 g (95%) of a light yellow oil, compound 2a (white waxy solid when frozen). 
3.2.2 ENZYMATIC RESOLUTION 
Procedure to synthesise 2b and MCUU. Lactam 2a (5.17 g, 47.4 mmol) was dissolved 
in methyl tert-butyl ether (MTBE) (200 mL) and H2O (0.85 mL, 47.4 mmol) was added 
followed by Lipase (10.3 g, 2g/g of substrate) and the mixture was left stirring at room 
temperature. Monitoring of enzymatic activity was carried out by HPLC. After 72 hours 
there was no evidence of the presence of (1R,5S)-6-azabicyclo[3.2.0]hept-3-ene-7-one 
(2c) and the enzyme was filtered and washed with MTBE. The filtrate was concentrated 
under reduced pressure and the product recrystallized from Et2O. A crystalline 
yellowish solid, 2b (2.53 g, 98%) was obtained. The filtered solid was thoroughly 
washed with water to separate the enzyme from the free  amino acid (MCUU). The 
water was eliminated under reduced pressure and the obtained solid was recrystallized 
from water with acetone to afford a light creamy solid, MCUU (2.95 g, 98%). 
3.2.3 LACTAM RING OPENING 
Procedure to synthesise 8a and 8b. A solution of 2a (1.77 g, 12.6 mmol) in 10% HCl 
(20.0 mL) was stirred at room temperature for 2 hours. The mixture was concentrated to 
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dryness, dissolved in the minimum amount of hot ethanol (EtOH) and the product was 
precipitated adding Et2O. The suspension was filtered and dried under suction to afford 
2.53 g (95%) of a white shiny powder (8a). 
3.2.4 PROTECTION OF THE AMINO AND ACID GROUPS 
3.2.4.1 Amino Group Protection 
Procedure to synthesise 3a-c. To a solution of 2-aminocyclopent-3-ene-1-carboxylic acid 
hydrochloride (8a) (0.97 g, 5.91 mmol) in dioxane:water (18.0 mL, 2:1), 1M NaOH was 
added (6.00 mL) at 0ºC. Di-tert-butyl dicarbonate (Boc2O) (1.42 g, 6.50 mmol) was 
then added in portions followed by dropwise addition of 1M NaOH until pH 8-9. The 
mixture was stirred at room temperature for 4 hours. The mixture was then diluted in 
EtOAc (30 mL) and the layers separated. The aqueous layer was acidified with 10% 
HCl until the pH dropped to 3-4 and then extracted with EtOAc. The combined organic 
layers were dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure. A pale-brown solid, 3a, was obtained and recrystallized using EtOAc/Hexane 
(1.27g, 94%) 
3.2.4.2 Acid Group Protection 
Procedure to synthesise 9a-c. N,N-diisopropylethylamine (DIPEA) (1.18 mL, 6.80 
mmol) followed by (benzotriazol-1-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate (PyBop) (1.42 g, 2.72 mmol) were added to a solution of 2-((tert-
butoxycarbonyl)amino)cyclopent-3-ene-1-carboxylic acid, 3a (0.52 g, 2.27 mmol) in 
DCM and left stirring for 15 minutes at room temperature. Benzyl alcohol (BnOH) was 
added (0.24 mL, 2.27 mmol) and the mixture left stirring for 24 hours. Water was added 
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and the layers separated. The organic layer was washed with saturated NaHCO3, H2O 
and 1M HCl in repetitive cycles until almost or complete elimination of 1-
hydroxybenzotriazole (HOBt, a by-product from PyBOP). The organic layer was then 
dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The 
crude was purified by column chromatography (CC) and eluted with Hexane:EtOAc 
(1:1, v/v) to afford 0.46 g (64%), Rf = 0.6 (Hexane:EtOAc, 3:1), of a white solid, 9a. 
3.2.5 HYDROXYLATION 
Procedure to synthesise 10a-c. 0.45g (1.42 mmol) of 9a were dissolved in acetone (10 
mL), N-methylmorpholine N-oxide (NMO) (0.50 g, 4.25 mmol) and OsO4 (0.14 mL, 2.5 
wt% in 
t
BuOH) were added and left stirring at room temperature for 2 hours. The 
reaction was monitored by TLC (product’s Rf = 0.42 in Hexane:EtOAc, 1:3). The 
mixture was filtered over celite and silica and washed with acetone. After reduced 
pressure concentration, the resulting crude was taken into EtOAc and crystallized in 
hexane to obtain 0.32 g (64%) of a white solid, 10a. 
3.2.6 ORTHOGONAL DEPROTECTION OF THE AMINO AND ACID GROUPS 
Procedure to synthesise monomers MMU, MCDU, MMH, MCDH and MCUH 
3.2.6.1 Acid group deprotection 
Benzyl 2-((tert-butoxycarbonyl)amino)cyclopent-3-ene-1-carboxylate, 10a, (0.47 g, 
1.48 mmol) was dissolved in MeOH (10 mL) and Palladium on Carbon (Pd/C) was 
added (catalytic amount). The flask was sealed with a septum and H2 (1 atm) was 
attached in a balloon. The mixture was left stirring at room temperature and controlled 
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by TLC. After 4 hours, the mixture was filtered over celite and silica, concentrated 
under reduced pressure and the resulting crude was used in the next step with no further 
purification. 
3.2.6.2 Amino group deprotection 
Trifluoroacetic acid (TFA) (30.0 eq) was slowly added to a solution of Boc protected 
compound (from previous step – acid group deprotection) in DCM at 0ºC. The mixture 
was left stirring at room temperature for up to 8h. The excess of acid was eliminated 
under reduced pressure and the product precipitated with Et2O. The product was 
analysed by NMR to confirm the absence of the Boc group and then taken to the next 
step. 
3.2.7 ION EXCHANGE 
2-aminocyclopent-3-ene-1-carboxylic acid hydrochloride
c
, 8a, (0.51 g, 3.12 mmol) was 
dissolved in the minimum amount of 0.1M HCl solution and loaded into a column 
packed with Dowex® 50WX8 hydrogen form (previously rinsed with water) and eluted 
with 2M ammonia solution. The column was then rinsed with water to dissolve any 
remaining product. The solvent was eliminated under reduced pressure and the residue 
dissolved in the minimum amount of water. Acetone was added to precipitate the 
product (MMU) as a white solid; after filtration 0.36 g (90%) were obtained. 
                                                          
 
 
c
 For compound MCDU, the starting material was the trifluoroacetate salt. 
_______________________Synthesis and Water Uptake of Unnatural Amino Acids 
 
 
 
57 
 
 
3.2.8 PRECURSORS CHARACTERISATION 
 
6-azabicyclo[3.2.0]hept-3-en-7-one (2a). Yield 95%. 
1
H NMR (400 MHz, CDCl3):  
2.44 (dd, J = 18.0 Hz, J = 10.4 Hz, 1H, H5), 2.71 (dt, J = 18.4 Hz, J = 2.4 Hz, 1H, H5), 
3.82 (d, J = 10.4 Hz, 1H, H1), 4.39-4.45 (m, 1H, H2), 5.83-5.88 (m, 1H, H4), 5.90-5.97 
(m, 1H, H3), 6.94 (br.s, 1H, NH). 
13
C NMR (100 MHz, CDCl3): 30.9 (C5), 53.4 (C1), 
59.4 (C2), 130.9 (C4), 137.2 (C3), 172.5 (C=O). IR (, cm
-1
): 3211, 2975, 2924, 2907, 
2842, 1726, 1602, 1437, 1353, 1315, 1256, 1183, 1128, 1054, 1012. HRMS (ESI, 
MeOH) calculated for C9H9NO: 109.0528, found M+H: 110.0603. 
 
(1S,5R)-6-azabicyclo[3.2.0]hept-3-ene-7-one (2b). Yield 98%. mp 74-76ºC (lit.
85
 76-
77ºC). 
1
H NMR (400 MHz, CDCl3):  2.42 (dd, J = 18.4 Hz, J = 10.4 Hz ,1H, H5), 2.67 
(dt, J = 18.4 Hz, J = 2.4 Hz, 1H, H5), 3.79 (d, J = 10.4 Hz, 1H, H1), 4.47 (s, 1H, H2), 
5.87-5.94 (m, 1H, H4), 5.95-6.02 (m, 1H, H3), 6.64 (br.s, 1H, NH). 
13
C NMR (100 
MHz, CDCl3): 30.9 (C2), 53.3 (C1), 59.4 (C5), 130.7 (C3), 137.1 (C4), 172.6 (C=O). 
HPLC trace: 15 min (
i
PA:Hexane, 5:95, v/v). [𝛂]𝐃
𝟐𝟎  - 31.4, c = 0.01 g.mL-1 in CHCl3 
(lit.
85
 [𝜶]𝐃
𝟐𝟓  - 34.8, c = 0.45, CHCl3). IR (, cm
-1
): 3270, 3057, 2922, 2846, 1725, 1645, 
1552, 1435, 1377, 1349, 1312, 1270, 1228, 1180, 1128, 1087, 1054, 1014. HRMS (ESI, 
MeOH) calculated for C6H7NO: 109.0528, found M
+
: 110.0600. 
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2-aminocyclopent-3-ene-1-carboxylic acid hydrochloride (8a). Yield 95%. mp 165-
168ºC (lit.
86
 178-180ºC). 
1
H NMR (400 MHz, D2O):  2.71-2.85 (m, 2H, H5), 3.54 (q, J 
= 8.4 Hz, 1H, H1), 4.46 (d, J = 7.6 Hz, 1H, H2), 5.83 (dd, J = 8.0 Hz, J = 2.2 Hz, 1H, 
H4), 6.24-6.32 (m, 1H, H3). 
13
C NMR (100 MHz, D2O): 34.2 (C5), 43.5 (C2), 55.9 (C1), 
125.9 (C4), 138.7 (C3), 175.3 (C=O). IR (, cm
-1
): 3331, 3234, 2903, 1703, 1699, 1651, 
1615, 1568, 1488, 1440, 1407, 1378, 1337, 1291, 1260, 1166, 1132, 1113, 1100, 1071, 
1017. HRMS (ESI, H2O) calculated for C9H9NO2: 127.0633, found M+H: 128.0702. 
 
(1S,2R)-2-aminocyclopent-3-ene-1-carboxylic acid hydrochloride (8b). Yield 83%. 
mp 169-171ºC. 
1
H NMR (400 MHz, D2O):  2.64-2.89 (m, 2H, H5), 3.54 (q, J = 8.4 
Hz, 1H, H1), 4.46 (d, J = 7.2 Hz, 1H, H2), 5.77-5.86 (m, 1H, H4), 6.26 (t, J = 2.8 Hz, 
1H, H3). 
13
C NMR (100 MHz, D2O): 34.2 (C5), 43.5 (C1), 55.9 (C2), 125.9 (C4), 138.7 
(C3), 175.3 (C=O). [𝜶]𝑫
𝟐𝟎  - 80.6, c = 0.01 g.mL-1 in H2O (lit.
85
 [𝜶]𝐃
𝟐𝟓  - 80.2, c = 0.30, 
H2O). IR (, cm
-1
): 3351, 2974, 2936, 2898, 1798, 1739, 1711, 1686, 1517, 1443, 1388, 
1364, 1342, 1326, 1274, 1241, 1166, 1065, 1039, 1022, 1011. HRMS (ESI, H2O) 
calculated for C6H10NO2: 127.0633, found M+H: 128.0706. 
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2-((tert-butoxycarbonyl)amino)cyclopent-3-ene-1-carboxylic acid (3a). Yield 94%. 
mp 107-114ºC (lit.
86
134-137ºC). 
1
H NMR (400 MHz, DMSO):  1.35 (s, 9H, H7), 
2.25-2.36 (m, 1H, H5), 2.65-2.75 (m, 1H, H5), 3.14 (q, J = 8.0, 1H, H1), 4.79-4.87 (m, 
1H,H2), 5.52 (d, J = 3.1, 1H, H3), 5.80-5.86 (m, 1H, H4), 6.61 (d, J = 9.5, 1H, NH), 
12.02 (s, 1H, COOH). 
13
C NMR (100 MHz, DMSO): 28.3 (3xC7), 33.5 (C5), 46.2 (C2), 
56.7 (C1), 77.6 (C6)), 129.7 (C4), 132.6 (C3), 154.7 (C=O, NHCO), 173.4 (C=O). IR (, 
cm
-1
): 3301, 2977, 2522, 1708, 1699, 1682, 1651, 1644, 1634, 1475, 1450, 1397, 1366, 
1284, 1241, 1233, 1208, 1160, 1126, 1107, 1041, 1024. HRMS (ESI, MeOH) 
calculated for C11H17NO4: 227.1158, found M+Na: 250.1050. 
 
(1S,2R)-2-((tert-butoxycarbonyl)amino)cyclopent-3-ene-1-carboxylic acid (3b). 
Yield 95%. mp 128-132ºC. 
1
H NMR (400 MHz, DMSO):  1.32 (s, 9H, H7), 2.15-2.39 
(m, 1H, H5), 2.62-2.83 (m, 1H, H5), 3.29 (q, J = 8.4 Hz, 1H, H1), 4.96 (t, J = 8.8 Hz, 1H, 
H2), 5.46-5.63 (m, 1H, H3), 5.78-5.92 (m, 1H, H4), 7.02 (d, J = 9.6 Hz, 1H, NH), 12.03 
(s, 1H, COOH). 
13
C NMR (100 MHz, DMSO): 28.1 (C7), 33.5 (C5), 47.3 (C2), 56.7 
(C1), 77.6 (C6), 129.7 (C4), 132.6 (C3), 154.7 (C=O, NHCO), 173.4 (C=O). [𝜶]𝑫
𝟐𝟎  - 
42.0, c = 0.01 g.mL
-1
 in CHCl3. IR (, cm
-1
): 3351, 3071, 2975, 2936, 2998, 2839, 
2160, 1798, 1739, 1687, 1516, 1466, 1443, 1387, 1364, 1342, 1325, 1274, 1241, 1165, 
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1064, 1039, 1021, 1011. HRMS (ESI, MeOH) calculated for C11H17NO4: 227.1158, 
found M+Na: 250.1048. 
 
(1R,2S)-2-((tert-butoxycarbonyl)amino)cyclopent-3-ene-1-carboxylic acid (3c). 
Yield 93%. mp 146-150ºC. 
1
H NMR (400 MHz, DMSO):  1.36 (s, 9H, H7), 2.26-2.37 
(m, 1H, H5, anti), 3.63-2.77 (m, 1H, H5, syn), 3.08-3.19 (m, 1H, H1), 4.77-4.89 (m, 1H, 
H2), 5.47-5.59 (d, J = 3.2 Hz, 1H, H3), 5.78-5.88 (m, 1H, H2), 6.61 (d, J = 9.6 Hz, 1H, 
NH), 12.02 (s, 1H, COOH). 
13
C NMR (100 MHz, DMSO): 28.3 (3xC7), 33.5 (C5), 46.2 
(C2), 56.7 (C1), 77.6 (C6), 129.8 (C4), 132.6 (C3), 154.8 (C=O, NHCO), 173.4 (C=O). 
[𝜶]𝑫
𝟐𝟎  + 109, c = 0.01 g.mL-1 in CHCl3. IR (, cm
-1
): 3345, 2974, 2928, 1732, 1687, 
1645, 1515, 1449, 1390, 1365, 1332, 1313, 1285, 1241, 1210, 1164, 1046, 1025. 
HRMS (ESI, MeOH) calculated for C11H17NO4: 227.1158, found M+Na: 250.1048. 
 
Benzyl 2-((tert-butoxycarbonyl)amino)-3-ene-1-carboxylate (9a). Yield 56%, Rf 
0.60 (Hex:EtOAc, 3:1). 
1
H NMR (400 MHz, CDCl3):  1.41 (s, 9H, H7), 2.45-2.55 (m, 
1H, H5), 2.77-2.88 (m, 1H, H5), 3.32-3.48 (m, 1H, H1), 4.71 (d, J = 9.2 Hz, 1H, NH), 
4.98 (d, J = 12.4 Hz, 1H, H8), 5.04-5.16 (m, 1H, H2), 5.22 (d, J = 12.4 Hz, 1H, H8), 
5.56-5.69 (m, 1H,H4), 5.84-5.96 (m, 1H, H3), 7.30-7.44 (m, 5H, H9).
 13
C NMR (100 
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MHz, CDCl3): 28.5 (C7), 34.6 (C5), 46.3 (C1), 57.8 (C2), 66.8 (C8), 79.6 (C6), 128.3 
(C7), 128.4 (C9), 128.7 (C9) 130.1 (C4), 133.2 (C3), 155.0 (C=O, NHCO), 173.1 (C=O). 
IR (, cm-1): 3365, 2919, 2850, 1719, 1703, 1498, 1453, 1390, 1365, 1356, 1333, 1287, 
1250, 1155, 1070, 1047, 1025. HRMS (ESI, MeOH) calculated for C18H23NO4: 
317.1627, found M+Na: 340.1515. 
 
Benzyl (1S,2R)-2-((tert-butoxycarbonyl)amino)cyclopent-3-ene-1-carboxylate (9b). 
Yield 94%. Rf 0.60 (Hex:EtOAc, 3:1). 
1
H NMR (400 MHz, CDCl3):  1.41 (s, 9H, H7), 
2.42-2.57 (m, 1H, H5), 2.73-2.91 (m, 1H, H5), 3.40 (q, J = 8.0 Hz, 1H, H1), 4.70 (d, J = 
8.4 Hz, 1H, NH), 4.98 (d, J = 12.4 Hz, 1H, H8), 5.03-5.14 (m, 1H, H2), 5.22 (d, J = 12.4, 
1H, H8), 5.57-5.67 (m, 1H,H4), 5.85-5.95 (m, 1H, H3), 7.28-7.43 (m, 5H, H9). 
13
C NMR 
(100 MHz, CDCl3): 28.5 (C7), 34.6 (C5), 46.3 (C1), 57.8 (C2), 66.8 (C8), 79.6 (C6), 128.3 
(C9), 128.4 (C9), 128.7 (C9) 130.0 (C9), 133.2 (C4), 135.9 (C3), 155.0 (C=O, NHCO), 
173.2 (C=O). IR (, cm-1): 3367, 2972, 1704, 1618, 1497, 1454, 1309, 1365, 1355, 
1333, 1287, 1248, 1153, 1046, 1025. HRMS (ESI, MeOH) calculated for C18H23NO4: 
317.1627, found M+Na: 340.1510. 
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Benzyl (1R,2S)-2-((tert-butoxycarbonyl)amino)cyclopent-3-ene-1-carboxylate (9c). 
Yield 67%. Rf 0.60 (Hex:EtOAc, 3:1). mp 200-208ºC. 
1
H NMR (400 MHz, CDCl3):  
1.41 (s, 9H, H8), 2.47-2.54 (m, 1H, H5anti), 2.78-2.86 (m, 1H, H5syn), 3.37-3.43 (m, 1H, 
H1), 4.71 (d, J = 9.2 Hz, 1H, NH), 4.98 (d, J=12.4, 1H, H8), 5.07-5.14 (m, 1H, H2), 5.21 
(d, J = 12.4 Hz, 1H, H8), 5.61-5.64 (m, 1H, H4), 5.88-5.91 (m, 1H, H3), 7.33-7.39 (m, 
5H, H9).
 13
C NMR (100 MHz, CDCl3): 28.5 (C7), 34.6 (C5), 46.3 (C1), 57.8 (C2), 66.8 
(C8), 79.6 (C6), 128.4 (C9), 128.7 (C9) 130.0 (C9), 133.2 (C4), 135.9 (C3), 155.0 (C=O, 
NHCO), 173.2 (C=O). [𝜶]𝑫
𝟐𝟎  + 32.8, c = 0.01 g.mL-1 in CHCl3. IR (, cm
-1
): 3366, 
2975, 1709, 1495, 1454, 1389, 1365, 1352, 1238, 1153, 1045, 1024. HRMS (ESI, 
MeOH) calculated for C18H23NO4: 317.1627, found M+Na: 340.1522. 
 
Benzyl 2-((tert-butoxycarbonyl)amino)-3,4-dihydroxycyclopentane-1-carboxylate 
(10a). Yield 65%. mp 182-187ºC. 
1
H NMR (400 MHz, CDCl3):  1.42 (s, 9H, H7), 
1.53-1.74 (br.s, 1H, OH), 2.01-2.30 (m, 2H, H5), 2.80 (br.s, 1H, OH), 3.23-3.49 (m, 1H, 
H1), 3.92-4.06 (m, 1H, H4), 4.09-4.34 (m, 2H, H3 and H2), 5.14 (s, 2H, H8), 5.51 (br.s, 
1H, NH), 7.29-7.41 (m, 5H, H9).
 13
C NMR (100 MHz, CDCl3): 28.4 (C7), 34.1 (C5), 
41.8 (C1), 56.9 (C4), 67.1 (C8), 70.2 (C3), 80.7 (C2), 84.5 (C6), 128.4 (C9), 128.8 (C9), 
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156.1 (C=O, NHCO), 174.2 (C=O). IR (, cm-1): 3412, 3351, 2980, 2928, 1718, 1679, 
1518, 1456, 1402, 1392, 1363, 1322, 1283, 1239, 1216, 1195, 1178, 1162, 1109, 1080, 
1063, 1047, 1021. HRMS (ESI, MeOH) calculated for C18H25NO6: 351.1682, found 
M+Na: 374.1575. 
 
Benzyl (1S,2S,3R,4S)-2-((tert-butoxycarbonyl)amino)-3,4.dihydroxycyclopentane-
1-carboxylate (10b). Yield 90%. mp 181-189ºC. 
1
H NMR (400 MHz, CDCl3):  1.42 
(s, 9H, H7), 1.68 (br.s, 2H, OH), 2.10 (dd, J = 14.0 Hz, J = 9.6 Hz, 1H, H5), 2.22 (dt, J = 
14.4 Hz, J = 5.6 Hz 1H, H5), 3.35 (td, J = 8.8 Hz, J = 6.4 Hz, 1H, H1), 4.00 (dd, J = 8.8 
Hz, J = 4.8 Hz m, 1H, H4), 4.08-4.25 (m, 2H, H3 and H2), 5.14 (s, 2H, H8), 5.50 (br.s, 
1H, NH), 7.29-7.43 (m, 5H, H9).
 13
C NMR (100 MHz, CDCl3): 28.4 (C7), 33.9 (C5), 
42.0 (C1), 56.9 (C4), 67.1 (C8), 70.2 (C3), 79.0 (C2), 80.6 (C6), 128.2 (C9), 128.4 (C9), 
128.7 (C9), 128.8 (C9), 153.2 (C=O, NHCO), 174.2 (C=O). IR (, cm
-1
): 3408, 3350, 
2980, 2929, 1719, 1681, 1515, 1455, 1391, 1364, 1319, 1283, 1239, 1216, 1195, 1161, 
1112, 1089, 1045, 1021. HRMS (ESI, MeOH) calculated for C18H25NO6: 351.1682, 
found M+Na: 374.1564. 
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Benzyl (1R,2R,3S,4R)-2-((tert-butoxycarbonyl)amino)-3,4-dihydroxycyclopentane-
1-carboxylate (10c). Yield 90%. mp 183-190ºC. 
1
H NMR (400 MHz, CDCl3):  1.43 
(s, 9H, H7), 2.0 (dd, J = 14.8 Hz, J = 9.2 Hz, 1H, H5), 2.24 (dt, J = 14.8 Hz, J = 6.0 Hz, 
1H, H5), 2.73 (br.s, 1H, OH), 3.35 (td, J = 9.2 Hz, J = 6.4 Hz, 1H, H1), 4.00 (dd, J = 8.4 
Hz, J = 4.8 Hz, 1H, H4), 4.15-4.21 (m, 3H, H3, H2 and OH), 5.14 (s, 2H, H8), 5.52 (br.s, 
1H, NH), 7.33-7.38 (m, 5H, H9).
 13
C NMR (100 MHz, CDCl3): 28.4 (C7), 33.5 (C5), 
41.8 (C1), 56.7 (C4), 66.9 (C8), 70.1 (C3), 78.9 (C2), 128.4 (C9), 173.8 (C=O). IR (, cm
-
1
): 3349, 2980, 2928, 1719, 1681, 1517, 1457, 1391, 1363, 1319, 1284, 1239, 1216, 
1197, 1175, 1162, 1113, 1089, 1062, 1045, 1021. HRMS (ESI, MeOH) calculated for 
C18H25NO6: 351.1682, found M+Na: 374.1564. 
 
3.2.9 MONOMERS CHARACTERISATION 
 
2-aminocyclopent-3-ene-1-carboxylic acid (MMU). Yield 91%. mp 160-165ºC. 
1
H 
NMR (400 MHz, D2O):  2.59 (ddd, J = 17.2 Hz, J = 8.4 Hz, J = 2.0 Hz, 1H, H5), 2.73 
(ddt, J = 17.2 Hz, J = 8.8 Hz, J = 2.0 Hz, 1H, H5), 3.29 (q, J = 8.4 Hz, 1H, H1), 4.25-
4.36 (m, 1H, H2), 5.75-5.89 (m, 1H, H4), 6.16-6.34 (m, 1H, H3). 
13
C NMR (100 MHz, 
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D2O): 34.9 (C5), 45.6 (C1), 56.0 (C2), 126.4 (C4), 139.3 (C3), 179.4 (C=O). IR (, cm
-1
): 
2850, 2686, 2589, 2164, 1615, 1591, 1562, 1458, 1370, 1335, 1274, 1251, 1177, 1150, 
1088, 1097, 1022. HRMS (ESI, H2O) calculated for C6H9NO2: 127.0633, found M+Na: 
150.0524. 
 
(1S,2R)-aminocyclopent-3-ene-1-carboxylic acid (MCDU). Yield 85%. mp 173-
175ºC. 
1
H NMR (400 MHz, D2O):  2.59 (ddd, J = 17.2 Hz, J = 8.0 Hz, J = 2.0 Hz, 1H, 
H5), 2.72 (ddt, J = 17.2 Hz, J = 9.2 Hz, J = 2.0 Hz, 1H, H5), 3.29 (q, J = 8.4 Hz, 1H, 
H1), 4.30 (d, J = 7.6 Hz, 1H, H2), 5.82 (dd, J = 6.0 Hz, J = 2.4 Hz, 1H, H4), 6.26 (t, J = 
2.8 Hz, 1H, H3). 
13
C NMR (100 MHz, D2O): 35.0 (C5), 45.5 (C1), 56.3 (C2), 126.3 (C4), 
139.3 (C3), 179.4 (C=O). [𝜶]𝑫
𝟐𝟎  - 77.3, c = 0.01 g.mL-1in H2O. IR (, cm
-1
): 3144, 
2851, 2112, 1975, 1610, 1557, 1442, 1385, 1340, 1294, 1268, 1183, 1135, 1071, 1022, 
1007. HRMS (ESI, H2O) calculated for C6H9NO2: 127.0633, found M+H: 128.0706. 
 
(1R,2S)-2-aminocyclopent-3-ene-1-carboxylic acid (MCUU). Yield 98%. mp 207-
210ºC, (lit.
85
 > 240ºC). 
1
H NMR (400 MHz, D2O):  2.59 (ddd, J = 17.2 Hz, J = 8.0 Hz, 
J = 2.0 Hz, 1H, H5), 2.73 (ddt, J = 17.2 Hz, J = 9.2 Hz, J = 2.4 Hz, 1H, H5), 3.29 (q, J = 
8.4 Hz, 1H, H1), 4.30 (d, J = 7.6 Hz, 1H, H2), 5.82 (dd, J = 6.0 Hz, J = 2.0 Hz, 1H, H4), 
6.26 (t, J = 2.8 Hz, 1H, H3). 
13
C NMR (100 MHz, D2O): 34.9 (C5), 45.7 (C1), 56.1 (C2), 
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126.4 (C4), 139.2 (C3), 179.5 (C=O). [𝜶]𝑫
𝟐𝟎  + 95.0, c = 0.01 g.mL-1 in H2O (lit.
85
 [𝛼]𝐷
25  
+ 96.7, c = 0.30 in H2O). IR (, cm
-1
): 2594, 2160, 1593, 1562, 1459, 1370, 1335, 1275, 
1178, 1150, 1087, 1022. HRMS (ESI, H2O) calculated for C6H9NO2: 127.0633, found 
M+H: 128.0703. 
 
2-aminocyclopentane-1-carboxylic acid (MMS). Yield 70%. mp 204-210ºC. 
1
H 
NMR (400 MHz, D2O):  1.55-189 (m, 4H, H5 and H4), 1.90-2.17 (m, 2H, H3), 2.80 (q, 
J = 6.8 Hz, 1H, H1), 3.56-3.81 (m, 1H, H2). 
13
C NMR (100 MHz, D2O): 21.2 (C4), 27.9 
(C3), 29.4 (C5), 47.6 (C1), 52.9 (C2), 180.9 (C=O). IR (, cm
-1
): 2914, 2657, 2160, 1621, 
1573, 1504, 1459, 1436, 1409, 1385, 1336, 1310, 1197, 1180, 1122, 1073. HRMS (ESI, 
H2O) calculated for C6H11NO2: 129.0790, found M+H: 130.0860. 
 
(1S,2R)-2-aminocyclopentane-1-carboxylic acid (MCDS). Yield 95%, over three 
steps. mp 209-213ºC. 
1
H NMR (400 MHz, D2O):  1.62-1.89 (m, 4H, H3 H5 and 2xH4), 
1.96-2.15 (m, 2H, H3 and H5), 2.84 (ddd, J = 16.8 Hz, J = 8.4 Hz, J = 6.4 Hz, 1H, H1), 
3.70 (ddd, J = 13.6 Hz, J = 6.8 Hz, J = 4.8 Hz, 1H, H2). 
13
C NMR (100 MHz, D2O): 
21.2 (C4), 27.9 (C3), 29.4 (C5), 47.5 (C1), 52.9 (C2), 180.9 (C=O). IR (, cm
-1
): 2934, 
2195, 1644, 1520, 1463, 1438, 1407, 1377, 1333, 1319, 1305, 1287, 1208, 1165, 1114, 
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1071, 1025, 1006. HRMS (ESI, H2O) calculated for C6H9NO2: 129.0790, found M+H: 
130.0860. 
 
(1R,2S)-2-aminocyclopentane-1-carboxylic acid (MCUS). Yield 99%. mp 203-
206ºC. 
1
H NMR (400 MHz, D2O):  1.57-1.90 (m, 4H, H3, H5 and 2xH4), 1.96-2.14 (m, 
2H, H3 and H5), 2.84 (q, J = 6.8 Hz, 1H, H1), 3.70 (q, J = 6.4 Hz, 1H, H2). 
13
C NMR 
(100 MHz, D2O): 21.2 (C4),27.9 (C3), 29.4 (C5), 47.6 (C1), 52.9 (C2), 180.9 (C=O). IR 
(, cm-1): 2936, 2361, 2182, 2169, 2142, 2047, 2027, 2019, 2001, 1968, 1957, 1942, 
1540, 1463, 1438, 1410, 1377, 1333, 1319, 1305, 1287, 1165, 1114, 1071. HRMS (ESI, 
H2O) calculated for C6H11NO2: 129.0790, found M+H: 130.0860. 
 
2-amino-3,4-dihydroxycyclopentane-1-carboxylic acid (MMH). Yield 62%, over 3 
steps. mp 203-207ºC. (lit.
87
 230-232ºC). 
1
H NMR (400 MHz, D2O):  2.12 (ddd, J = 
14.8 Hz, J = 9.6 Hz, J = 2.0 Hz, 1H, H5), 2.20 (dt, J = 14.8 Hz, J = 6.0 Hz, 1H, H5), 
3.09 (dt, J = 15.6 Hz, J = 6.4 Hz, 1H, H1), 3.57 (t, J = 9.2 Hz, 1H, H2), 4.15 (td, J = 5.2 
Hz, J = 2.4 Hz, 1H, H4), 4.19 (dd, J = 8.8 Hz, J = 4.8 Hz, 1H, H3).
 13
C NMR (100 MHz, 
CDCl3): 34.7 (C5), 40.5 (C1), 55.0 (C2), 69.5 (C4), 75.0 (C3), 180.2 (C=O). IR (, cm
-
1
):3302, 3209, 3074, 2862, 1644, 1570, 1484, 1391, 1374, 1355, 1324, 1302, 1248, 
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1226, 1158, 1141, 1114, 1079, 1026. HRMS (ESI, H2O) calculated for C6H11NO4: 
161.0688, found M+H: 162.0759. 
 
(1S,2S,3R,4S)-2-amino-3,4-dihydroxycyclopentane-1-carboxylic acid (MCDH). 
Yield 95%, over 3 steps. mp 192-196ºC. 
1
H NMR (400 MHz, D2O):  2.14 (ddd, J = 
12.0 Hz, J = 9.6 Hz, J = 2.4 Hz, 1H, H5), 2.22 (dt, J = 11.6 Hz, J = 6.0 Hz, 1H, H5), 
3.11 (dt, J = 9.2 Hz, J = 6.4 Hz, 1H, H1), 3.60 (t, J = 8.8 Hz, 1H, H2), 4.17 (td, J = 5.6 
Hz, J = 2.4 Hz, 1H, H4), 4.21 (dd, J = 9.2 Hz, J = 5.2 Hz, 1H, H3).
 13
C NMR (100 MHz, 
CDCl3): 35.0 (C5), 40.3 (C1), 55.1 (C2), 69.7 (C4), 75.1 (C3), 180.4 (C=O). [𝜶]𝑫
𝟐𝟎  + 
87.6, c = 0.01 g.mL
-1
 in H2O. IR (, cm
-1
): 2188, 2160, 2031, 1972, 1605, 1505, 1397, 
1354, 1311, 1178, 1104. HRMS (ESI, H2O) calculated for C6H11NO4: 161.0688, found 
M+H: 162.0759. 
 
(1R,2R,3S,4R)-2-amino-3,4-dihydroxycyclopentane-1-carboxylic acid (MCUH). 
Yield 91%, over 3 steps. mp 197-200ºC. 
1
H NMR (400 MHz, D2O):  2.14 (ddd, J = 
14.8 Hz, J = 9.6 Hz, J = 2.4 Hz, 1H, H5), 2.22 (dt, J = 15.2 Hz, J = 6.0 Hz, 1H, H5), 
3.11 (dt, J = 15.6 Hz, J = 6.4 Hz, 1H, H1), 3.57 (t, J = 8.8 Hz, 1H, H2), 4.17 (td, J = 5.2 
Hz, J = 2.4 Hz, 1H, H4), 4.21 (dd, J = 9.2 Hz, J = 4.8 Hz, 1H, H3).
 13
C NMR (100 MHz, 
CDCl3): 34.8 (C5), 40.5 (C1), 55.0 (C2), 69.5 (C4), 75.0 (C3), 180.2 (C=O). [𝜶]𝑫
𝟐𝟎  - 104, 
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c = 0.01 g.mL
-1
 in H2O. IR (, cm
-1
): 2189, 2150, 2136, 2066, 2036, 1607, 1506, 1396, 
1355, 1311, 1178, 1125. HRMS (ESI, H2O) calculated for C6H11NO4: 161.0688, found 
M+H: 162.0759. 
 
L-alanine (L-Ala): L-Alanine was synthesised via hydrogenation from commercially 
available L-Alanine OBn. Yield 90%. mp 220-223ºC. 
1
H NMR (400 MHz, D2O):  
1.44 (d, J = 7.2 Hz, 3H, H1), 3.75 (q, J = 7.2 Hz, 1H, H2). 
13
C NMR (100 MHz, D2O): 
16.2 (C1), 50.5 (C2), 175.8 (C=O). IR (, cm
-1
): 3037, 2807, 2600, 1759, 1615, 1588, 
1519, 1453, 1408, 1360, 1305, 1236, 1151, 1113, 1013. HRMS (ESI, H2O) calculated 
for C3H7NO2: 89.0940, found M+H: 90.0545. 
 
3.3 RESULTS AND DISCUSSION 
3.3.1 SYNTHESIS OF THE UNSATURATED, SATURATED AND HYDROXYLATED 
MONOMERS AS A MIXTURE OF TWO ENANTIOMERS. 
The unnatural  amino acids were synthesised according to the synthetic route described 
in this section. The key amino acid 8a (Scheme 3.3) was obtained via a cycloaddition 
followed by acid hydrolysis of lactam 2a. 
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Scheme 3.3 Synthetic route to obtain precursor 8a. i) CSI, Et2O, -20ºC; ii) 10% HCl, r.t. 
 
Compound 2a was synthesised adding CPD to an isocyanate. It has been reported that 
this reaction’s yield is solvent dependent and the product is reaction time and 
temperature dependent.
88,89
 At room temperature its product is the well-known 
compound “Vince lactam” used in the synthesis of antiviral drugs.90,91 The 
thermodynamic control of this reaction, at -20ºC, leads to a [2+2] cycloaddition 
resulting from the formation of two new  bonds from a pair of electrons of a  bond 
from the diene (CPD) and another pair from a  bond from the dienophile (CSI) 
according to the mechanism illustrated in Figure 3.2. 
 
Figure 3.2 Proposed mechanism for the formation of compound 2a. 
 
Two pairs of enantiomers, with cis conformation are formed, compound 2a and 2% 
(calculated by 
1
H NMR) of the constitutional isomer 2a’ (Figure 3.3), when the best 
reaction conditions are achieved. The retention factor of both compounds is very 
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similar, and the last fractions of the purification procedure are a mixture of both 
compounds. Figure 3.4 shows the 
1
H NMR spectrum of the unseparated mixture. The 
highlighted peaks indicate the NMR shifts for the minority compound. The double bond 
lower field shifts (6.6 and 6.7 ppm) for compound 2a’ can be explained by its proximity 
to a more electronegative atom than in the majority compound (2a). 
 
 
Figure 3.3 Structure of the cycloaddition reaction products. 
 
Theoretically, there is a 50% chance for both products to form but, in fact, this does not 
happen. This could be explained by the higher stability of the major product in 
detriment to the stability of 2a’. 
This reaction is described in the literature with a 40-60% yield but, when the reaction 
conditions were optimized, the yield improved to 95%. Fresh doubly-distilled CPD, 
controlled temperature (-20ºC, MeOH bath cooled with a cryocooler), an amber round 
bottom flask and dropwise addition of CSI were the best reaction conditions found, as 
well as a slight change in the workup to maximize the yield. Durst and O’Sullivan92 
investigated the reduction of N-Chlorosulfonyl -lactams with sodium sulfite and 
Benedek et al.
87
 report the workup as treating the reaction mixture with an aqueous 
solution of Na2SO3 and pH adjustment to 8-9 with 15% KOH solution in water. 
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Figure 3.4 
1
H NMR spectrum of the unseparated mixture of the products from the cycloaddition reaction. 
 
The expected results were not obtained. It was theorised that the neutralization of the 
chlorosulfuric acid (𝑝𝐾𝑎(𝐻𝑆𝑂3𝐶𝑙)-6.0) from the leaving group wasn’t very successful 
and the corresponding amino acid was formed and lost to the aqueous layer during 
workup. This observation led to a change in the workup. Based on a theoretical study,
93
 
the ring opening of a lactam is less favoured in alkaline conditions and so, treating the 
reactional mixture simultaneously with both aqueous solutions (increasing the alkaline 
power of the aqueous layer), led to a shorter and more efficient workup. A yield of 95 % 
was achieved when scaling up the reaction. 
Compound 8a was generated by acidic hydrolysis of 2a (Scheme 3.3), according to the 
mechanism shown in Figure 3.5, and isolated by precipitation with Et2O from EtOH. In 
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the literature,
87
 concentrated HCl is used and a 74% yield is achieved, the reproduction 
of this procedure gave a brownish solid with variable yield (50-80%). A 10% HCl 
solution gave higher yields (80-95%) and a cleaner product. 
 
Figure 3.5 Proposed mechanism for the acidic lactam ring opening. 
 
Hydrochloride 8a was converted into the free  amino acid MMU with an ion exchange 
resin, scheme 3.4. The hydrochloride was loaded into a column packed with Dowex 
hydrogen form and neutralised to the corresponding salt with 2M NH4OH aqueous 
solution. The column was then rinsed with water to recover the free amino acid. 
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Scheme 3.4 Hydrochloride neutralisation followed by ion exchange. i) Dowex, 2M NH4OH, H2O. 
 
Compound MMU gave the starting material to obtain the saturated compound MMS 
via hydrogenation at atmospheric pressure with Pd/C catalyst as depicted in Scheme 3.5 
following the mechanism illustrated in Figure 3.6. 
 
Scheme 3.5 Hydrogenation reaction. i) H2, Pd/C, MeOH. 
 
Hydrogen and the alkene attach to the catalyst surface and two hydrogen atoms are 
added to the same face of the double bond (syn addition) and the saturated alkane is 
released from the catalyst surface. 
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Figure 3.6 Postulated mechanism for the olefin hydrogenation. 
 
Scheme 3.6 illustrates the steps followed to obtain the hydroxylated derivative MMH. 
 
 
Scheme 3.6 Synthetic route to obtain compound MMH. i) Boc2O, 1M NaOH, Dioxane:H2O; ii) BnOH, 
Pybop, DIPEA, DCM; iii) OsO4, NMO, Acetone; iv) H2, Pd/C, MeOH; v) TFA, DCM, vi) Dowex, 2M 
NH4OH, H2O. 
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N-Boc protection of amino groups and O-Bn protection of carboxylic acid groups is a 
common strategy in solution phase peptide synthesis because they are orthogonal 
protecting groups and easily allow access to free acid or amino groups for further 
coupling. Treating 8a with NaOH and Boc2O led to compound 3a according to the 
mechanism shown in Figure 3.7. 
 
 
Figure 3.7 Proposed mechanism for the amino group protection. 
 
The lone pair in the nitrogen attacks one of the carbonyl groups of Boc2O adding the 
Boc group. The protonated amine is deprotonated in alkaline conditions and the final 
product is formed. 
The first attempt to couple 3a and BnOH was made via a Steglich esterification using 
dicyclohexylcarbodiimide (DCC) and 4-(dimethylamino)pyridine (DMAP). The 
synthesis was successful but with a low yield (20%). Furthermore, DCC has a side 
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product that is difficult to remove (dicyclohexylurea - DCU). Compound 9a was 
synthesised using a coupling agent (benzotriazol-1-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate – PyBop) according to the mechanism illustrated in Figure 3.8. 
PyBop has long been used in peptide synthesis and it was first reported as a substituent 
for Bop coupling agents due to its lower reaction times, lower toxicity and low 
racemization effects.
94
 The carboxylic acid is activated to a better leaving group with 
PyBop and the esterification occurs in higher yields (64%) than with DCC coupling 
agent. 
 
Figure 3.8 Proposed mechanism for the acid group protection. 
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Finally, an Upjohn dihydroxylation was performed to access the hydroxylated 
derivative (MMH). Compound 10a was oxidised with OsO4 (catalytic amount) as 
oxidant and NMO as co-oxidant
95
 (Figure 3.9). This reaction gives access to a cis diol 
preserving the desired “enantiopure character” of these compounds as the bulk of the 
osmium complex results in dihydroxylation from the least hindered face. 
 
 
Figure 3.9 Catalytic cycle for the Upjohn dihydroxylation. 
 
To obtain the final compound, 10a was orthogonally deprotected in two steps. The 
benzyl group was eliminated via catalytic hydrogenation (Figure 3.10) and the Boc 
group was cleaved (Figure 3.11) resulting in a TFA salt derivative. The tert-butyl 
carbamate is protonated and the loss of tert-butyl cation results in carbamic acid that 
decarboxylates resulting in the free amine. Under acidic conditions the amine protonates 
to give the final product as a TFA salt.
 1
H NMR analysis was run to confirm the 
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removal of the benzyl peaks in the aromatic region (7.20-7.50 ppm) as well as the 
singlet at 5.14 ppm for the -CH2-, and the singlet (1.42 ppm) corresponding to the tert-
butyl group. 
 
As described before, the final product was isolated running a column packed with 
Dowex and eluting with 2M NH4OH solution and water. 
 
 
Figure 3.10 Catalytic cycle for the benzyl hydrogenation. 
 
The orthogonal deprotection of 9a-c also led to MMS, MCDS and MCUS as illustrated 
in Scheme 3.2. This route was only used when the compound was needed and MMU, 
MCDU and MCUU were not available. 
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Figure 3.11 Proposed mechanism for the cleavage of the amine protecting group. 
 
3.3.2. SYNTHESIS OF ENANTIOMERICALLY PURE UNSATURATED, SATURATED AND 
HYDROXYLATED MONOMERS  
Nature is a perfect synthetic chemist and essentially makes all types of molecules by 
enzymes. As a result of the commercial availability of a large library of different 
enzymes, their application in synthesis has become more and more useful.
96
 The 
drawback of the use of enzymes is that they, often, are specific to one chemical 
transformation. Lipases are versatile enzymes and have been reported to perform a wide 
variety of transformations
97,98
 and, very often, with enviable enantiomeric excesses (ee). 
An enzymatic resolution was performed to assess the compounds previously 
synthesised in their enantiomerically pure forms (cis conformation). A Lipase from 
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Candida antarctica was used to “digest” one of the enantiomers of lactam 2a as 
reported by Forró et al.
99,85
 (Scheme 3.7). The authors used diisopropyl ether (
i
Pr2O) as 
solvent; for safety reasons, here the solvent was substituted by MTBE. 
 
 
Scheme 3.7 Enzymatic resolution of lactam 2a. i) Lipase, MTBE, H2O. 
 
A catalytic triad of amino acid residues is responsible for the activity of Candida 
antarctica. The triad consists of Aspartate (Asp), Histidine (His) and Serine (Ser),
100
 
and the mechanism of action is outlined in Figure 3.12. 
 
Figure 3.12 Proposed mechanism for the enzymatic resolution. 
 
The enzyme preferentially digests the enantiomer MCUU leaving lactam 2b 
enantiomerically pure in solution. Filtering the reaction mixture and eliminating MTBE 
under reduced pressure allowed isolation of 2b. Washing the filtered solid with water 
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and filtering the solution gave access to enantiomerically pure MCUU. The isolated 
enzyme was stored at 4ºC and reused. The reaction was monitored by HPLC, 
monitoring the progressive decrease of lactam 2c. Figure 3.13 shows the chromatogram 
of racemic 2a and enantiomerically pure 2b, after 48 h. To evaluate the activity of the 
enzyme in different solvents and its behaviour when recovered, an incipient experiment 
was run (Table 3.1). The enzyme lost some activity when reused; it took 3 more days to 
resolve less than half of the amount of substrate. The replacement of iPr2O by MTBE 
resulted in half the reaction time even with approximately 2.5-fold the amount of 
substrate. A single crystal X-ray analysis (Figure 3.14) confirmed that the Rt of 14 
minutes corresponded to lactam 2b. 
Table 3.1 Solvent and recovered/fresh enzyme reaction times dependence. 
 Solvent Lipase (g) Substrate (g) Time (days) ee (%) 
Recovered MTBE 2.96 1.88 5 >99 
Fresh 
i
Pr2O 2.99 1.82 4 >99 
Fresh MTBE 7.95 4.81 2 >99 
 
 
Figure 3.13 HPLC trace for compounds 2a (left) and 2b (right). 
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Figure 3.14 a) Structure determined from a single crystal X-Ray of compound 2b. b) Packing pattern of 
crystal structure. 
 
Compounds 2b and MCUU provided the starting materials to synthesise the 
enantiomerically pure versions of racemic MMU, MMS and MMH; following the same 
synthetic steps previously described. 
 
3.3.3. WATER UPTAKE DETERMINATION 
The water uptake of each synthesised compound was determined by thermogravimetric 
analysis. TGA is a technique in which one (or more) property of a sample is studied 
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while subjected to a controlled temperature program. Particularly, the mass loss (of 
water) from hydrated samples was evaluated while heating at 5ºC/min. As a positive 
control, -lactose monohydrate was used. Thermograms for each compound can be 
found in Appendix A5. 
By way of example, urea is a highly hydrophilic101 molecule widely used in cosmetic 
and pharmaceutical formulations and it has a Donor/Acceptor (D/A) hydrogen bond 
count of 2/3 and a D/A binding sites of 4/4. Potentially, it could bind to a total of 8 
molecules of water but it binds to 5 as demonstrated by Rezus et al.102 (Figure 3.15). An 
analogous analysis was done to determine the D/A ratio for the monomeric structures in 
study, with the majority having the same D/A relationship (Table 3.2). 
 
 
Figure 3.15 Urea solvated in five molecules of water. Adapted from
102
 
 
Figure 3.16 shows the loss of 5% of -lactose monohydrate’s (360.31 Da) weight up to 
approximately 160ºC corresponding to the loss of one molecule of water per molecule 
of lactose. The region of the thermogravimetric profiles (Figure 3.17) of particular 
interest for this study is the up to ~145ºC. The weight loss up to ~115ºC is due to 
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adsorbed water evaporation from the material surface (water that is not “bound”). The 
second weight loss observed is due to “bound” or “structural” water that is typically 
hydrogen bonded to the material. For the example in Figure 3.19, bound water is 
measured between 123 and 144 ºC with a loss of 2.539 mg, corresponding to 3 
molecules of water per molecule of MCUU. All samples were run in triplicate and the 
reproducibility of the results is exemplified in Figure 3.18, for MCUU. Figure 3.20 
illustrates the results for all the monomers and Table 3.2 lists the temperature interval at 
which the weight loss was measured and the number of water molecules (𝑁𝑤) bound per 
monomer molecule. 
The first approach to calculate 𝑁𝑤 was done by means of use of the first derivative of 
the weight loss (Table 3.3). Comparing both results it can be observed that the first and 
second derivative give approximately the same results but the second derivative was 
chosen because the differences in mass loss were larger and it gave lower standard 
deviation values; besides, the weight loss step was often difficult to visualise using the 
first derivative. 
As mentioned before, the wight loss profile up to ~100ºC is due to surface water and all 
samples present the same profile except for compound MCUH. This monomer presents 
a weight loss step at ~40ºC that could be due to structural changes in the molecule 
caused by the raising temperature. This behaviour was also observed in larger molecules 
(see Chapter 4 and 5) and it would be of interest to run further studies to better 
understand what was happening with this specific molecules; due to lack of time and no 
interest in this temperature intervals no further studies were conducted. 
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Figure 3.16 Thermogravimetric profile of -lactose monohydrate showing the loss of 5% of its weight. 
 
 
Figure 3.17 Thermogravimetric profiles of the monomeric structures. 
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Figure 3.18 Experimental reproducibility of the thermogravimetric profile for compound MCUU. 
 
 
Figure 3.19 Analysis of the thermogravimetric profile for compound MCUU. 
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Figure 3.20 Water uptake of the monomeric structures. Data are mean  SD from n=3. 
 
Thermogravimetric analysis profile screening revealed that the 𝑁𝑤 bound to each 
compound is different from theoretically expected when analysing the D/A possibilities. 
In fact, the hydroxylated series contradicts expectations, since it was predicted to have 
the highest water holding capacity (MCDH presents one water molecule bound, but the 
number was rounded from 0.54 to the nearest unit with a SD of 0.41). The monomers 
from the unsaturated series (MMU, MCDU and MCUU) have a significantly different 
𝑁𝑤 between enantiomerically pure and mixture of two enantiomers. MCUU has 1.5 and 
3-fold higher water holding capacity than its mirror image and the mixture, respectively. 
The saturated series also presents marked differences between mixture and 
enantiomerically pure compounds. Whilst 𝑁𝑤 in MMS and MCDS is the same, MCUS 
binds to half the amount of water molecules. 
The monomers discussed in this chapter are hydrophilic molecules and six of them have 
a D/A count of 2/3 and D/A sites of 3/5; the other three have a D/A count of 4/5, and 
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D/A sites of 5/9. This would imply that these molecules might hydrogen bond in higher 
rates than the ones observed. It can be assumed that the coordination level between 
water and monomers is not linear and this could be due to two possible events: more 
than one binding site, within the same molecule, coordinates with one water molecule 
or/and the intermolecular bonds between the monomeric structures prevent them from 
being available to bind to water. 
 
Table 3.2 Physico chemical properties of the monomers. 
Structure Mw T/ºC mp/ºC D/A D/A sites 𝑵𝒘 
Control 
-lactose monohydrate 
360.31 100-160 219 8/11 8/22 10.01 
 
L-Ala 
89.09 128-148 220-223 2/3 3/5 10.09 
 
MMU 
127.14 105-130 160-165 2/3 3/5 10.48 
 
MMS 
129.16 110-135 204-210 2/3 3/5 20.13 
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Table 3.2 (Continued) 
Structure Mw T/ºC mp/ºC D/A D/A sites 𝑵𝒘 
 
MMH 
161.16 100-150 203-207 4/5 5/9 0 
 
MCDU 
127.14 115-135 173-175 2/3 3/5 20.15 
 
MCDS 
129.16 108-140 209-213 2/3 3/5 20.08 
 
MCDH 
161.16 110-145 192-196 4/5 5/9 10.41 
 
MCUU 
127.14 122-143 207-210 2/3 3/5 30.04 
 
MCUS 
129.16 115-135 203-206 2/3 3/5 10.23 
 
MCUH 
161.16 100-150 197-200 4/5 5/9 0 
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Table 3.3 Number of waters determined using the first weight loss derivative 
Structure 𝑵𝒘 Structure 𝑵𝒘 
 
L-Ala 
20.41 
 
MCDS 
20.78 
 
MMU 
10.66 
 
MCDH 
10.35 
 
MMS 
30.56 
 
MCUU 
40.33 
 
MCDU 
20.26 
 
MCUS 
31.23 
 
3.4 CONCLUSIONS 
Three series of amino acids (unsaturated, saturated and hydroxylated) have been 
synthesised in good yields. All synthesised structures were successfully characterised by 
NMR, IR and MS. The enantiomerically pure compounds were obtained via enzymatic 
resolution of lactam 2a with an excellent ee value (> 99%) and the structure of lactam 
2b was confirmed by X-Ray analysis. 
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The thermogravimetric profile of the monomeric structures shows that chirality is an 
important feature to account for when it comes to hydrogen bonding to water. MCUU 
binds to 3-fold the 𝑁𝑤 when compared to the racemic and 1.5-fold when compared to its 
mirror image. The saturated series presents no difference between MMS and MCDS but 
MCUS binds to half the 𝑁𝑤. The hydroxylated series does not bind to water. 
Chapter 4 describes a series of peptides (dimers) derived from the monomers herein 
discussed and evaluates the effects of increasing D/A ratio as well as the increase of the 
molecular weight. 
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4. SYNTHESIS AND WATER UPTAKE OF PEPTIDES (DIMERS) 
4.1 INTRODUCTION 
This chapter is divided, as Chapter 3, into four sections. The current section gives an 
overview of the compounds synthesised and the synthetic strategy followed. Section 4.2 
describes the synthetic procedures involved in obtaining the dimers (Figure 4.1) and 
their characterisation. Section 4.3 discusses the synthetic approaches and the results 
obtained when assessing the water uptake ability of the referred dimers and finally, 
section 4.4 provides the chapter’s conclusions. The rational followed in Chapter 3 to 
code dimers (D here as opposed to M in Chapter 3 for monomers) and identify 
compounds a, b and c was applied. 
 
Figure 4.1 Summary of the synthesised dimeric structures. 
 
_____________________________________Synthesis and water uptake of Peptides 
 
 
 
95 
 
 
The synthetic strategy is outlined in Schemes 4.1 and 4.2. Spectral data for the 
described compounds can be found in Appendix A6. 
 
 
Scheme 4.1 Synthetic route to obtain the dimeric precursors. i) Coupling: L-Ala, DIPEA, PyBop, DCM; 
ii) Hydrogenation: H2, Pd/C, MeOH; iii) Hydroxylation: OsO4, NMO, Acetone. 
 
 
Scheme 4.2 Synthetic route to obtain the dimers. i) LiOH, MeOH, r.t; ii) TFA, DCM; iii) Dowex®, 2M 
NH4OH, H2O; iv) H2, Pd/C, MeOH. 
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4.2 EXPERIMENTAL 
4.2.1 COUPLING 
Procedure to synthesise compounds 13a-c and 16a-c. DIPEA (1.72 mL, 9.86 mmol) 
followed by PyBop (2.05 g, 3.94 mmol) was added to a solution of 3a (0.75 g, 3.29 
mmol) in DCM and left stirring for 15 minutes at room temperature. L-alanine-OBn was 
added (0.71 g, 3.29 mmol) and the mixture left stirring for 24 hours. Water was added 
and the layers separated. The organic layer was washed with sat. NaHCO3, H2O, HCl 
1M in repetitive cycles until almost complete elimination of HOBt (by-product of 
PyBOP). The organic layer was then dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. The crude was purified by column 
chromatography (CC) and eluted with Hexane:EtOAc (1:1) to afford 1.18 g (92%, 
Rf=0.70) of the desired product. 
4.2.2 HYDROXYLATION 
Procedure to synthesise compounds 14a-c. As described in Chapter 3, section 3.2.5. 
4.2.3 ORTHOGONAL DEPROTECTION OF THE AMINO AND ACID GROUPS 
4.2.3.1 Acid group deprotection 
Via alkaline hydrolysis (Saponification) 
Compound 13a (0.51 g, 1.32 mmol) was dissolved in MeOH (5.00 mL) and lithium 
hydroxide (LiOH) (0.33 g, 7.89 mmol) was added. The mixture was left stirring at room 
temperature and controlled by TLC for 24 hours. The reaction mixture was concentrated 
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under reduced pressure and the crude taken in H2O (5.00 mL) and cooled to 0ºC. 1M 
H2SO4 was added dropwise until pH 4. The water was eliminated under reduced 
pressure and the crude dissolved in CHCl3. The precipitate (Li2SO4) was filtered and the 
filtrate concentrated under reduced pressure to afford the free carboxylic acid (0.33 g, 
84%). 
1
H NMR was run to confirm the absence of the benzyl group and the product 
taken into the next step without further purification. 
Via Hydrogenation 
As described in Chapter 3, section 3.2.6.1. 
4.2.3.2 Amino group deprotection 
As described in Chapter 3, via TFA cleavage, section 3.2.6.2. 
4.2.4 ION EXCHANGE 
Procedure to synthesise compounds DMU, DMS, DMH, DCDU, DCDS, DCDH, 
DCUU, DCUS and DCUH. As described in Chapter 3, section 3.2.7. 
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4.2.5 PRECURSORS CHARACTERISATION 
 
Benzyl (2-((tert-butylcarbonyl)amino)cyclopent-3-ene-1-carbonyl)-L-alaninate 
(13a). Yield 92%. mp 117-121ºC. 
1
H NMR (400 MHz, CDCl3): diastereomers  1.37-
1.43 (m, 12H, H7 and H9), 2.43-2.52 (m, 1H, H5), 2.81-2.90 (m, 1H, H5), 3.15-3.23 (m, 
1H, H1), 4.46-4.63 (m, 1H, H8), 4.86 (m, 1H, CONH), 4.98-5.05 (m, 1H, H2), 5.09-5.23 
(m, 1H, H10), 5.56-5.61 (m, 1H, H4), 5.88-5.92 (m, 1H, H3), 6.29 (d, J = 6.8 Hz, 1H, 
NHCOOCCH3), 6.53 (d, J = 5.2 Hz, 1H, NHCOOCCH3), 7.31-7.39 (m, 5H, H11).
 13
C 
NMR (100 MHz, CDCl3): 18.0, (C9), 28.4 (C7), 34.5 (C5), 46.9 (C1), 48.6 (C8), 57.4 
(C2), 66.9 (C10), 79.6 (C6), 128.3 (C11), 128.4 (C11), 128.6 (C11), 128.7 (C11), 129.8 (C4), 
135.7 (C3), 155.7 (C=O, NHCOOC(CH3)3), 171.6 (C=O, COOBn), 173.3 (C=O, 
CONH). IR (, cm-1): 3325, 2982, 2936, 1753, 1725, 1675, 1646, 1623, 1514, 1445, 
1365, 1353, 1335, 1296, 1280, 1245, 1204, 1161, 1108, 1072, 1045, 1027, 1008. 
HRMS (ESI, MeOH) calculated for C21H28N2O5: 388.4640, found M+Na: 411.1882. 
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Benzyl ((1S,2R)-2-((tert-butoxycarbonyl)amino) cyclopent-3-ene-1-carbonyl)-L-
alaninate (13b). Yield 54%. mp 134-139ºC. 
1
H NMR (400 MHz, CDCl3):  1.37 (s, 
9H, H7), 1.42 (d, J = 7.2 Hz, 3H, H9), 2.44-2.53 (m, 1H, H5), 2.78-2.89 (m, 1H, H5), 
3.13-3.21 (m, 1H, H1), 4.44-4.57 (m, 1H, H8), 4.86 (d, J = 9.6 Hz, 1H, 
NHCOOC(CH3)3), 4.98-5.04 (m, 1H, H2), 5.07-5.25 (m, 2H, H10), 5.57-5.62 (m, 1H, 
H4), 5.88-5.94 (m, 1H, H3), 6.55 (d, J = 5.2 Hz, 1H, CONH), 7.29-7.39 (m, 5H, H11).
 
13
C NMR (100 MHz, CDCl3): 19.0 (C9), 28.4 (C7), 34.7 (C5), 47.1 (C1), 48.8 (C8), 57.5 
(C2), 67.1 (C10), 79.6 (C6), 128.2 (C11), 128.3 (C11), 128.5 (C11), 128.7 (C11) 130.1 (C4), 
133.5 (C3), 155.9 (C=O, NHCOOC(CH3)3), 171.9, (C=O, COOBn), 172.6 (C=O, 
CONH). [𝜶]𝑫
𝟐𝟎 - 36.8, c = 0.01 g.mL
-1
 in CHCl3. IR (, cm
-1
): 3321, 3050, 2036, 1751, 
1726, 1676, 1647, 1631, 1595, 1565, 1543, 1517, 1459, 1417, 1336, 1250, 1212, 1162, 
1110, 1065, 1045, 1028. HRMS (ESI, MeOH) calculated for C21H28N2O5: 388.4640, 
found M+Na: 411.1882. 
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Benzyl ((1R,2S)-2-((tert-butoxycarbonyl)amino)cyclopent-3-ene-1-carbonyl)-L-
alaninate (13c). Yield 86%. mp 135-139ºC. 
1
H NMR (400 MHz, CDCl3):  1.31-1.48 
(m, 12H, H7 and H9), 2.37-2.54 (m, 1H, H5), 2.77-2.93 (m, 1H, H5), 3.15-3.26 (m, 1H, 
H1), 4.59 (q, J = 7.2 Hz, 1H, H8), 4.83 (d, J = 9.6 Hz, 1H, NHCOOC(CH3)3), 5.03 (t, J = 
9.2 Hz, 1H, H2), 5.17 (dd, J = 18.0 Hz, J = 6.4 Hz, 2H, H10), 5.54-5.60 (m, 1H, H4), 
5.88-5.94 (m, 1H, H3), 6.28 (d, J=6.8, 1H, CONH), 7.29-7.41 (m, 5H, H11).
 13
C NMR 
(100 MHz, CDCl3): 18.3 (C9), 28.5 (C7), 34.6 (C5), 47.1 (C1), 48.3 (C8), 57.8 (C2), 67.3 
(C10), 79.6 (C6), 128.3 (C11), 128.66 (C11), 128.7 (C11), 129.9 (C11) 133.8 (C4), 135.6 
(C3), 155.7 (C=O, NHCOOC(CH3)3), 171.6, (C=O, COOBn), 173.0 (C=O, CONH). 
[𝜶]𝑫
𝟐𝟎  + 17.4, c = 0.01 g.mL-1 in CHCl3. IR (, cm
-1
): 3346, 3322, 2958, 2171, 1753, 
1731, 1682, 1647, 1624, 1526, 1446, 1388, 1364, 1353, 1337, 1314, 1280, 1245, 1219, 
1196, 1161, 1069, 1048, 1031. HRMS (ESI, MeOH) calculated for C21H28N2O5: 
388.4640, found M+Na: 411.1884. 
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Benzyl (2-((tert-butoxycarbonyl)amino)cyclopentane-1-carbonyl)-L-alaninate 
(16a). Yield 77%. mp 114-117ºC. 
1
H NMR (400 MHz, CDCl3):  1.37-1.43 (m, 12H, 
H7 and H9), 1.61-1.75 (m, 2H, H3 and H4), 1.77-2.07 (m, 4H, H3, H4 and H5), 2.80-2.88 
(m, 1H, H1), 4.08-4.13 (m, 1H, H2), 4.50-4.63 (m, 1H, H8), 4.99 (d, J = 8.0 Hz, 1H, 
NHCOOC(CH3)3), 5.11-5.24 (m, 2H, H10), 6.18 (br.s, 1H, CONH), 7.31-7.39 (m, 5H, 
H11).
 13
C NMR (100 MHz, CDCl3): 18.6, (C9), 22.2 (C4), 27.8 (C5), 28.4 (C7), 32.9 (C3), 
47.8 (C1), 48.3 (C8), 54.0 (C2), 66.9 (C10), 79.4 (C6), 128.3 (C11), 128.4 (C11), 128.6 
(C11), 128.7 (C11), 155.8 (C=O, NHCOOC(CH3)3), 172.9 (CONH and COOBn). IR (, 
cm
-1
): 3344, 2981, 1732, 1687, 1645, 1532, 1519, 1455, 1365, 1355, 1329, 1312, 1286, 
1246, 1213, 1171, 1108, 1050, 1015. HRMS (ESI, MeOH) calculated for C21H30N2O5: 
390.4800, found M+Na: 413.2047. 
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Benzyl ((1S,2R)-2-((tert-butoxycarbonyl)amino) cyclopentane-1-carbonyl)-L-
alaninate (16b). Yield 72%. mp 130-133ºC . 
1
H NMR (400 MHz, CDCl3):  1.37-1.42 
(m, 12H, H7 and H9), 1.61-1.75 (m, 2H, H3 and H4), 1.76-2.06 (m, 4H, H3, H4 and H5), 
2.74-2.87 (m, 1H, H1), 4.03-4.18 (m, 1H, H2), 4.46-4.60 (m, 1H, H8), 5.05-5.29 (m, 3H, 
NHCOOC(CH3)3 and H10), 6.19 (d, J = 6.0 Hz, 1H, CONH), 7.28-7.42 (m, 5H, H11).
 
13
C NMR (100 MHz, CDCl3): 18.1, (C9), 22.2 (C4), 27.8 (C5), 28.5 (C7), 32.2 (C3), 47.5 
(C1), 48.5 (C8), 54.4 (C2), 67.2 (C10), 79.3 (C6), 128.4 (C11), 128.6 (C11), 128.8 (C11), 
135.5 (C11), 156.1 (C=O, NHCOOC(CH3)3), 172.8 (C=O, COOBn), 173.7 (NHCO). 
[𝜶]𝑫
𝟐𝟎  + 36.7, c = 0.01 g.mL-1 in CHCl3. IR (, cm
-1
): 3343, 2937, 2868, 2359, 1726, 
1682, 1645, 1518, 1455, 1389, 1365, 1353, 1328, 1312, 1286, 1244, 1204, 1167, 1108, 
1049, 1015. HRMS (ESI, MeOH) calculated for C21H30N2O5: 390.4800, found M+Na: 
413.2059. 
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Benzyl ((1R,2S)-2-((tert-butoxycarbonyl)amino) cyclopentane-1-carbonyl)-L-
alaninate (16c). Yield 77%. mp 131-134ºC . 
1
H NMR (400 MHz, CDCl3):  1.32-1.47 
(m, 12H, H7 and H9), 1.48-1.51 (m, 1H, H4), 1.62-1.73 (m, 1H, H3), 1.77-2.06 (m, 4H, 
H3, H4 and H5), 2.80-2.89 (m, 1H, H1), 4.08-4.19 (m, 1H, H2), 4.60 (q, J = 7.2 Hz, 1H, 
H8), 4.99 (d, J = 8.0 Hz, 1H, NHCOOC(CH3)3), 5.17 (dd, J = 21.2 Hz, J = 8.8 Hz, 2H, 
H10), 6.16 (d, J = 6.8 Hz, 1H, CONH), 7.29-7.40 (m, 5H, H11).
 13
C NMR (100 MHz, 
CDCl3): 18.7, (C9), 22.7 (C4), 28.1 (C5), 28.6 (C7), 32.9 (C3), 47.9 (C1), 48.4 (C8), 54.3 
(C2), 67.3 (C10), 79.4 (C6), 128.3 (C11), 128.6 (C11), 128.8 (C11), 154.9 (C=O, 
NHCOOC(CH3)3), 172.9 (C=O, COOBn) 173.5 (C=O, NHCO). [𝜶]𝑫
𝟐𝟎  - 67.9, c = 0.01 
g.mL
-1
 in CHCl3. IR (, cm
-1
): 3344, 2979, 2936, 2161, 2029, 1731, 1686, 1644, 1530, 
1516, 1448, 1386, 1364, 1352, 1312, 1286, 1244, 1212, 1169, 1101, 1059, 1039, 1009. 
HRMS (ESI, MeOH) calculated for C21H30N2O5: 390.4800, found M+Na: 413.2047. 
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Benzyl (2-((tert-butylcaboxyl)amino)-3,4-dihydroxycyclopentane-1-carbonyl)-L-
alaninate (14a). Yield 85%. mp 190-195ºC. 
1
H NMR (400 MHz, CDCl3):  1.33-1.50 
(m, 12H, H7 and H9), 1.91-2.09 (m, 1H, H5), 2.10-2.27 (m, 1H, H5), 3.12-3.34 (m, 2H, 
H1 and OH), 3.80 (br.s, 1H, OH), 4.05 (br.s, 1H, H2), 4.16 (br.s, 2H, H3 and H4), 4.46-
4.62 (m, 1H, H8), 5.07-5.25 (m, 2H, H10), 5.51 (d, J = 7.6 Hz, 1H, 
NHCOdiastereomers), 5.75 (d, J = 6.6 Hz, 1H, NHCOdiastereomers), 6.54 (br.s, 1H, 
CONH), 6.66 (d, J = 5.3 Hz, 1H, COOBn), 7.28-7.43 (m, 5H, H11).
 13
C NMR (100 
MHz, CDCl3): 18.4 (C9), 28.5 (C7), 33.6 (C5), 43.4 (C1), 48.4 (C8), 57.1 (C4), 67.3 (C10), 
70.8 (C3), 78.6 (C2), 80.2 (C6), 128.3 (C11), 128.6 (C11), 128.8 (C11), 155.0 
(NHCOOC(CH3)3), 172.7 (C=O, COOBn), 173.4 (C=O, CONH). IR (, cm
-1
): 3331, 
2977, 2935, 1729, 1689, 1645, 1532, 1455, 1390, 1364, 1335, 1288, 1245, 1163, 1112, 
1061, 1028. HRMS (ESI, MeOH) calculated for C21H30N2O7: 422.4780, found M+Na: 
445.1945. 
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Benzyl ((1S,2S,3R,4S)-2-((tert-butoxycarbonyl) amino)-3,4-dihydroxycyclopentane-
1-carbonyl)-L-alaninate (14b). Yield 68%. mp 168-172ºC. 
1
H NMR (400 MHz, 
CDCl3):  rotamers 1.38 (d, J = 7.2 Hz, 3H, H9), 1.43 (s, 9H, H7), 1.63 (br.s, 2H, OH), 
1.97-2.06 (m, 1H, H5), 2.16-2.26 (m, 1H, H5), 3.11-3.21 (m, 1H, H1), 4.01-4.09 (m, 1H, 
H2) 4.12-4.22 (m, 2H, H3 and H4), 4.46-4.52 (m, 1H, H8), 5.03 (d, J = 7.6 Hz, 1H, 
NHCOOC(CH3)3), 5.10-5.26 (m, 2H, H10), 6.22 (d, J = 6.8 Hz, 1H, CONH), 7.29-7.42 
(m, 5H, H11).
 13
C NMR (100 MHz, CDCl3): 19.1 (C9), 28.5 (C7), 33.3 (C5), 43.5 (C1), 
48.6 (C8), 57.5 (C4), 67.2 (C10), 70.6 (C3), 79.5 (C2), 80.3 (C6), 128.2 (C11), 128.4 (C11), 
128.7 (C11), 128.8 (C11), 156.3 (NHCOOC(CH3)3), 172.7 (C=O, COOBn), 173.2 (C=O, 
CONH). IR (, cm-1): 3326, 2934, 2361, 2342, 1750, 1730, 1684, 1661, 1645, 1632, 
1540, 1455, 1388, 1366, 1336, 1285, 1249, 1199, 1172, 1111, 1061, 1021. HRMS (ESI, 
MeOH) calculated for C21H30N2O7: 422.4780, found M+Na: 445.1945. 
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Benzyl ((1R,2R,3S,4R)-2-((tert-butoxycarbonyl)amino)-3,4-dihydroxycyclopentane-
1-carbonyl)-L-alaninate (14c). Yield 83%. mp 180-185ºC. 
1
H NMR (400 MHz, 
CDCl3):  1.34-1.47 (m, 12H, H7 and H9), 1.86 (br.s, 1H, OH), 1.94-2.06 (m, 1H, H5), 
2.11-2.25 (m, 1H, H5), 3.15 (br.s, 1H, OH), 3.17-3.29 (m, 1H, H1), 3.99-4.07 (m, 1H, 
H2) 4.11-4.22 (m, 2H, H3 and H4), 4.57 (q, J = 7.2 Hz, 1H, H8), 5.15 (dd, J = 23.3 Hz, J 
= 10.8 Hz, 2H, H10), 5.52 (d, J = 7.6 Hz, 1H, NHCOOC(CH3)3), 6.55 (d, J = 7.2 Hz, 
1H, CONH), 7.29-7.40 (m, 5H, H11).
 13
C NMR (100 MHz, CDCl3): 18.4 (C9), 28.5 
(C7), 33.7 (C5), 43.4 (C1), 48.4 (C8), 57.1 (C4), 67.4 (C10), 70.8 (C3), 78.8 (C2), 80.2 
(C6), 128.4 (C11), 128.7 (C11), 128.8 (C11), 157.3 (NHCOC(CH3)3), 172.7 (C=O, 
COOBn), 173.2 (C=O, CONH). [𝜶]𝑫
𝟐𝟎  - 117, c = 0.01 g.mL-1 in MeOH. IR (, cm-1): 
3334, 2985, 1733, 1682, 1644, 1538, 1526, 1449, 1428, 1389, 1364, 1314, 1284, 1251, 
1215, 1166, 1104, 1064, 1048, 1020. HRMS (ESI) calculated for C21H30N2O7: 
422.4780, found M+Na: 445.1946. 
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4.2.6 DIMERS CHARACTERISATION 
 
(2-aminocyclopent-3-ene-1-carbonyl)-L-alanine (DMU). Yield 54%. mp 103-106ºC. 
1
H NMR (400 MHz, D2O): diastereomers  1.33 (d, J = 7.2 Hz, 3H, H7), 1.34 (d, J = 
7.6 Hz, 3H, H7), 2.63 (ddt, J = 17.2 Hz, J = 8.8 Hz, J = 2 Hz, 1H, H5), 2.71-2.83 (m, 
1H, H5), 3.78 (q, J = 8.0 Hz, 1H, H1), 3.46 (q, J = 8.0 Hz, H1), 4.12 (q, J = 7.2 Hz, 1H, 
H6), 4.12 (q, J = 7.6 Hz, 1H, H6), 4.42 (d, J = 8.0 Hz, 1H, H2), 4.50 (d, J = 8.0,1H, H2), 
5.76 (ddd, J = 8.0 Hz, J = 4.4 Hz, J = 2.4 Hz, 1H, H4), 6.26 (t, J = 4.8 Hz, 1H, H3). 
13
C 
NMR (100 MHz, D2O): 16.7 (C7), 17.0 (C7), 33.8 (C5), 34.8 (C5), 44.2 (C1), 44.1 (C1) 
51.0 (C6), 51.2 (C6), 57.1 (C2), 58.1 (C2), 125.3 (C3), 125.8 (C3), 138.8 (C4), 139.1 (C4), 
172.5 (C=O, CONH), 172.6 (C=O, CONH), 180.2 (C=O, COOH), 180.5 (C=O, 
COOH). IR (, cm-1): 2924, 1548, 1451, 1393, 1359, 1307, 1269, 1237, 1136, 1051, 
1020. HRMS (ESI, H2O) calculated for C9H14N2O3: 198.1004, found M+H: 199.1077. 
 
((1S,2R)-2-aminocyclopent-3-ene-1-carbonyl-L-alanine (DCDU). Yield 64%. mp 
210-213ºC. 
1
H NMR (400 MHz, D2O):  1.35 (d, J = 7.2 Hz, 3H, H7), 2.60 (ddt, J = 
17.6 Hz, J = 8.8 Hz, J = 2.4 Hz, 1H, H5), 2.76 (ddd, J = 17.6 Hz, J = 8.0 Hz, J = 2.4 Hz, 
1H, H5), 3.45 (q, J = 8.4 Hz, 1H, H1), 4.15 (q, J = 7.2 Hz, 1H, H6), 4.48-4.54 (m, 1H, 
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H2), 5.74-5.82 (m, 1H, H4), 6.25-6.29 (m, 1H, H3).
 13
C NMR (100 MHz, D2O): 16.6 
(C7), 33.8 (C5), 44.3 (C1), 50.9 (C6), 58.1 (C2), 125.2 (C4), 139.1 (C3), 172.4 (C=O, 
CONH), 180.5 (C=O, COOH). [𝜶]𝑫
𝟐𝟎  - 52.1, c = 0.01 g.mL-1in H2O. IR (, cm
-1
): 3451, 
3292, 2002, 2156, 1620, 1590, 1573, 1455, 1398, 1368, 1334, 1317, 1266, 1244, 1143, 
1065, 1031, 1001. HRMS (ESI, H2O) calculated for C9H14N2O3 198.1004, found M+H: 
199.1077 
 
((1R,2S)-2-aminocyclopent-3-ene-1-carbonyl)-L-alanine (DCUU). Yield 74%. mp 
176-180ºC. 
1
H NMR (400 MHz, D2O):  1.35 (d, J = 7.2 Hz, 3H, H7), 2.72-2.81 (m, 
2H, H5), 3.39 (q, J = 8.4 Hz, 1H, H1), 4.13 (q, J = 7.2 Hz, 1H, H6), 4.45 (d, J = 7.6 Hz, 
1H, H2), 5.77-5.84 (m, 1H, H4), 6.25-6.32 (m, 1H, H3).
 13
C NMR (100 MHz, D2O): 
16.9 (C7), 34.5 (C5), 44.1 (C1), 51.0 (C6), 57.1 (C2), 125.8 (C4), 139.0 (C3), 171.0 (C=O, 
CONH), 180.6 (C=O, COOH). [𝜶]𝑫
𝟐𝟎  + 31.3, c = 0.01 g.mL-1in H2O. IR (, cm
-1
): 
3306, 2988, 2063, 1646, 1615, 1556, 1459, 1442, 1395, 1374, 1364, 1340, 1287, 1258, 
1240, 1173, 1127, 1117, 1081, 1022. HRMS (ESI, H2O) calculated for C9H14N2O3 
198.1004, found M+H: 199.1077 
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(2-aminocyclopentane-1-carbonyl)-L-alanine (DMS). Yield 62%. mp 205-208ºC. 
1
H 
NMR (400 MHz, CDCl3): diastereomers  1.36 (d, J = 7.2 Hz, 3H, H7), 1.62-1.93 (m, 
4H, H3, 2xH4 and H5), 1.97- 2.13 (m, 2H, H3 and H5), 2.90-3.03 (m, 1H, H1), 3.72-3.87 
(m, 1H, H2), 4.21-4.37 (m, 1H, H6).
 13
C NMR (100 MHz, CDCl3): 16.8 (C7), 17.0 (C7), 
21.5 (C4), 21.9 (C4), 27.4 (C5), 27.5 (C5), 30.3 (C3), 30.4 (C3), 51.0 (C1), 51.1 (C1), 53.7 
(C2), 54.1 (C2), 173.6 (C=O, CONH), 173.8 (C=O, CONH), 180.2 (C=O, COOH), 
180.5 (C=O, COOH). IR (, cm-1): 3288, 2972, 2872, 2355, 2164, 1681, 1632, 1606, 
1537, 1493, 1455, 1403, 1361, 1303, 1277, 1253, 1166, 1069, 1000. HRMS (ESI, H2O) 
calculated for C9H16N2O3 200.2380, found M+H: 201.1234. 
 
((1S,2R)-2-aminocyclopentane-1-carbonyl)-L-alanine (DCDS). Yield 63%. mp 188-
191ºC. 
1
H NMR (400 MHz, D2O):  1.32 (d, J = 7.2 Hz, 3H, H7), 1.64-1.96 (m, 4H, H3, 
2xH4 and H5), 1.97- 2.08 (m, 1H, H3), 2.09-2.20 (m, 1H, H5), 3.04 (td, J = 7.2 Hz, J = 
6.8 Hz, 1H, H1), 3.86 (td, J = 6.8 Hz, J = 4.8 Hz, 1H, H2), 4.11 (q, J = 7.2 Hz, 1H, H6).
 
13
C NMR (100 MHz, D2O): 16.7 (C7), 21.3 (C4), 27.3 (C3), 30.4 (C5), 46.1 (C1), 50.9 
(C6), 54.1 (C2), 173.8 (C=O, CONH), 180.5 (C=O, COOH). [𝜶]𝑫
𝟐𝟎  - 30.5, c = 0.01 
g.mL
-1
in H2O. IR (, cm
-1
): 3359, 3212, 3039, 2926, 2179, 1648, 1630, 1568, 1547, 
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1503, 1462, 1393, 1365, 1313, 1276, 1256, 1220, 1185, 1163, 1129, 1056, 1046. 
HRMS (ESI, H2O) calculated for C9H16N2O3 200.2380, found M+H: 201.1234. 
 
((1R,2S)-2-aminocyclopentane-1-carbonyl)-L-alanine (DCUS). Yield 63%. mp 172-
178ºC. 
1
H NMR (400 MHz, D2O):  1.32 (d, J = 7.2 Hz, 3H, H7), 1.68-1.97 (m, 4H, H3, 
2xH4 and H5), 2.05-2.18 (m, 2H, H3 and H5), 2.98 (td, J = 8.4 Hz, J = 6.0 Hz, 1H, H1), 
3.83 (td, J = 6.4 Hz, J = 4.0 Hz, 1H, H2), 4.09 (q, J = 7.2 Hz, 1H, H6).
 13
C NMR (100 
MHz, D2O): 7.0 (C7), 21.5 (C4), 27.5 (C3), 30.3 (C5), 46.0 (C1), 51.1 (C6), 53.7 (C2), 
173.7 (C=O, CONH), 180.2 (C=O, COOH). [𝜶]𝑫
𝟐𝟎  - 19.2, c = 0.01 g.mL-1in H2O. IR 
(, cm-1): 3286, 2972, 2872, 1681, 1632, 1607, 1537, 1493, 1455, 1404, 1361, 1303, 
1277, 1253, 1253, 1166, 1069, 1000. HRMS (ESI, H2O) calculated for C9H16N2O3 
200.2380, found M+H: 201.1234. 
 
(2-amino-3,4-dihydroxycyclopentane-1-carbonyl)-L-alanine (DMH). Yield 54%. 
mp 228-233ºC. 
1
H NMR (400 MHz, D2O): diastereomers  1.31 (d, J = 7.2 Hz, 3H, 
H7), 2.00-2.25 (m, 2H, H5), 3.26-3.42 (m, 1H, H1), 3.63-3.77 (m, 1H, H2), 4.02-4.13 (m, 
1H, H6), 4.15-4.30 (m, 2H, H3 and H4).
 13
C NMR (100 MHz, D2O): 16.9 (C7), 33.8 
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(C5), 40.3 (C1), 50.9 (C6), 55.8 (C2), 69.9 (C4), 75.5 (C3), 173.2 (C=O, CONH), 180.5 
(C=O, COOH). IR (, cm-1): 3452, 3300, 2882, 1661, 1651, 1615, 1562, 1556, 1552, 
1538, 1524, 15199, 1455, 1431, 1408, 1368, 1348, 1304, 1287, 1247, 1232, 1185, 1110, 
1049, 1039. HRMS (ESI, H2O) calculated for C9H16N2O5 232.2360, found M+H: 
233.1133. 
 
((1S,2S,3R,4S)-2-amino-3,4-dihydroxycyclopentane-1-carbonyl)-L-alanine (DCDH). 
Yield 85%. mp 225-229ºC. 
1
H NMR (400 MHz, D2O):  1.35 (d, J = 7.2 Hz, 3H, H7), 
2.08-2.14 (m, 1H, H5), 2.18-2.25 (m, 1H, H5), 3.40 (q, J = 8.8 Hz, 1H, H1), 3.76 (t, J = 
9.2 Hz, 1H, H2), 4.13 (q, J = 7.2 Hz, 1H, H6), 4.23 (t, J = 4 Hz, 1H, H4), 4.28 (dd, J = 
9.2 Hz, J = 4.8 Hz, 1H, H3).
 13
C NMR (100 MHz, D2O): 16.9 (C7), 33.8 (C5), 40.3 (C1), 
51.2 (C6), 55.7 (C2), 70.0 (C4), 75.7 (C3), 173.2 (C=O, CONH), 180.3 (C=O, COOH). 
[𝜶]𝑫
𝟐𝟎  + 26.5, c = 0.01 g.mL-1in H2O. IR (, cm
-1
): 3284, 2872, 2650, 1659, 1550, 1457, 
1404, 1372, 1304, 1288, 1242, 1209, 1166, 1115, 1099, 1057. HRMS (ESI, H2O) 
calculated for C9H16N2O5 232.2360, found M+H: 233.1132. 
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((1R,2R,3S,4R)-2-amino-3,4-dihydroxycyclopentane-1-carbonyl)-L-alanine 
(DCUH). Yield 78%. mp 216-220ºC. 
1
H NMR (400 MHz, D2O):  1.31 (d, J = 7.2 Hz, 
3H, H7), 2.11-2.23 (m, 2H, H5), 3.32 (q, J = 8.8 Hz, 1H, H1), 3.69 (t, J = 9.2 Hz, 1H, 
H2), 4.06 (q, J = 7.2 Hz, 1H, H6), 4.19 (dt, J = 4.8 Hz, J = 2.4 Hz, 1H, H4), 4.27 (dd, J = 
9.2 Hz, J = 4.8 Hz, 1H, H3). 
13
C NMR (100 MHz, D2O): 17.0 (C7), 34.3 (C5), 39.8 (C1), 
51.2 (C6), 55.4 (C2), 70.0 (C4), 75.7 (C3), 173.1 (C=O, CONH), 180.0 (C=O, COOH). 
[𝜶]𝑫
𝟐𝟎  - 86.7, c = 0.01 g.mL-1in H2O. IR (, cm
-1
): 3447, 3301, 2876, 1654, 1611, 1551, 
1523, 1455, 1430, 1408, 1393, 1367, 1347, 1332, 1286, 1248, 1230, 1184, 1127, 1109, 
1048, 1030. HRMS (ESI, H2O) calculated for C9H16N2O5 232.2360, found M+H: 
233.1133. 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 SYNTHESIS OF THE UNSATURATED, SATURATED AND HYDROXYLATED DIMERS. 
The first attempt to synthesise compound 13a was made following the synthetic route in 
Scheme 4.3. 
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Scheme 4.3 Synthetic route to obtain dipeptide 13a. i) 22% HCl/EtOH, r.t.; ii) Et3N, Boc2O, 
Dioxane:H2O, r.t.; iii) 0.1 M NaOH, EtOH, then 1 M HCl (workup). 
 
Compound 17a and 18a were successfully synthesised, but in lower yields than 
expected, 47% and 59% respectively (64% and 69%).
87
 The ester hydrolysis to obtain 
compound 3a was also successfully carried out via saponification with NaOH forming a 
sodium carboxylate salt followed by acid hydrolysis during workup. The 
1
H NMR 
analysis (Figure 4.2) of the product revealed a duplication of the peaks and it was 
theorised that there was epimerization at the  carbon compromising the subsequent 
enantiomerically pure desired compounds; for this reason, the synthetic route was 
abandoned. Compound 13a was synthesised through the steps indicated in Scheme 4.1. 
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Figure 4.2 
1
H NMR spectrum showing possible epimerization of compound 3a. 
 
Compound 14a was synthesised as a derivative of 13a allowing access to the 
hydroxylated precursor, using the same strategy as for the hydroxylated series of the 
monomers described in Chapter 3. The saturated series was obtained via the synthetic 
steps illustrated in Scheme 4.4. 
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Scheme 4.4 Synthetic route to obtain the dimeric saturated precursor, 16a. i) H2, Pd/C, MeOH; ii) L-Ala-
OBn.HCl, DIPEA, PyBop, DCM. 
 
The orthogonal deprotection of compounds 14a and 16a, performed as described in 
Chapter 3, gave access to the final dimeric structures DMS and DMH, respectively. The 
unsaturated dimer could not be deprotected as previously described because the 
catalytic hydrogenation of 13a reduced the double bond in the five membered ring 
(Scheme 4.5) giving 20a as the product and a different approach had to be used. 
 
 
Scheme 4.5 Synthetic steps to obtain DMU. i) LiOH, MeOH, r.t.; ii) TFA, DCM, r.t.; iii) Dowex®, 2M 
NH4OH, H2O; iv) H2, Pd/C, MeOH. 
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The second attempt to deprotect compound 13a was carried out following the work of 
Giulliano et al.
103
 with 4M HCl (Scheme 4.6) for 3 hours to cleave the Boc group. 
Reproduction of this procedure did not give the expected result (compound 21a). After 
3 hours there was still evidence of the starting material (TLC analysis) and after 5 hours 
a sample was analysed by NMR (Figure 4.3). It was evident that the acid labile group 
(Boc) was successfully removed (no peak at 1.29 ppm integrating for a total of 12 H) 
but the benzyl group was also removed (integration between 7.2 and 7.4 ppm is not 
proportional to the remaining peaks, 5 H were expected). A different method, by Kaul et 
al.,
104
 described the removal of both protective groups with ZnBr2 in DCM. 
Unfortunately, again the expected result was not achieved, and the product was 
compound 23a (Scheme 4.6; NMR in Figure 4.4). Though it was also of interest to have 
a method that would give access to the final compound in one step, the orthogonal 
deprotection was needed for further coupling. 
 
 
Scheme 4.6 Synthetic approaches to deprotect 13a. 
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Figure 4.3 
1
H NMR of compound 21a. 
 
 
Figure 4.4 
1
H NMR of compound 23a. 
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Compound 19a was obtained via alkaline hydrolysis (saponification) of 13a as 
suggested in Figure 4.5. LiOH was used as base to avoid possible epimerization, as 
previously observed with a stronger nucleophile (NaOH). 
 
Figure 4.5 Proposed mechanism for the alkaline hydrolysis of 13a. 
 
4.3.2 SYNTHESIS OF ENANTIOMERICALLY PURE UNSATURATED, SATURATED AND 
HYDROXYLATED DIMERS. 
The synthetic steps to obtain the enantiomerically pure dimers were a repeat of the 
previous section; the difference resided in the starting materials being, of course, the 
enantiomerically pure precursors synthesised in Chapter 3. There were no special events 
in the synthetic strategy and the yields were essentially the same. The exception was the 
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occurrence of, what was theorised to be, rotamers (Figure 4.6) when synthesising 
compound 3b. 
 
 
Figure 4.6 Representation of the rotation of the carbamate group for compound 3b. 
 
It is not uncommon to observe the presence of rotamers when a Boc carbamate is 
present in a molecule. The reported compounds are no exception and it was most 
notorious in compound 3b. Figure 4.7 shows the variable temperature proton NMR 
experiment (VT-1H NMR) that was run to confirm the observation of rotamers. The 
selected region of the spectrum shows that the peaks corresponding to the NH (6.60 and 
7.00 ppm) proton, as well as the peaks from the double bond (5.55 and 5.85 ppm) and 
the chiral proton at 4.80 ppm, coalesce as temperature rises. 
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Figure 4.7 VT-
1
H NMR experiment for compound 3b, from 25 to 85ºC. 
 
Given this strong evidence that 3b is a rotamer, the previous assumption of 
epimerization of compound 3a (section 4.3.1) is questionable as the result could also be 
explained by the presence of rotamers. Further scrutiny of both NMR spectra seems to 
support this conclusion for both compounds. However, as the synthetic route to 
compound 3a was abandoned, no further studies were performed, though could be 
pursued as future studies. IR analysis can also provide evidence of rotamers as it is 
possible to observe multiple stretching bands for the C=O groups. 
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4.3.3 WATER UPTAKE DETERMINATION 
The weight loss profile of the dimers was analysed as previously for the monomeric 
structures. Figure 4.8 shows their behaviour as temperature rises and Figure 4.9 
illustrates the 𝑁𝑤 per molecule of dimer. When analysing the weight loss profile, it is 
notable that some compounds show no weight change. These compounds (DCUH and 
DMH, 204 and 154, respectively in Figure 4.8) were “dry” after one week exposure to 
100% RH. In contrast, DCDU, DCDH and DMS (186, 228 and 169, respectively in 
Figure 4.8) were in solution but all the water is lost up to ~100ºC and the compounds 
then maintain their weight until they reach their decomposition temperatures. 
 
Figure 4.8 Thermogravimetric profiles for the dimeric structures. Sample codes, top to bottom: 175 – 
DMU, 169 – DMS, 154 – DMH, 186 – DCDU, 252 – DCDS, 228 – DCDH, 206 – DCUU, 155 – DCUS, 
204 – DCUH. 
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As observed in the monomeric structures, the hydroxylated series has no water holding 
capacity suggesting that either intra or intermolecular hydrogen bonds occur and the 
hydrogen bond donor/acceptor (D/A) sites are not available to bind to water. The most 
remarkable observation comes from the saturated series. Having the same D/A 
relationship (Table 4.1), DMS holds one molecule of water whilst DCUS and DCDS 
bind to 7 and 1 molecule of water, respectively. Thermograms for each compound can 
be found in Appendix A7. 
 
 
Figure 4.9 Water uptake of the dimeric structures, given as the number of water molecules per dimer 
molecule. Data are mean  SD from n=3. 
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Table 4.1 Physico chemical properties of the dimers. 
Structure Mw T/ºC mp/ºC D/A D/A sites 𝑵𝒘 
 
DMU 
198.22 112-140 103-106 3/5 4/8 10.03 
 
DMS 
200.12 112-135 205-208 3/5 4/8 10.28 
 
DMH 
232.24 100-150 228-233 5/7 6/12 0 
 
DCDU 
198.22 100-150 210-213 3/5 4/8 0 
 
DCDS 
200.12 118-153 188-191 3/5 4/8 10.08 
 
DCDH 
232.24 100-150 225-229 5/7 6/12 0 
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Table 4.1 (Continued) 
Structure Mw T/ºC mp/ºC D/A D/A sites 𝑵𝒘 
 
DCUU 
198.22 125-150 176-180 3/5 4/8 40.29 
 
DCUS 
200.12 116-145 172-175 3/5 4/8 70.69 
 
DCUH 
232.24 100-150 216-220 5/7 6/12 0 
 
In an attempt to explain these data, at a structural level, NOESY (Nuclear Overhauser 
Effect Spectroscopy) NMR experiments were run on compounds DCUU, DCUS, 
DCDU, DCDS, DCUH and DCDH (Appendix A8). 
 
The results provide insight into the spatial arrangement of atoms in these molecules, and 
the results are summarised in Figure 4.10. The NOESY experiment can be used to 
measure interatomic distances; in this way, a strong NOE (red) means that the atoms are 
of 1.8-2.7 Å apart, a medium NOE (green) up to ~3.3 Å and a weak NOE (blue) for 
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atoms up to 5.0 Å. In this study data was used qualitatively to understand proximity 
between atoms. 
 
DCDU 
 
DCUU 
 
DCDS 
 
DCUS 
 
DCDH 
 
DCUH 
  
Figure 4.10 NOEs of the enantiomerically pure dimers. Samples were prepared at ~20 mg/mL in 
H2O:D2O (9:1, v:v). 
 
With regard to the water holding capacity studies, some observations about geometry 
can be inferred. The unsaturated compounds (DCDU and DCUU) only share a strong 
NOE to the  hydrogen, implying that their geometry is significantly different, and this 
might be the reason of such different behaviour towards water holding capacity. The 
saturated compounds (DCDS and DCUS) differ in the proximity of the amide hydrogen 
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to the hydrogens in the methyl group of the alanine residue, conferring a different 
volume to the molecules and hence, a different availability of D/A sites. Finally, the 
hydroxylated compounds (DCDH and DCUH) have similar NOEs. 
An attempt was made to further understand how water was binding to each structure; 
ChemDraw’s Chem3D package was used to generate theoretical spatial arrangements of 
the dimers. Water molecules were added to the minimised energy structure of each 
compound and molecular dynamics calculations were performed. Three of the structures 
failed to reach an equilibrium state and so would require more detailed modelling 
studies. Figure 4.11 shows the results obtained where modelling was realistic. It is clear 
that all successfully modelled structures can “theoretically” bind to water, contradicting 
experimental data. In order to test the reliability of the modelling, measurements for 
expected NOEs were taken (Figure 4.11, right side) and the results are illustrated in 
Figure 4.12, comparing the experimentally derived NOE interactions against those from 
the theoretical modelling, using the same simplified scheme for interatomic distances. 
The results in Figure 4.11 and 4.12 show that the generated theoretical structures are 
close to the experimental ones. DCUS and DCUU have an experimental/theoretical 𝑁𝑤 
of 7/7 and 4/5 respectively, and it can be assumed that the atomic spatial arrangement is 
fairly well represented by the theoretically modelled structures. The same conclusion 
cannot be drawn for compound DCDU (𝑁𝑤, 0/7); experimental data showed no water 
holding capacity contradicting expectations. It was theorised that the structures could 
dimerise, and two molecules of each compound were modelled to understand how they 
could interact. As previously, the modelling was not successful for all compounds and 
the generated structures can be found in Appendix A9. 
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Figure 4.11 Theoretically bound water (left) and atomic distances (right) for DCDU, DCUU and DCUS. 
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Figure 4.12 Comparison of proximity inferences between experimental and theoretical atomic distances. 
 
4.4 CONCLUSIONS 
Three series of dimers (unsaturated, saturated and hydroxylated) were synthesised in 
good yields providing a total of 9 compounds. The coupling agent gave higher yields for 
the amide condensation than those obtained for the ester (Chapter 3). 
The increase of the molecule size had a significant impact on water uptake. Increasing 
the D/A relationship had no pronounced effect except for compounds DCUS and 
DCDU. There is no marked difference between racemic and enantiomerically pure 
_____________________________________Synthesis and water uptake of Peptides 
 
 
 
129 
 
 
compounds except for DCUU and DCUS. Both compounds are derived from the same 
cis conformation (cis up). The compounds with the opposite conformation (cis down) 
do not bind to water. The hydroxylated series has the same behaviour as in the 
monomeric structures with no water holding capacity. Theoretically generated structures 
agree with experimental data for compound DCUU and DCUS, with 
experimental/theoretical 𝑁𝑤 of 4/5 and 7/7, respectively. 
Chapter 5 further investigates these results by generating potentially foldameric 
structures with additional rotational degree of freedom and analysing the possible 
inter/intramolecular interactions. 
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5. SYNTHESIS AND WATER UPTAKE OF HIGHER MOLECULAR WEIGHT 
MOLECULES 
5.1. INTRODUCTION 
This chapter follows the same organisational logic of the previous two. An overview of 
the synthesised compounds (Figure 5.1) and the synthetic route followed is given in the 
current section. Synthetic procedures and the characterisation of the synthesised 
compounds are given in section 5.2. Section 5.3 discusses the synthetic approaches and 
the results obtained for water holding capacity and finally, section 5.4 provides the 
chapter’s conclusions. The rational followed in previous chapters to code the structures 
herein synthesised was applied (T for tetramer, H for hexamer and O for octamer 
substitutes D for dimer from Chapter 4 and M for monomer from Chapter 3).  
 
Figure 5.1 Summary of the synthesised structures. 
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Figure 5.1 (Continued). 
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Figure 5.1 (continued) 
 
The synthetic route (Schemes 5.1 and 5.2) follows the same strategy as previously 
described in Chapter 4. It involves the orthogonal deprotection of the amine and the acid 
groups followed by condensation into an amide bond. 
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Scheme 5.1 Synthetic route to obtain the foldameric precursors. i) LiOH, MeOH, r.t. ii) TFA, DCM, 0ºC 
iii) Pybop, DIPEA, DMSO iv) H2, Pd/C, MeOH v) OsO4, NMO, Acetone. vi) 20c, Pybop, DIPEA, 
DMSO. 
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Scheme 5.1 (continued). vii) 19b or 19c, PyBop, DIPEA, DMSO. 
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The final compounds were obtained, as before, by deprotecting the acid and the amino 
group followed by ion exchange to assess the free foldameric structures illustrated in 
Figure 5.1. Spectral data for the described compounds can be found in Appendix A10. 
 
5.2 EXPERIMENTAL 
5.2.1 ORTHOGONAL DEPROTECTION OF THE AMINO AND ACID GROUPS 
5.2.1.1 Acid group deprotection 
As described in Chapter 4, via saponification, section 4.3.3.1. 
Via hydrogenation 
As described in Chapter 3, via hydrogenation, section 3.2.6.1. 
5.2.1.2 Amino group deprotection 
As described in Chapter 3, via TFA cleavage, section 3.2.6.2. 
5.2.2 COUPLING 
Procedure to synthesise compounds 24a-c, 25a-c, 27c, 28b-c and 30c. DIPEA (6.03 
mL, 4.47 mmol) followed by PyBop (0.93 g, 1.79 mmol) was added to a solution of the 
suitable OBn deprotected dimer (0.45 g, 1.49 mmol) in DMSO and left stirring for 15 
minutes at room temperature. The corresponding Boc deprotected dimer (0.60 mL, 1.49 
mmol) and the mixture was left stirring for 48 hours. Water was added, and the mixture 
poured into a separating funnel. EtOAc (3x) was added and the layers separated. The 
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combined organic layers were dried over anhydrous Na2SO4, filtered and concentrated 
under reduced pressure. EtOAc was added (minimum amount) followed by hexane to 
precipitate the product. The solid (white/creamy powder) was then filtered and dried 
under suction. 
5.2.3 HYDROXYLATION 
Procedure to synthesise compounds 26a-c and 29b-c. As described in Chapter 3, section 
3.2.5. 
5.2.4 ION EXCHANGE 
Procedure to synthesise compounds TMU, TMS, TMH, TCDU, TCDS, TCDH, 
TCUU, TCUS, TCUH, HCUS, HCDH, HCUH, and OCUS. As described in Chapter 
3, section 3.2.7. 
5.2.5 PRECURSORS CHARACTERISATION 
 
Benzyl (2-((2S)-2-(2-((tert-butoxycarbonyl)amino)cyclopent-3-ene-1-carboxamino) 
propanamido)cyclopent-3-ene-1-carbonyl)-L-alaninate (24a). Yield 96%. 
1
H NMR 
(400 MHz, DMSO): diastereomers  1.06-1.13 (m, 3H, H9), 1.28 (m,3H, H9’), 1.29-1.43 
(m, 9H, H7), 2.18-2.43 (m, 2H, H5 and H5’), 2.55-2.78 (m, 2H, H5 and H5’), 3.10-3.28 
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(m, 2H, H1 and H1’), 4.10-4.32 (m, 2H, H8 and H8’), 4.64-4.84 (m, 1H, H2), 5.00-5.18 
(m, 3H, H2’ and H10), 5.42-5.58 (m, 2H, H4 and H4’), 5.72-5.97 (m, 2H, H3 and H3’), 
6.07-6.50 (m, 1H, NHCOOCCH3), 7.29-7.41 (m, 5H, H11), 7.46-7.93 (m, 2H, CONHH1 
and CONHH2’), 8.15-8.40 (m, 1H, CONHH1’). 
13
C NMR (100 MHz, DMSO): 16.6 (C9’), 
17.8 (C9), 28.2 (C7), 32.9 (C5 and C5’), 45.3 (C1 and C1’), 48.3 (C8’), 49.8 (C8), 55.0 
(C2’), 57.0 (C2), 65.7 (C10), 82.7 (C6), 127.6 (C11), 127.7 (C11), 128.0 (C11), 128.4 (C11), 
130.1 (C4 and C4’), 132.3 (C3 and C3’), 136.1 (C11), 156.7 (C=O, NHCOOCCH3), 171.4 
(C=O, CONHH1 and CONHH1’), 172.3 (C=O, CONHH2’), 173.4 (C=O, COOBn). 
HRMS (ESI, MeOH) calculated for C30H40N4O7: 568.6710, found M+Na: 591.2777. 
 
Benzyl ((1S,2R)-2-((S)-2((1S,2R)-2((tert-butoxycarbonyl)amino)cyclopent-3-ene-1-
carboxamido)propanamido)cyclopent-3-ene-1-carbonyl)-L-alaninate (24b). Yield 
55%. 
1
H NMR (400 MHz, DMSO):  rotamers, 1.09 (d, J = 7.2 Hz, 3H, H9), 1.26 (d, J 
= 7.2 Hz, 3H, H9’), 1.32 (s, 9H, H7), 2.23-2.39 (m, 2H, H5 and H5’), 2.55-2.74 (m, 1H, 
H5 and H5’), 3.13-3.26 (m, 2H, H1 and H1’), 4.15-4.24 (m, 1H, H8), 4.26-4.33 (m, 1H, 
H8’), 4.73-4.85 (m, 1H, H2), 4.96-5.06 (m, 1H, H2’), 5.07-5.15 (m, 2H, H10), 5.45-5.61 
(m, 2H, H4 and H4’), 5.76-5.93 (m, 2H, H3 and H3’), 6.07 (d, J = 9.2 Hz, 1H, 
NHCOOCCH3), 7.29-7.41 (m, 5H, H11), 7.55 (d, J = 8.8 Hz, 1H, CONHH2’), 7.89 (d, J 
= 7.2 Hz, 1H, CONHH1), 8.37 (d, J = 7.2 Hz, 1H, CONHH1’).
 13
C NMR (100 MHz, 
DMSO): 17.4 (C9’), 17.9 (C9), 28.2 (C7), 33.7 (C5’), 34.8 (C5), 45.0 (C1), 45.7 (C1’), 47.8 
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(C8’), 48.3 (C8), 55.0 (C2’), 57.0 (C2), 66.8 (C10), 77.6 (C6), 127.7 (C11), 128.3 (C11), 
128.4 (C11), 129.8 (C11), 130.3 (C4 and C4’), 132.8 (C3 and C3’), 136.0 (C11), 154.6 
(C=O, NHCOOCCH3), 171.2 (C=O, CONHH1), 171.3 (C=O, CONHH1’), 172.2 (C=O, 
CONHH2’), 173.4 (C=O, COOBn). IR (, cm
-1
): 3293, 2929, 1750, 1714, 1687, 1634, 
1537, 1452, 1386, 1357, 1333, 1247, 1213, 1197, 1172, 1147, 1051, 1026. HRMS (ESI, 
MeOH) calculated for C30H40N4O7: 568.6710, found M+Na: 591.2785. 
 
Benzyl ((1R,2S)-2-((S)-2((1R,2S)-2((tert-butoxycarbonyl)amino)cyclopent-3-ene-1-
carboxamido)propanamido)cyclopent-3-ene-1-carbonyl)-L-alaninate (24c). Yield 
91%. 
1
H NMR (400 MHz, DMSO):  rotamers, 1.10 (d, J = 7.2 Hz, 3H, H9), 1.19-1.27 
(m, J = 7.2 Hz, 3H, H9’), 1.33 (s, 9H, H7), 2.18-2.40 (m, 2H, H5 and H5’), 2.56-2.78 (m, 
1H, H5 and H5’), 2.98-3.28 (m, 2H, H1 and H1’), 4.09-4.38 (m, 1H, H8 and H8’), 4.54-
4.87 (m, 1H, H2), 5.01-5.19 (m, 3H, H2’ and H10), 5.40-5.74 (m, 2H, H4 and H4’), 5.75-
5.97 (m, 2H, H3 and H3’), 6.26 (dd, J = 9.2 Hz, J=8.8 Hz, 1H, NHCOOCCH3), 7.28-7.41 
(m, 5H, H11), 7.54 (dd, J=8.8 Hz, J = 9.6 Hz, 1H, CONHH2’), 7.85 (dd, J = 7.6 Hz, J = 
7.6 Hz, 1H, CONHH1’), 8.37 (dd, J = 6.8 Hz, J = 6.8 Hz, 1H, CONHH1).
 13
C NMR (100 
MHz, DMSO): 16.6 (C9’), 18.4 (C9), 28.2 (C7), 34.7 (C5’), 35.4 (C5), 45.9 (C1 and C1’), 
48.5 (C8 and C8’), 55.6 (C2’), 57.3 (C2), 65.7 (C10), 77.8 (C6), 127.7 (C11), 128.0 (C11), 
128.4 (C11), 129.3 (C3’), 19.4 (C4 and C4’), 129.6 (C3), 136.1 (C11), 154.7 (C=O, 
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NHCOOCCH3), 170.6 (C=O, CONHH1), 171.5 (C=O, CONHH1’), 172.4 (C=O, 
CONHH2’), 174.9 (C=O, COOBn). IR (, cm
-1
): 3293, 2930, 2360, 2341, 1738, 1686, 
1637, 1532, 1452, 1389, 1364, 1355, 1281, 1244, 1218, 1152, 1051. HRMS (ESI, 
MeOH) calculated for C30H40N4O7: 568.6710, found M+Na: 591.2786. 
 
Benzyl (2-((2S)-2-(2-((tert-butoxycarbonyl)amino)cyclopentane-1-
carboxamido)propanamido)cyclopentane-1-carbonyl)-L-alaninate (25a). Yield 
27%. 
1
H NMR (400 MHz, DMSO):  diastereomers, 1.07-1.18 (m, 3H, H9), 1.20-1.30 
(m, 3H, H9’), 1.34 (s, 9H, H7), 1.39-1.91 (m, 12H, H3, H3’, H4, H4’, H5 and H5’), 2.65-
2.89 (m, 2H, H1 and H1’), 3.85-4.06 (m, 1H, H2), 4.08-4.34 (m, 3H, H2’, H8 and H8’), 
5.02-5.17 (m, 2H, H10), 6.19-6.46 (m, 1H, NHCOOCCH3), 7.27-7.41 (m, 5H, H11), 7.54 
(dddd, J = 8.4 Hz, J = 8.4 Hz, J = 7.6 Hz, J = 7.2 Hz, 1H, CONHH2’), 7.85 (ddd, J = 7.6 
Hz, J = 6.8 Hz, J = 6.8 Hz, 1H, CONHH1’), 8.37 (ddd, J = 8.0 Hz, J = 6.4 Hz, J = 3.2 
Hz, 1H, CONHH1). 
13
C NMR (101 MHz, DMSO): 17.1 (C9’), 18.6 (C9), 22.2 (C4 and 
C4’), 27.6 (C5 and C5’), 28.5 (C7), 32.2 (C3 and C3’), 46.8 (C1 and C1’), 48.2 (C8), 48.8 
(C8’), 52.4 (C2’), 54.0 (C2), 66.4 (C10), 128.4 (C11), 173.0 (4xC=O, CONH). HRMS 
(ESI, MeOH) calculated for C30H44N4O7: 572.7030, found M+Na: 595.3096. 
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Benzyl ((1S,2R)-2-((S)-2((1S,2R)-2((tert-butoxycarbonyl)amino)cyclopentane-1-
carboxamido)propanamido)cyclopentane-1-carbonyl)-L-alaninate (25b). Yield 
59%. 
1
H NMR (400 MHz, DMSO):  rotamers, 1.10 (d, J = 6.8 Hz, 3H, H9), 1.26 (d, J 
= 7.2 Hz, 3H, H9’), 1.33 (s, 9H, H7), 1.46-1.93 (m, 12H, H3, H3’, H4, H4’ H5, and H5’), 
2.79 (dd, J = 7.2 Hz, J = 7.6 Hz, H1 and H1’), 3.92-4.07 (m, 1H, H2), 4.10-4.23 (m, 2H, 
H2’ and H8), 4.23-4.34 (m, 1H, H8’), 5.10 (s, 2H, H10), 6.25 (d, J = 7.2 Hz, 
NHCOOCCH3), 7.26-7.42 (m, 5H, H11), 7.46 (d, J = 8.0 Hz, 1H, CONHH1), 7.81 (d, J = 
7.2 Hz, 1H, CONHH2’), 8.34 (d, J = 6.8 Hz, J=6.8 Hz1H, CONHH1’). 
13
C NMR (101 
MHz, DMSO): 17.1 (C9’), 17.6 (C9), 21.9 (C4 and C4’), 27.5 (C5 and C5’), 28.2 (C7), 
32.1 (C3 and C3’), 45.9 (C1 and C1’), 47.6 (C8), 48.1 (C8’), 53.1 (C2’), 53.6 (C2), 65.9 
(C10), 77.7 (C6), 127.9 (C11), 128.1 (C11), 128.5 (C11), 135.9 (C11), 154.8 (C=O, 
NHCOOCCH3), 171.5 (C=O, CONHH1), 172.2 (C=O, CONHH1’), 172.4 (C=O, 
CONHH2’), 172.8 (C=O, COOBn). IR (, cm
-1
): 3325, 2966, 2359, 1740, 1684, 1646, 
1637, 1536, 1449, 1389, 1366, 1315, 1288, 1247, 1215, 1195, 1173, 1138, 1058, 1042, 
1018. HRMS (ESI, MeOH) calculated for C30H44N4O7: 572.7030, found M+Na: 
595.3095. 
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Benzyl ((1R,2S)-2-((S)-2((1R,2S)-2((tert-butoxycarbonyl)amino)cyclopentane-1-
carboxamido)propanamido)cyclopentane-1-carbonyl)-L-alaninate (25c). Yield 
93%. 
1
H NMR (400 MHz, DMSO): , 1.11 (d, J = 7.2 Hz, 3H, H9), 1.23 (d, J = 7.6 Hz, 
3H, H9’), 1.34 (s, 9H, H7), 1.42-1.92 (m, 12H, H3, H3’, H4, H4’ H5, and H5’), 2.73-2.87 
(m, 2H, H1 and H1’), 3.92-4.07 (m, 1H, H2), 4.09-4.34 (m, 3H, H2’, H8 and H8’), 5.09 
(dd, J = 20.0 Hz, J = 12.8 Hz, 2H, H10), 6.31 (d, J = 8.0 Hz, NHCOOCCH3), 7.24-7.42 
(m, 5H, H11), 7.53 (d, J = 8.4 Hz, 1H, CONHH1), 7.78 (d, J = 7.2 Hz, 1H, CONHH2’), 
8.29 (d, J = 6.4 Hz, 1H, CONHH1’). 
13
C NMR (101 MHz, DMSO): 16.1 (C9’), 18.3 (C9), 
22.4 (C4 and C4’), 28.1 (C5 and C5’), 28.2 (C7), 32.2 (C3 and C3’), 46.4 (C1 and C1’), 
47.7 (C8 and C8’), 51.6 (C2 and C2’), 65.7 (C10), 77.5 (C6), 128.0 (C11), 171.6 (C=O, 
CONHH1 and C=O, CONHH1’), 172.6 (C=O, CONHH2’ and C=O, COOBn). IR (, cm
-
1
): 3323, 2961, 2358, 2342, 2177, 1759, 1685, 1638, 1529, 1447, 1364, 1311, 1286, 
1167, 1055, 1011. HRMS (ESI, MeOH) calculated for C30H44N4O7: 572.7030, found 
M+Na: 595.3091. 
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Benzyl (2-((2S)-2-(2-((tert-butoxycarbonyl)amino)-3,4-dihydroxycyclopentane-1-
carboxamido)propanamido)-3,4-dihydroxycyclopentane-1-carbonyl)-L-alaninate 
(26a). Yield 53%. 
1
H NMR (400 MHz, DMSO):  diastereomers, 1.10 (dd, J = 6.8 Hz, 
J = 6.8 Hz, 3H, H9), 1.22 (d, J = 7.2 Hz, 3H, H9’), 1.35 (s, 9H, H7), 1.53-1.69 (m, 2H, H5 
and H5’), 1.86-2.05 (m, 2H, H5 and H5’), 2.97-3.13 (m, 2H, H1 and H1’), 3.70-3.96 (m, 
5H, H2, H2’, H3, H4 and H4’), 4.09-4.38 (m, 3H, H3’, H8 and H8’), 4.67 (s.br, 4H, OH), 
5.01-5.19 (m, 2H, H10), 6.16 (dddd, J = 8.4 Hz, J = 8.4 Hz, J = 8.4 Hz, J = 4.8 Hz, 1H, 
NHCOOCCH3), 7.26-7.41 (m, 5H, H11), 7.48 (d, J = 9.2 Hz, 1H, CONHH2’), 7.81 (dd, J 
= 8.0 Hz, J = 6.0 Hz, 1H, CONHH1’), 8.33 (ddd, J = 8.0 Hz, J = 6.8 Hz, J = 6.4 Hz, 1H, 
CONHH1). 
13
C NMR (101 MHz, DMSO): 16.8 (C9’), 18.6 (C9), 28.5 (C7), 34.4 (C5’), 
34.2 (C5), 42.6 (C1 and C1’), 48.4 (C8 and C8’), 55.2 (C2’), 56.8 (C4), 66.1 (C10), 70.0 
(C3), 77.8 (C6), 127.6 (C11), 128.0 (C11), 128.4 (C11), 136.1 (C11), 172.5 (C=O, 
CONHH1), 173.2 (C=O, CONHH1’), 173.4 (C=O, CONHH2’), 173.8 (C=O, COOBn). 
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Benzyl ((1S,2S,3R,4S)-2((S)-2-((1S,2S,3R,4S)-2-((tert-butoxycarbonyl)amino)-3,4-
dihydroxycyclopentane-1-carboxamido)propanamido)-3,4-dihydroxycyclopentane-
1-carbonyl)-L-alaninate (26b). Yield: 56%. 
1
H NMR (400 MHz, DMSO)  1.09 (d, J 
= 6.8 Hz, 3H, H9), 1.23 (d, J = 7.2 Hz, 3H, H9’), 1.33 (s, 9H, H7), 1.55-1.69 (m, 2H, H5 
and H5’), 1.90-2.05 (m, 2H, H5 and H5’), 2.98-3.14 (m, 2H, H1 and H1’), 3.69-3.99 (m, 
5H, H2, H2’, H3, H4 and H4’), 4.11-4.32 (m, 3H, H3’, H8 and H8’), 4.56 (s.br, 4H, OH), 
5.08 (s.br, 2H, H10), 6.04 (d, J = 8.4 Hz, 1H, NHCOOCCH3), 7.26-7.46 (m, 6H, H11 and 
CONHH2’), 7.83 (d, J = 7.6 Hz, 1H, CONHH1’), 8.36 (d, J = 6.8 Hz, 1H, CONHH1). 
13
C 
NMR (101 MHz, DMSO) 17.3 (C9’), 18.3 (C9), 28.3 (C7), 33.0 (C5’), 33.7 (C5), 42.0 
(C1) 42.7 (C1’), 47.7 (C8 and C8’), 55.1 (C2 and C2’), 56.5 (C4 and C4’), 66.1 (C10), 69.1 
(C3 and C3’), 76.2 (C6), 127.9 (C11), 128.5 (C11), 136.0 (C11), 171.7 (C=O, CONHH1), 
173.0 (C=O, CONHH1’; C=O, CONHH2’ and C=O, COOBn). IR (, cm
-1
): 3304, 2973, 
1739, 1632, 1537, 1451, 1391, 1365, 1318, 1198, 1167, 1113, 1060. 
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Benzyl ((1R,2R,3S,4R)-2((S)-2-((1R,2R,3S,4R)-2-((tert-butoxycarbonyl)amino)-3,4-
dihydroxycyclopentane-1-carboxamido)propanamido)-3,4-dihydroxycyclopentane-
1-carbonyl)-L-alaninate (26c). Yield 62%. 
1
H NMR (400 MHz, DMSO)  1.11 (d, J = 
6.4 Hz, 3H, H9), 1.20 (d, J = 7.2 Hz, 3H, H9’), 1.35 (s, 9H, H7), 1.55-1.69 (m, 2H, H5 
and H5’), 1.90-2.05 (m, 2H, H5 and H5’), 3.01-3.14 (m, 2H, H1 and H1’), 3.50-3.97 (m, 
5H, H2, H2’, H3, H4 and H4’), 4.09-4.26 (m, 3H, H3’, H8 and H8’), 4.58 (s.br, 4H, OH), 
5.08 (dd, J = 29.6 Hz, J = 12.8 Hz, 2H, H10), 6.12 (d, J = 8.8 Hz, 1H, NHCOOCCH3), 
7.26-7.41 (m, 5H, H11), 7.47 (d, J = 8.4 Hz, 1H, CONHH2’), 7.77 (d, J = 7.6 Hz, 1H, 
CONHH1’), 8.27 (d, J = 6.0 Hz, 1H, CONHH1). 
13
C NMR (101 MHz, DMSO) 16.9 
(C9’), 19.1 (C9), 28.5 (C7), 33.0 (C5’), 33.3 (C5 and C5’), 42.8 (C1) 42.7 (C1’), 47.7 (C8 
and C8’), 55.1 (C2 and C2’), 56.5 (C4 and C4’), 65.9 (C10), 70.2 (C3 and C3’), 76.7 (C6), 
128.3 (C11), 173.8 (C=O, CONHH1; C=O, CONHH1’; C=O, CONHH2’ and C=O, 
COOBn). HRMS (ESI, MeOH) calculated for C30H44N4O11: 636.6990, found M+Na: 
659.2900. 
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Benzyl ((1S,2R)-2-((S)-2-((1S,2R)-2-((S)-2-((1S,2R)-2-((tert-butoxycarbonyl)amino) 
cyclopent-3-ene-1-carboxamido)propanamido)cyclopent-3-ene-1-carboxamido) 
propanamido)cyclopent-3-ene-1-carbonyl)-L-alaninate (28b). Yield 51%. 
1
H NMR 
(400 MHz, DMSO)  1.08 (d, J = 7.2 Hz, 3H, H9), 1.14 (d, J = 6.8 Hz, 3H, H9’), 1.29 (d, 
J = 7.2 Hz, 3H, H9’’), 1.33 (s, 9H, H7), 2.24-2.46 (m, 3H, H5, H5’ and H5’’), 2.57-2.84 
(m, 3H, H5, H5’ and H5’’), 2.98-3.28 (m, 3H, H1, H1’ and H1’’), 3.91-4.12 (m, 3H, H8, H8’ 
and H8’’), 4.59-4.87 (m, 1H, H2), 4.90-5.20 (m, 4H, H2’, H2’’ and H10), 5.38-5.65 (m, 3H, 
H4, H4’ and H4’’), 5.76-5.97 (m, 3H, H3, H3’ and H3’’), 6.26 (dd, J = 9.2 Hz, J = 8.0 Hz, 
1H, NHCOOCCH3), 7.28-7.41 (m, 5H, H11), 7.42-7.65 (m, 2H, CONHH1 and 
CONHH2’), 7.72-8.25 (m, 2H, CONHH1’ and CONHH2’’), 8.40 (d, J = 7.2 Hz, 1H, 
CONHH1’’). 
13
C NMR (101 MHz, DMSO): 18.5 (C9, C9’ and C9’’), 28.5 (C7), 35.1 (C5, 
C5’ and C5’’), 45.6 (C1, C1’ and C1’’), 48.2 (C8, C8’ and C8’’), 55.3 (C2, C2’ and C2’’), 66.2 
(C10), 128.5 (C11), 130.4 (C4, C4’ and C4’’), 133.6 (C3, C3’ and C3’’), 173.2 (6xC=O). 
HRMS (ESI, MeOH) calculated for C39H52N6O9: 748.8280, found M+Na: 771.3696. 
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Benzyl ((1R,2S)-2-((S)-2-((1R,2S)-2-((S)-2-((1R,2S)-2-((tert-butoxycarbonyl)amino) 
cyclopent-3-ene-1-carboxamido)propanamido)cyclopent-3-ene-1-carboxamido) 
propanamido)cyclopent-3-ene-1-carbonyl)-L-alaninate (28c). Yield 98%. 
1
H NMR 
(400 MHz, DMSO)  rotamers 1.07 (d, J = 7.2 Hz, 3H, H9), 1.08 (d, J = 6.8 Hz, 3H, 
H9’), 1.24 (d, J = 6.8 Hz, 3H, H9’’), 1.33 (s, 9H, H7), 2.18-2.41 (m, 3H, H5, H5’ and H5’’), 
2.56-2.84 (m, 3H, H5, H5’ and H5’’), 2.96-3.28 (m, 3H, H1, H1’ and H1’’), 4.02-4.38 (m, 
3H, H8, H8’ and H8’’), 4.58-4.98 (m, 1H, H2), 5.00-5.20 (m, 4H, H2’, H2’’ and H10), 5.41-
5.63 (m, 3H, H4, H4’ and H4’’), 5.75-5.97 (m, 3H, H3, H3’ and H3’’), 6.25 (dd, J = 9.2 Hz, 
J = 8.4 Hz, 1H, NHCOOCCH3), 7.30-7.40 (m, 5H, H11), 7.51 (ddd, J = 9.6 Hz, J = 9.2 
Hz, J = 8.4 Hz, 2H, CONHH1 and CONHH2’), 7.85 (dd, J = 11.6 Hz, J = 6.8 Hz, 2H, 
CONHH1’ and CONHH2’’), 8.20 (dd, J = 6.4 Hz, J = 5.6 Hz, 1H, CONHH1’’). 
13
C NMR 
(101 MHz, DMSO) 18.6 (C9, C9’ and C9’’), 28.5 (C7), 34.5 (C5, C5’ and C5’’), 46.1 (C1, 
C1’ and C1’’), 48.8 (C8, C8’ and C8’’), 55.3 (C2, C2’ and C2’’), 66.0 (C10), 128.4 (C11), 
130.0 (C4, C4’ and C4’’), 133.7 (C3, C3’ and C3’’), 173.1 (6xC=O). HRMS (ESI, MeOH) 
calculated for C39H52N6O9: 748.8280, found M+Na: 771.3685. 
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Benzyl ((1R,2S)-2-((S)-2((1R,2S)-2-((S)-(1R,2S)-2-((tert-butoxycarbonyl)amino) 
cyclopentane-1-carboxamido)propanamido)cyclopentane-1-carboxamido) 
propanamido)cyclopentane-1-carbonyl)-L-alaninate (27c). Yield 90%. 
1
H NMR 
(400 MHz, DMSO)  rotamers 1.03-1.20 (m, 6H, H9 and H9’), 1.25 (d, J = 7.2 Hz, 3H, 
H9’’), 1.33 (s, 9H, H7), 1.38-2.02 (m, 18H, H3, H3’, H3’’, H4, H4’, H4’’, H5, H5’ and H5’’), 
2.64-2.90 (m, 3H, H1, H1’ and H1’’), 3.90-4.39 (m, 6H, H2, H2’, H2’’, H8, H8’ and H8’’), 
4.96-5.21 (m, 2H, H10), 6.29 (ddd, J = 8.4 Hz, J = 7.2 Hz, J = 6.8 Hz, 1H, 
NHCOOCCH3), 7.25-7.42 (m, 5H, H11), 7.42-8.02 (m, 4H, CONHH1, CONHH2’, 
CONHH1’ and CONHH2’’), 8.22 (dd, J = 6.4 Hz, J = 6.0 Hz, 1H, CONHH1’’). 
13
C NMR 
(101 MHz, DMSO): 16.9 (C9 and C9’), 18.6 (C9’’), 22.5 (C4, C4’ and C4’’), 27.2 (C5, C5’ 
and C5’’), 28.5 (C3, C3’ and C3’’), 47.2 (C1, C1’ and C1’’), 52.0 (C8, C8’ and C8’’), 54.1 (C2, 
C2’ and C2’’), 66.0 (C10), 128.3 (C11), 173.2 (6xC=O). HRMS (ESI, MeOH) calculated 
for C39H58N6O9: 754.9260, found M+Na: 777.4142. 
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Benzyl ((1S,2S,3R,4S)-2-((S)-2-((1S,2S,3R,4S)-2-((S)-2-((1S,2S,3R,4S)-2-((tert-
butoxycarbonyl)amino)-3,4-dihydroxycyclopentane-1-carboxamido)propanamido) 
-3,4-dihydroxycyclopentane-1-carboxamido)propanamido)-3,4-dihydroxycyclo 
pentane-1-carbonyl)-L-alaninate (29b). Yield 74%. 
1
H NMR (400 MHz, DMSO)  
rotamers 0.91-1.44 (m, 18H, H7, H9, H9’ and H9’’), 1.55-2.09 (m, 6H, H5, H5’ and H5’’), 
2.92-3.20 (m, 3H, H1, H1’ and H1’’), 3.64-4.39 (m, 12H, H3, H3’, H3’’, H4, H4’, H4’’, H8, 
H8’ and H8’’), 4.63 (s.br, 4H, OH), 5.08 (s.br, 2H, H10), 6.12 (dd, J = 8.8 Hz, J = 8.4 Hz, 
1H, NHCOOCCH3), 7.26-7.40 (m, 5H, H11), 7.50 (dd, J = 8.0 Hz, J = 8.0 Hz, 1H, 
CONH), 7.88 (ddd, J = 8.0 Hz, J = 7.2 Hz, J = 6.8 Hz, 2H, CONH), 8.40 (d, J = 6.8 Hz, 
1H, CONH). HRMS (ESI, MeOH) calculated for C39H58N6O15: 850.9200, found 
M+Na: 873.3857. 
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Benzyl ((1R,2R,3S,4R)-2-((S)-2-((1R,2R,3S,4R)-2-((S)-2-((1R,2R,3S,4R)-2-((tert-
butoxycarbonyl)amino)-3,4-dihydroxycyclopentane-1-carboxamido)propanamido) 
-3,4-dihydroxycyclopentane-1-carboxamido)propanamido)-3,4-dihydroxycyclo 
pentane-1-carbonyl)-L-alaninate (29c). Yield 85%. 
1
H NMR (400 MHz, DMSO)  
rotamers 1.00-1.15 (m, 6H, H9, and H9’), 1.22 (d, J = 4.4 Hz, 1H, H9’’), 1.34 (s, 9H, H7), 
1.47-2.06 (m, 6H, H5, H5’ and H5’’), 2.95-3.13 (m, 3H, H1, H1’ and H1’’), 3.64-4.33 (m, 
12H, H3, H3’, H3’’, H4, H4’, H4’’, H8, H8’ and H8’’), 4.53 (s.br, 6H, OH), 5.09 (dd, J = 32.0 
Hz, J = 13.2 Hz, 2H, H10), 6.09 (d, J = 7.2 Hz, 1H, NHCOOCCH3), 7.22-7.44 (m, 6H, 
H11 and CONH), 7.50 (d, J = 5.6 Hz, 1H, CONH), 7.75 (d, J = 7.2 Hz, 1H, CONH), 
7.84 (d, J = 6.4, 1H, CONH), 8.27 (d, J = 3.6 Hz, 1H, CONH). 
13
C NMR (101 MHz, 
DMSO) 16.8 (C9), 19.1 (C9’ and C9’’), 28.5 (C7), 33.3 (C5, C5’ and C5’’), 43.0 (C1, C1’ 
and C1’’), 48.3 (C8, C8’ and C8’’), 55.0 (C2, C2’ and C2’’), 56.9 (C4, C4’ and C4’’), 66.0 
(C10), 70.3 (C3, C3’ and C3’’), 128.6 (C11), 173.2 (5xC=O,CONH). 
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Benzyl ((1R,2S)-2-((S)-2-((1R,2S)-2-((S)-2-((1R,2S)-2-((S)-2-((1R,2S)-2-((tert-
butoxycarbonyl)amino)cyclopentane-1-carboxamido)propanamido)cyclopentane-
1-carboxamido)propanamido)cyclopentane-1-carboxamido)propanamido) 
cyclopentane-1-carbonyl)-L-alaninate (30c). Yield 77%. 
1
H NMR (400 MHz, 
DMSO)  rotamers 1.01-1.20 (m, 9H, H9, H9’ and H9’’), 1.24 (d, J = 7.2 Hz, 3H, H9’’’), 
1.34 (s, 9H, H7), 1.38-1.93 (m, 24H, H3, H3’, H3’’,H3’’’, H4, H4’, H4’’, H4’’’, H5, H5’, H5’’ 
and H5’’’), 2.64-2.93 (m, 4H, H1, H1’, H1’’ and H1’’’), 3.93-4.36 (m, 8H, H2, H2’, H2’’, 
H2’’’, H8, H8’, H8’’ and H8’’’), 5.03-5.17 (m, 2H, H10), 6.16-6.47 (m, 1H, NHCOOCCH3), 
7.27-7.40 (m, 5H, H11), 7.41-7.64 (m, 2H, CONHH1 and CONHH2’), 7.65-7.96 (m, 4H, 
CONHH1’, CONHH2’’, CONHH1’’, CONHH2’’’), 8.21 (dd, J = 6.4 Hz, J = 6.4 Hz, 1H, 
CONHH1’’’). 
13
C NMR (101 MHz, DMSO): 16.9 (C9), 18.5 (C9’, C9’’, C9’’’), 22.5 (C4, 
C4’, C4’’ and C4’’’), 27.3 (C5, C5’, C5’’ and C5’’’), 28.5 (C7, C7’, C7’’ and C7’’’), 32.5 (C3, 
C3’, C3’’, C3’’’) 47.2 (C1, C1’, C1’’ and C1’’’), 52.0 (C8, C8’, C8’’, and C8’’’), 54.4 (C2, C2’, 
C2’’ and C2’’’), 66.0 (C10), 128.3 (C11), 172.6 (6xC=O). 
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5.2.6 TETRAMERS, HEXAMERS AND OCTAMER CHARACTERISATION 
 
(2-((2S)-2-(2-aminocyclopent-3-ene-1-carboxamido)propanamido)cyclopent-3-ene-
1-carbonyl)-L-alanine (TMU). Yield 49%. mp 168-176ºC. 
1
H NMR (400 MHz, D2O) 
 diastereomers 1.24-1.38 (m, 6H, H7 and H7’), 2.46-3.04 (m, 4H, H5 and H5’), 3.09-3.51 
(m, 2H, H1 and H1’), 3.96-4.36 (m, 1H, H6 and H6’), 4.39-4.68 (m, 1H, H2), 5.16 (br.s, 
1H, H2’), 5.49-5.87 (m, 2H, H4 and H4’), 5.92-6.33 (m, 2H, H3 and H3’). 
13
C NMR (101 
MHz, D2O) 16.7 (C7 and C7’), 30.5 (C5), 34.0 (C5’), 43.6 (C1), 46.8 (C1’), 49.8 (C6), 50.1 
(C6’), 56.8 (C2), 56.9 (C2’), 125.9 (C4), 128.0 (C4’), 135.1 (C3), 139.1 (C3’), 173.2 
(3xC=O, CONH), 180.3 (C=O, COOH). HRMS (ESI, H2O) calculated for C18H26N4O5: 
378.4290, found M+H 379.1977. 
 
(2-((2S)-2-(2-aminocyclopentane-1-carboxamido)propanamido)cyclopentane-1-
carbonyl)-L-alanine (TMS). Yield: 53%. mp 175-185ºC. 
1
H NMR (400 MHz, D2O): 
 diastereomers 1.22-1.31 (m, 6H, H7 and H7’), 1.54-2.12 (m, 12H, H3, H3’, H4, H4’, H5 
and H5’), 2.86-3.02 (m, 2H, H1 and H1’), 3.73-3.83 (m, 1H, H2’), 4.07 (q, J = 7.2 Hz, 1H, 
H6), 4.12-4.23 (m, 1H, H6’), 4.30 (ddd, J = 20.8 Hz, J = 13.6 Hz, J = 6.8 Hz, 1H, H2). 
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13
C NMR (101 MHz, D2O): 16.5 (C7), 16.8 (C7’), 21.5 (C3), 22.0 (C5), 28.2 (C4 and 
C4’), 30.3 (C3’), 30.7 (C5’), 45.5 (C1), 47.9 (C1’), 49.2 (C6), 49.9 (C6’), 53.6 (C2), 53.7 
(C2’), 175.1 (3xC=O), 178.3 (C=O, COOH). 
 
(2-((2S)-2-(2-amino-3,4-dihydroxycyclopentane-1-carboxamido)propanamido)-3,4-
dihydroxycyclopentane-1-carbonyl)-L-alanine (TMH). Yield: 87%. mp 170-181 ºC. 
1
H NMR (400 MHz, D2O):  1.25-1.43 (m, 6H, H7 and H7’), 1.89-2.31 (m, 4H, H5 and 
H5’), 3.10-3.45 (m, 2H, H1 and H1’), 3.65-3.80 (m, 1H, H2), 3.97-4.46 (m, 7H, H2’, H3, 
H3’, H4, H4’, H6 and H6’). 
 
((1S,2R)-2-((S)-2((1S,2R)-2-aminocyclopent-3-ene-1-carboxamido)propanamido) 
cyclopent-3-ene-1-carbonyl)-L-alanine (TCDU). Yield: 33%. mp 195-205 ºC. 
Note: Compound TCDU was synthesised and characterised by NMR and the melting 
point measured. The NMR did not give a good reading, but some peaks were present, 
and a posterior analysis was to be run after further purification. When running it again 
the expected result was not achieved. Furthermore, the mass spectrometry did not 
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correspond to the expected molecular weight, so it was theorised that the compound 
degraded and due to time limitations and the fact that it was not of interest for further 
studies it was not synthesised again. 
 
((1S,2R)-2-((S)-2((1S,2R)-2-aminocyclopentane-1-carboxamido)propanamido) 
cyclopentane-1-carbonyl)-L-alanine (TCDS). Yield: 86%. mp 190-205 ºC. 
1
H NMR 
(400 MHz, D2O):  1.28 (d, J = 7.2 Hz, 3H, H7), 1.29 (d, J = 7.2 Hz, 3H, H7’), 1.52-1.69 
(m, 2H, H3 and H5), 1.70-2.04 (m, 8H, H3, H3’, 2xH4, 2xH4’, H3’ and H5’), 2.05-2.22 (m, 
2H, H3’ and H5’), 2.91-3.05 (m, 2H, H1 and H1’), 3.82 (dt, J = 6.4 Hz, J = 4.0 Hz, 1H, 
H2’), 4.10 (q, J = 7.2 Hz, 1H, H6), 4.23 (q, J = 7.2 Hz, H6’), 4.43 (dt, J = 14.8 Hz, J = 7.6 
Hz, 1H, H2). 
13
C NMR (101 MHz, D2O): 16.9 (C7), 17.8 (C7’), 21.5 (C3), 22.1 (C5), 
27.4 (C4), 28.0 (C4’), 30.2 (C3’), 31.5 (C5’), 45.6 (C1), 47.1 (C1’), 49.6 (C6), 50.9 (C6’), 
53.0 (C2), 53.5 (C2’), 175.6 (3xC=O), 181.0 (C=O, COOH). IR (, cm
-1
): 2924, 1548, 
1451, 1393, 1359, 1307, 1269, 1237, 1136, 1051, 1020. HRMS (ESI, H2O) calculated 
for C18H30N4O5: 382.4610, found M+H 383.2292. 
 
 
____________Synthesis and Water Uptake of Higher Molecular Weight Molecules 
 
 
 
155 
 
 
 
((1S,2S,3R,4S)-2((S)-2-((1S,2S,3R,4S)-2-amino-3,4-dihydroxycyclopentane-1-
carboxamido)propanamido)-3,4-dihydroxycyclopentane-1-carbonyl)-L-alanine 
(TCDH): Yield: 45%. mp 174-182 ºC. HRMS (ESI, H2O) calculated for C18H30N4O9: 
446.4570, found M+Na: 469.1788. 
Note: compound TCDH was synthesised and the NMR showed contamination with 
NMO from the previous step, further purification did not afford enough amount for a 
proper characterisation and mass spectrometry was performed to confirm the expected 
molecular weight. Due to time limitations and the fact that this compound was no longer 
needed, a second batch was not performed to fully characterise it. 
 
((1R,2S)-2-((S)-2((1R,2S)-2-aminocyclopent-3-ene-1-carboxamido)propanamido) 
cyclopent-3-ene-1-carbonyl)-L-alanine (TCUU). Yield 23%. mp 158-170 ºC. 
1
H 
NMR (400 MHz, D2O):  1.32 (d, J = 7.2 Hz, 3H, H7), 1.35 (d, J = 7.2 Hz, 3H, H7’), 
2.47-2.59 (m, 1H, H5), 2.68-2.85 (m, 3H, H5 and 2xH5’), 3.39 (dq, J = 8.4 Hz, J = 8.4 
Hz, 2H, H1 and H1’), 4.15 (q, J = 7.2 Hz, 1H, H6), 4.22 (q, J = 7.2 Hz, H6’), 4.43 (d, J = 
7.6 Hz, 1H, H2), 5.17 (d, J = 7.6 Hz, 1H, H2’), 5.61 (dd, J = 5.6 Hz, J = 2.4 Hz, 1H, H4), 
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5.81 (dd, J = 5.6 Hz, J = 2.4 Hz, 1H, H4’), 6.07 (dd, J = 5.6 Hz, J = 1.6 Hz, 1H, H3), 
6.29 (dd, J = 7.4 Hz, J = 3.2 Hz, 1H, H3’). 
13
C NMR (101 MHz, D2O): 16.5 (C7), 16.8 
(C7’), 33.8 (C5), 35.3 (C5’), 43.7 (C1), 46.7 (C1’), 49.6 (C6), 49.7 (C6’), 56.6 (C2), 56.9 
(C2’), 125.8 (C4), 127.8 (C4’), 135.2 (C3), 138.9 (C3’), 173.2 (C=O, CONHH1), 173.7 
(C=O, CONHH1’), 174.1 (C=O, CONHH2’), 178.4 (C=O, COOH). IR (, cm
-1
): 2924, 
1548, 1451, 1393, 1359, 1307, 1269, 1237, 1136, 1051, 1020. HRMS (ESI, H2O) 
calculated for C18H26N4O5: 378.4290, found M+H 379.1979. 
 
((1R,2S)-2-((S)-2((1R,2S)-2-aminocyclopentane-1-carboxamido)propanamido) 
cyclopentane-1-carbonyl)-L-alanine (TCUS). Yield: 56%. mp 180-194 ºC. 
1
H NMR 
(400 MHz, D2O):  1.30 (d, J = 7.2 Hz, 3H, H7), 1.31 (d, J = 7.2 Hz, 3H, H7’), 1.57-2.21 
(m, 12H, H3, H3’, H4, H4’, H5 and H5’), 2.95 (m, 2H, H1 and H1’), 3.80-3.89 (m, 1H, H2’), 
4.05 (q, J = 7.2 Hz, 1H, H6), 4.24 (q, J = 7.2 Hz, H6’), 4.39 (q, J = 7.2 Hz, 1H, H2). 
13
C 
NMR (101 MHz, D2O): 16.8 (C7), 17.0 (C7’), 21.5 (C3), 22.2 (C5), 26.9 (C4), 28.1 (C4’), 
30.2 (C3’), 31.9 (C5’), 45.5 (C1), 48.0 (C1’), 49.4 (C6), 50.7 (C6’), 52.9 (C2), 53.5 (C2’), 
174.2 (C=O, CONHH1), 174.3 (C=O, CONHH1’), 174.5, (C=O, CONHH2’), 180.0 (C=O, 
COOH). IR (, cm-1): 2924, 1548, 1451, 1393, 1359, 1307, 1269, 1237, 1136, 1051, 
1020. HRMS (ESI, H2O) calculated for C18H30N4O5: 382.4610, found M+H: 383.2290. 
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((1R,2R,3S,4R)-2((S)-2-((1R,2R,3S,4R)-2-amino-3,4-dihydroxycyclopentane-1-
carboxamido)propanamido)-3,4-dihydroxycyclopentane-1-carbonyl)-L-alanine 
(TCUH): Yield: 67%. mp 148-156 ºC. 
1
H NMR (400 MHz, D2O):  1.25-1.41 (m, 6H, 
H7 and H7’), 1.92-2.08 (m, 1H, H5), 2.13-2.28 (m, 3H, H5 and 2xH5’), 3.20-3.44 (m, 2H, 
H1), 3.65-3.80 (m, 1H, H2), 4.08-4.16 (m, 1H, H6), 4.17-4.24 (m, 3H, H2’, H3 and H4), 
4.26-4.38 (m, 3H, H1’, H3’ and H6’). 
13
C NMR (101 MHz, D2O): 18.6 (C7 and C7’), 
32.1 (C5), 34.6 (C5’), 39.2 (C1), 42.6 (C1’), 49.5 (C4), 54.8 (C4’), 70.0 (C3 and C3’), 
75.0 (C6), 76.0 (C6’), 175.0 (3xC=O), 180.3 (C=O, COOH). HRMS (ESI, H2O) 
calculated for C18H30N4O9: 446.4570, found M+H: 447.2084. 
 
((1R,2S)-2-((S)-2-((1R,2S)-2-((S)-2-((1R,2S)-2-aminocyclopentane-1-carboxamido) 
propanamido)cyclopentane-1-carboxamido)propanamido)cyclopentane-1-
carbonyl)-L-alanine (HCUS). Yield 76 %. mp 181-196ºC. 
1
H NMR (400 MHz, D2O): 
 1.22-1.37 (m, 9H, H7, H7’ and H7’’), 1.55-2.20 (m, 18H, H3, H3’, H3’’, H4, H4’, H4’’, H5, 
H5’ and H5’’), 2.87-3.07 (m, 3H, H1, H1’ and H1’’), 3.76-3.92 (m, 1H, H2), 3.98-4.16 (m, 
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2H, H6 and H6’), 4.17-4.28 (m,1H, H6’’), 4.30-4.46 (m, 2H, H2’ and H2’’). 
13
C NMR (101 
MHz, D2O): 16.8 (C7 and C7’), 21.9 (C3, C4 and C5), 27.2 (C3’, C4’ and C5’), 31.9 (C3’’, 
C4’’ and C5’’), 45.4 (C1), 47.9 (C1’ and C1’’), 49.4 (C6), 49.8 (C6’), 50.2 (C6’’), 52.8 (C2 
and C2’), 53.4 (C2’’), 174.4 (5xC=O, CONH), 180.4 (C=O, COOH). HRMS (ESI, H2O) 
calculated for C27H44N6O7: 564.6840, found M+H: 565.3342. 
 
((1S,2S,3R,4S)-2-((S)-2-((1S,2S,3R,4S)-2-((S)-2-((1S,2S,3R,4S)-2-amino-3,4-
dihydroxycyclopentane-1-carboxamido)propanamido)-3,4-dihydroxycyclopentane-
1-carboxamido)propanamido)-3,4-dihydroxycyclopentane-1-carbonyl)-L-alanine 
(HCDH). Yield: 24%. mp 163-174 ºC. 
1
H NMR (400 MHz, D2O):  1.10- 1.45 (m, 
9H, H7, H7’ and H7’’), 1.80-2.36 (m, 6H, H5, H5’ and H5’’), 3.05-3.50 (m, 3H, H1, H1’ and 
H1’’), 3.62-3.95 (m, 2H, H6 and H6’), 3.96-4.45 (m, 10H, H2, H2’, H2’’, H3, H3’, H3’’, H4, 
H4’, H4’’ and H6’’). 
13
C NMR (101 MHz, D2O): 17.7 (C7), 23.7 (C7’ and C7’’), 32.5 (C5, 
C5’and C5’’), 39.4 (C1), 43.0 (C1’ and C1’’), 49.6 (C2, C2’ and C2’’), 50.8 (C6), 54.7 (C6’ 
and C6’’), 70.1 (C4 and C4’ and C4’’), 75.6 (C3’, C3’’), 76.0 (C3), 175.6 (5xC=O, CONH), 
180.4 (C=O, COOH). HRMS (ESI, H2O) calculated for C27H44N6O13: 660.6780, found 
M+H: 661.3049. 
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((1R,2R,3S,4R)-2-((S)-2-((1R,2R,3S,4R)-2-((S)-2-((1R,2R,3S,4R)-2-amino-3,4-
dihydroxycyclopentane-1-carboxamido)propanamido)-3,4-dihydroxycyclopentane-
1-carboxamido)propanamido)-3,4-dihydroxycyclopentane-1-carbonyl)-L-alanine 
(HCUH). Yield: 33%. mp 163-190 ºC. 
1
H NMR (400 MHz, D2O):  1.25- 1.46 (m, 
9H, H7, H7’ and H7’’), 1.89-2.22 (m, 6H, H5, H5’ and H5’’), 3.22-3.45 (m, 3H, H1, H1’ and 
H1’’), 3.51-3.79 (m, 2H, H6 and H6’), 4.02-4.43 (m, 10H, H2, H2’, H2’’, H3, H3’, H3’’, H4, 
H4’, H4’’ and H6’’). 
13
C NMR (101 MHz, D2O): 16.2 (C7), 16.8 (C7’ and C7’’), 30.5 (C5), 
32.4 (C5’), 34.4 (C5’’), 39.2 (C1), 42.7 (C1’ and C1’’), 49.3 (C2, C2’ and C2’’), 54.8 (C6), 
55.2 (C6’ and C6’’), 70.0 (C4 and C4’ and C4’’), 75.5 (C3’, C3’’), 76.0 (C3), 176.7 
(6xC=O). HRMS (ESI, H2O) calculated for C27H44N6O13: 660.6780, found M+Na: 
683.2877. 
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((1R,2S)-2-((S)-2-((1R,2S)-2-((S)-2-((1R,2S)-2-((S)-2-((1R,2S)-2-aminocyclopentane-
1-carboxamido)propanamido)cyclopentane-1-carboxamido)propanamido) 
cyclopentane-1-carboxamido)propanamido)cyclopentane-1-carbonyl)-L-alanine 
(OCUS). Yield: 67%. mp 195-215 ºC. 
1
H NMR (400 MHz, D2O):  1.22-1.36 (m, 
12H, H7, H7’, H7’’, H7’’’), 1.53-2.20 (m, 24H, H3, H3’, H3’’, H3’’’, H4, H4’, H4’’, H4’’’, H5, 
H5’ H5’’ and H5’’’), 2.86-3.07 (m, 4H, H1, H1’, H1’’ and H1’’’), 3.72-3.89 (m, 1H, H2), 
4.03-4.45 (m, 7H, H2’ H2’’, H2’’’, H6, H6’, H6’’ and H6’’’). 
13
C NMR (101 MHz, D2O): 
16.8 (C7, C7’, C7’’ and C7’’’), 22.0 (C3, C4 and C5), 27.0 (C3’, C4’ and C5’), 30.0 (C3’’, C4’’ 
and C5’’), 31.9 (C3’’’, C4’’’ and C5’’’), 45.3 (C1), 47.9 (C1’, C1’’ and C1’’’), 49.3 (C6), 49.3 
(C6’), 49.5 (C6’’ and C6’’’), 52.8 (C2 and C2’), 53.4 (C2’’ and C2’’’), 174.4 (7xC=O, 
CONH), 178.5 (C=O, COOH). IR (, cm-1): 2924, 1548, 1451, 1393, 1359, 1307, 1269, 
1237, 1136, 1051, 1020. HRMS (ESI, H2O) calculated for C36H58N8O9: 746.9070, 
found M+H: 747.4404. 
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5.3 RESULTS AND DISCUSSION 
5.3.1 SYNTHESIS OF THE UNSATURATED, SATURATED AND HYDROXYLATED 
FOLDAMERS 
The synthetic steps to obtain the desired compounds, both as mixtures of the possible 
isomers and enantiomerically pure were, as in Chapter 4, reactions of deprotection, 
coupling and hydroxylation. Focus is given to details of the synthesis that differ from 
those discussed in Chapters 3 and 4. In this way, emphasis is given to the synthesis of 
the hydroxylated compounds. The unsaturated and saturated tetramers were obtained by 
deprotecting the amino and the acid groups in equal amounts of the corresponding 
dimer and coupling them together. This approach could not be followed for the 
hydroxylated compounds because the hydroxyl groups would compete with the acid 
group and condensate into an ester. 
To avoid this competing reaction the hydroxyl groups had to be protected (Figure 5.2). 
The challenge was to find a protecting group (G) resistant to an acid moiety when 
deprotecting the amine group. The first attempt to protect the hydroxyl groups used the 
monomeric derivative 10a (Scheme 5.2). Imidazole (Im) is often used as base to remove 
the HCl formed when the nucleophile (hydroxyl group) attacks the electrophile 
(TBSCl). Compound 31a was successfully synthesised and the methodology was 
applied to compound 13c with a 92% yield. The next step was to orthogonally deprotect 
compound 32a (Scheme 5.3) and couple both products to obtain 26a-c. 
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Figure 5.2 Representation of the synthetic strategy to obtain the hydroxylated tetrameric precursor. 
 
 
Scheme 5.2 Protection of the hydroxyl groups. i) TBSCl, Im, DMF, 0ºC, O.N. 
 
The expected result of the deprotection via hydrogenation was successful (compound 
33a, Scheme 5.3) but the NMR analysis of the deprotection of the amine group via TFA 
revealed the loss of the Boc group, as expected, and the loss of the TBS group as well 
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(Figure 5.3). The peaks at ~0.00 and ~1.00 ppm should integrate for 12 and 18 protons, 
respectively. This indicates that the protecting group is absent in the product. 
 
 
Scheme 5.3 i) TBSCl, Im, DMF; ii) H2 (1atm), Pd/C, MeOH; iii) TFA, DCM, 0ºC. 
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Figure 5.3 
1
H NMR spectrum of the deprotection product. 
 
Scheme 5.4 illustrates two other attempts to protect the hydroxyl groups using p-
Methoxybenzyl Chloride (PMBCl) following the procedure by Jenkins et al.
105
 and 1,3-
Dichloro-1,1,3,3-tetraisopropylsiloxane (TIPDSiCl2). The reaction with PMBCl was not 
successful and the expected product using TIPDSiCl2 was identified by NMR. The 
TIPDSiCl2 protection was labile to an acidic moiety making it impracticable to use this 
methodology. 
 
 
____________Synthesis and Water Uptake of Higher Molecular Weight Molecules 
 
 
 
165 
 
 
 
 
Scheme 5.4 i) PMBCl, NaH, DMF; ii) ,TIPDSiCl2, Et3N, DCM; iii) TFA, DCM, 0ºC. 
 
Compounds 26a-c were successfully synthesised using the same methodology as for the 
dimers, i.e., hydroxylating the unsaturated tetramer as illustrated in figure 5.1. 
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5.3.2. WATER UPTAKE DETERMINATION 
The thermogravimetric profiles of the compounds synthesised in this chapter is depicted 
in Figure 5.4 and Figure 5.5 with -lactose behaving as before. The weight loss analysis 
shows that the compounds herein synthesised are hygroscopic and, after equilibration 
with water, they then lose weight as temperature rises. However, the number of waters 
(𝑁𝑤) per molecule of compound (Figure 5.6) is relevant only for compound TCUS 
which is the compound with the lowest D/A (hydrogen bond donor/acceptor ratio) 
(Table 5.1). The hydroxylated series has a 𝑁𝑤 of 1 or 2 except for compound TCDH 
which follows the trend of the previous compounds with lower molecular weight. 
 
Figure 5.4 Thermogravimetric profiles for the tetrameric, hexameric and octameric structures. Sample 
codes, top to bottom: 265 – TMU, 262 – TMS, 218 – TMH, 297 – TCDU, 253 – TCDS, 241 – TCDH, 
214 – TCUU, 211 – TCUS, 280 – TCUH. 
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Figure 5.5 Thermogravimetric profiles for the hexamers and octamer. Sample codes, top to bottom: 296 – 
HCDH, 276 – HCUS, 289 – HCUH, 274 – OCUS. 
 
 
Figure 5.6 Water uptake of the higher molecular weight structures. Data are mean  SD from n=3. 
 
Thermograms for each compound can be found in Appendix A11. 
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Table 5.1 Physico chemical properties of the foldameric structures. 
Compound Mw T/ºC mp/ºC D/A D/A sites 𝑵𝒘 
TMU 378.43 120-150 168-176 5/9 6/14 0 
TMS 382.46 113-150 175-185 5/9 6/14 0 
TMH 446.46 115-149 170-181 9/13 10/22 2±0.48 
TCDU 378.43 117-152 195-205 5/9 6/14 2±0.23 
TCDS 382.46 110-155 190-205 5/9 6/14 0 
TCDH 446.46 108-150 174-182 9/13 10/22 0 
TCUU 378.43 115-150 158-170 5/9 6/14 0 
TCUS 382.46 128-150 180-194 5/9 6/14 7±0.59 
TCUH 446.46 120-150 148-156 9/13 10/22 1±0.22 
HCDH 660.68 110-155 163-174 13/19 14/32 2±0.08 
HCUS 564.68 115-152 181-196 7/13 8/20 1±0.30 
HCUH 660.68 105-150 163-190 13/19 14/32 2±0.22 
OCUS 746.91 110-155 195-215 9/17 10/26 0 
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The weight loss from the analysed compounds generally occurs at temperatures up to 
~115ºC (Figures 5.4 and 5.5). This correlated with “free” water and none or neglectable 
bound water which would be bound to the molecules and hence expected to be released 
at higher temperatures. As mentioned above, the outstanding compound is TCUS which 
has 𝑁𝑤 of 7 molecules of water per molecule of compound. To better understand this 
behaviour, circular dichroism spectra were recorded for all compounds to investigate 
whether there was a specific folding shape that could explain these date, perhaps due to 
internal hydrogen bonding which would occupy the potential water binding sites and, in 
particular to determine if any of the compounds would fold into a -helix. The results 
are depicted in figure 5.7. From the literature, it is well established that random coils 
give a CD profile with a maximum at 190 nm,  sheets at 200 nm and -helices give 
two three maximums (at 210, 190 and an opposite at 185 nm). It can be seen that most 
of the structures fold into a random coil (with a negative maximum at ~190 nm) and 4 
of the compounds (TCDS, TCDH, HCUH and HCDH) fold into a  sheet with a 
maximum at ~200 nm. 
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Figure 5.7 Circular dichroism spectra for the synthesised structures. Spectra were run in water between 2-
6 mM. 
 
5.3.3. DYNAMIC VAPOUR SORPTION 
From the results above and previous chapters, the behaviour of the hydroxylated series 
differed to expectations. DVS experiments were run to further investigate on the 
hydroxylated series. The samples tested were MMH, DMH and TMH and the results 
are illustrated in Figure 5.8-11 using the same positive control as for the TGA 
experiments. The data for the DVS experiments can be consulted in Appendix A12. 
The isothermal curves follow two typical patterns for sorption (Figure 5.12 a), i.e., type 
II (MMH) and type III (DMH and TMH), according to the classification by Brunauer 
et al.
106
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Figure 5.8 Sorption isotherm for -lactose. 
 
 
Figure 5.9 Sorption isotherm for compound MMH. 
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Figure 5.10 Sorption isotherm for compound DMH. 
 
 
Figure 5.11 Sorption isotherm for compound TMH. 
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The typical shape of an isotherm reflects the way in which the water binds to a system. 
An isotherm can typically be divided into three regions (Figure 5.12 b); region I 
represents strongly bound water, in region II water molecules bind less firmly and 
region III represents free water. The difference between sorption and desorption curves 
is termed hysteresis. 
The DVS experiments for compound MMH confirmed the result obtained from TGA, 
showing that any water adsorbed was free water (isotherm curve presents hysteresis at 
region III, Figure 5.9), and gave some insight into the behaviour of compounds DMH 
and TMH. Both compounds have marked hysteresis; DMH’s hysteresis has a 
maximum at region II (Figure 5.10), indicating weekly bound water, and TMH’s 
hysteresis infers the formation of a hydrate (region I of the desorption curve has 5% 
more weight than the starting amount of compound, Figure 5.11). 
 
 
Figure 5.12 a) The five types of van der Waals adsorption isotherms.
106
 b) Regions of a sorption 
isotherm.
107
 
 
a) b) 
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In order to understand if this could also be observed in the solid state, attempts to grow 
crystals of the tested compounds and their enantiomerically pure isomers were made. 
Several solvent systems were employed with no success. Three crystals grew in water at 
room temperature over a period of 7-10 days for compounds MCUH (Figure 5.13), 
DCUH (Figure 5.14) and DCDH (Figure 5.15). 
The single crystal unit cell of compound MCUH revealed two different structural 
arrangements (Figure 5.13 a). The overlap of the two structures (Figure 5.13 b) shows 
that they differ in the orientation of the –CH2– bond of the pentacycle. Canfield et al
108
 
recently described a new type of conformational isomerism for two enantiomers not 
describable within existing IUPAC nomenclature. This type of conformational 
isomerism does not change the relative spatial orientation of the chiral centres and so, 
they are basically the same compound. Figure 5.13 c) illustrates the inter and 
intramolecular hydrogen bonds that leave no available sites for any water to bind to 
while in solution. 
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Figure 5.13 a) Structure determined from a single crystal of compound MCUH. b) Overlay of the two 
conformational isomers of compound MCUH. c) Packing pattern of the crystal structure. 
 
The structure determined from a single crystal of compounds DCUH (Figure 5.14) and 
DCDH (Figure 5.15) drive to the same conclusion; inter and intramolecular hydrogen 
bonds occupy all the available binding sites. 
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Figure 5.14 a) Structure determined from a single crystal of compound DCUH. b) Packing pattern of the 
crystal structure. 
 
The packing pattern of both dimmers shows hydrophobic channels, which could 
contribute to the lack of dissolution of these compounds (recalling Figure 4.8, Chapter 
4, Section 4.3.3) in a 100% RH environment. 
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Figure 5.15 a) Structure determined from single crystal of compound DCDH. b) Packing pattern of the 
crystal structure. 
 
5.4 CONCLUSIONS 
A total of 13 compounds were successfully synthesised in reasonable to good yields 
though these were lower than previously obtained for similar couplings. 
____________Synthesis and Water Uptake of Higher Molecular Weight Molecules 
 
 
 
178 
 
 
The increase of the molecular weight to ~2 and ~2.5 fold, from Chapter 4, had no 
significant difference in the water holding capacity. Compound TCUS follows the same 
trend as observed for DCUS, being the only compound with a significant 𝑁𝑤; though 
the D/A relationship is much higher for TCUS, both compounds bind to 7 water 
molecules per molecule of compound. The saturated hexamer and octamer do not 
follow the trend of the cis up configuration compounds binding to 1 (one) and 0 (zero) 
water molecules per molecule of compound. This observation suggests that the 
foldameric structures are binding intramolecularly with no specific folding shape as 
demonstrated by the CD spectra. 
The hydroxylated series differs from the smaller molecules, binding to 2 molecules of 
water except for compound TCDH. The sorption isotherms indicate that the 
hydroxylated series could be forming hydrates as the peptide chain is increased. The 
structures determined from a single crystal explain the lack of water holding capacity of 
the hydroxylated series, showing that intra and intermolecular bonds occur in detriment 
of hydrogen bonding to water. 
Chapter 6 will evaluate the stratum corneum uptake of the selected compounds from 
Chapter 3, 4 and 5. 
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6. UPTAKE/DESORPTION STUDIES 
This Chapter is organised in three Sections. Section 6.1 gives a brief overview of the 
skin models commonly used and the compounds selected for the uptake assays. Section 
6.2 presents the methods used to assess the skin uptake of the selected compounds and 
the results obtained, and Section 6.3 shows the chapter’s conclusions. 
 
6.1 INTRODUCTION 
Skin has long been used as an entry point for drug delivery and the first barrier to 
overcome is the SC. Ideally, the assay of a candidate would be run in vivo, accounting 
for all the dynamics of a biological system. This is obviously not feasible for a 
completely unknown new chemical entity (NCE); table 6.1 lists a range of appropriate 
skin models with their advantages and disadvantages. 
Porcine skin has been frequently used as a surrogate for human skin due to its 
similarities. Its anatomy,
109
 physiology
110,111
 and immune system
112
 have been shown to 
have similar components and function with human skin.
113
 Table 6.2 and 6.3 illustrate 
the comparison of thickness between animal skins and human skin. 
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Table 6.1 Skin models.
114
 
Model Advantages Disadvantages 
Human skin   
In vivo Gold standard Often precluded for ethical 
reasons 
Ex vivo Best surrogate for in vivo 
humans 
Not readily available, 
variability 
Animal skin   
In vivo Reasonably easy to obtain 
animals, can be scaled up to 
humans, hairless species 
available 
Pigs: similar barrier to humans, 
but difficult to handle 
Rodents: different barrier 
properties from humans 
In vivo chimeric model Human skin xenografts on 
mice allows testing on living 
human skin 
Technically difficult 
Ex vivo Easy to obtain Different barrier properties, 
variability 
Artificial membranes   
Simple polymeric models Useful for studying basic 
diffusion mechanisms, 
consistent and homogenous 
Not representative of human 
skin 
Lipid-based models Useful for screening Not representative of human 
skin 
Reconstructed skin models   
Reconstructed human 
epidermis 
Built-in barrier properties Usually more permeable than 
human skin 
Living skin equivalents Can be engineered to include 
a range of normal or disease 
features 
Usually more permeable than 
human skin 
 
 
_________________________________________________Uptake/Desorption Studies 
 
 
 
182 
 
 
Table 6.2 Thickness of skin layers of different species.
115
 
Species, anatomic site SC (m) Epidermis (m) Whole skin (mm) 
Human, forearm 17 36 1.5 
Pig, back 26 66 3.4 
Pig, ear 10 50 1.3 
Mouse, back 5 13 0.8 
 
Table 6.3 Thickness of human and animal skin.
115
 
Species SC (m) Epidermis (m) Whole skin (mm) 
Human 16.8 46.9 2.97 
Pig 26.4 65.8 3.43 
Rat 18 32 2.09 
Mouse 9 29 0.10 
Hairless mouse 8.9 28.6 0.70 
 
Due to its similarities and ease of access, pig skin (isolated SC) from the flank was used 
in this project to assess the selected compounds in the uptake assays. 
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6.1.1 SELECTED COMPOUNDS AND SELECTION CRITERIA 
From the TGA results, a screening was done based on the water holding capacity under 
the assumption that compounds that hydrogen bond to water will penetrate/permeate 
into/through the SC. The compounds with the higher 𝑁𝑤 were chosen from the 
monomeric series (Chapter 3, Section 3.3.3). From the unsaturated and saturated series, 
the highest water holding compound were MCUU and MCDS. Their enantiomers were 
also assessed to evaluate the influence of chirality. From the library of compounds 
generated in Chapter 4, DCUS and DCUU were selected; DCUS holds 7 molecules of 
water per molecule of compound and DCUU holds 4. From Chapter 5, TCUS, TCUU, 
HCUS and OCUS were selected. Though TCUU, HCUS and OCUS do not hydrogen 
bond to water, inferences on other physical properties can be made. Also, the complete 
saturated series was assessed, allowing conclusions on molecular weight influence on 
uptake of a series. The summary of the selected compounds can be found in table 6.4 
and the structures visualised in Figure 6.1. 
 
Table 6.4 Water holding capacity of the selected compounds. 
 Compound 
 MCDU MCUU MCDS MCUS DCUS DCUU TCUS TCUU HCUS OCUS 
𝑵𝒘 2 3 2 1 7 4 7 0 1 0 
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Figure 6.1 Selected compounds  assessed for uptake into pig  stratum corneum. 
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6.2 COMPOUND UPTAKE DETERMINATION 
6.2.1 2,4,6-TRINITROBENZENE SULFONATE (TNBS) ASSAY 
The TNBSA assay for primary amines, amino acids and peptides was first reported in 
1960 by Satake et al.
116
 and the method has evolved ever since. The reaction involved is 
illustrated in Figure 6.2. 
 
 
Figure 6.2 Derivatisation of a free amine with TNBSA. 
 
The method is based on the chemical reaction between TNBSA and a free primary 
amine forming an intermediate chromophore (max = 420 nm) known as Meisenheimer 
complex. 
To test the method on the selected compounds, a preliminary assay was run using a 
commercially available dipeptide (Gly-Gly), following the procedure described by 
Snyder and Sobocinski.
117
 The buffer used in this procedure (sodium tetraborate pH 9.3) 
was substituted by NaHCO3/Na2CO3 buffer, pH 9.3, for readiness reasons. A good 
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linear correlation between concentration and absorbance was observed as can be seen in 
Figure 6.3. 
 
 
Figure 6.3 Calibration curve for peptide Gly-Gly. 
 
The method was then applied to the monomer MCUU. A sample (1.27 mg) of SC was 
dipped in a saturated solution of MCUU, following the procedure described in Chapter 
2. The SC was then removed, and the solution was freeze dried for 48 hours to afford a 
white solid (m < 0.1 mg). The solid was dissolved in 1 mL of buffer and 25 L of 
TNBSA were added and left reacting at room temperature along with the standard 
solutions. The absorbance was read at 420 nm and the correlation between read 
absorbances and concentration is depicted in Figure 6.4. The LOD (limit of detection) 
was determined to be 3 M for MCUU. 
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Dilution was required (1:16) to read the absorbance of the sample and the diluted 
solution gave 0.760 Au. Applying the calibration curve and considering the dilution 
factor, the sample had a concentration of 1200M (9.4 g, equivalent to 7.4g/mg SC). 
 
 
Figure 6.4 Calibration curve for compound MCUU. 
 
From preparing a saturated solution to calculating the amount of compound absorbed by 
SC a period of time of 4-5 days was needed. In an attempt to reduce analysis time, a 
saturated solution of MCUU was prepared in pH 9.3 buffer and a sample of SC was 
dipped into it. After a period of 24 hours the integrity of the SC was compromised as 
stated by Ali et al.
118
 and the sample degraded in solution. 
During the execution of the method, a change in colour for the most concentrated 
solutions was observed. The absorbance was measured again after 2 hours (2.5 hours of 
reaction) and, in fact, the readings were different (Table 6.5). 
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Table 6.5 Absorbance of MCUU standard solutions after reaction time of 30 minutes and 2.5 hours. 
 Concentration (M) 
 100 45 95 90 75 4.5 5 70 80 
Au 
(30 min) 
0.972 0.421 0.959 0.891 0.731 0.034 0.052 0.759 0.771 
Au 
(2.5 h) 
1.369 0.480 1.077 0.961 0.814 0.056 0 0.819 0.908 
 
Different TNBSA reaction times have been reported by Obi
119
 (2 hours) and Cayot
120
 
(24 hours); Sarantonis et al.
121
 reported that above pH 9.0 a parallel reaction occurs with 
HO
-
 and Grotzky and co-workers
122
 state that the side product formed (picric acid, 
Figure 6.5) absorbs at 355 nm with a shoulder at approximately 430 nm. 
 
 
Figure 6.5 Side reaction of TNBSA forming picric acid. 
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Due to the unreliability of this method’s results it was inappropriate to continue and so a 
new one was sought. 
 
6.2.2 LC/MS METHOD 
Method B, described in Chapter 2 (Section 2.16), was applied with the advantage of no 
requirement for derivatisation or labelling of the compounds. The concentration of each 
desorption solution was determined using the calibration curves depicted in Figures 6.6 
to 6.15. To ensure that the readings were not masked by the release of any compound 
from the SC, a blank consisting of SC dipped into the sorption/desorption solution 
(water) was run. The EIC (Extracted Ion Chromatogram) gave a MS of 226.95 Da at 2.3 
min, which represented no interference with the retention time of the analytes. The 
retention time (Rt) of each compound is listed in Table 6.6. 
 
Table 6.6 Retention times of the selected compounds. 
 Compound 
 MCDU MCUU MCDS MCUS DCUS DCUU TCUS TCUU HCUS OCUS 
Rt 
(min) 
3.2 3.2 3.2 3.2 3.2 3.2 \4.1 4.1 3.3 4.2 
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Figure 6.6 Calibration curve for compound MCUU. Data are mean  SD from n=2. 
 
 
 
Figure 6.7 Calibration curve for compound MCDU. Data are mean  SD from n=2. 
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Figure 6.8 Calibration curve for compound MCUS. Data are mean  SD from n=3. 
 
 
 
Figure 6.9 Calibration curve for compound MCDS. Data are mean  SD from n=3. 
 
y = 50632x - 111299 
R² = 0,9407 
-500000
0
500000
1000000
1500000
2000000
2500000
3000000
3500000
4000000
4500000
0 10 20 30 40 50 60 70 80
A
re
a
 
C (g/mL) 
MCUS 
y = 23832x - 72045 
R² = 0,9971 
-500000
0
500000
1000000
1500000
2000000
2500000
3000000
0 20 40 60 80 100 120
A
re
a
 
C (g/mL) 
MCDS 
_________________________________________________Uptake/Desorption Studies 
 
 
 
192 
 
 
 
 
Figure 6.10 Calibration curve for compound DCUU. Data are mean  SD from n=3. 
 
 
Figure 6.11 Calibration curve for compound DCUS. Data are mean  SD from n=2. 
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Figure 6.12 Calibration curve for compound TCUU. Data are mean  SD from n=3. 
 
 
Figure 6.13 Calibration curve for compound TCUS. Data are mean  SD from n=3. 
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Figure 6.14 Calibration curve for compound HCUS. Data are mean  SD from n=3. 
 
 
Figure 6.15 Calibration curve for compound OCUS. Data are mean  SD from n=2. 
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Due to time restrains the LOD and LOQ (limit of quantification) was not experimentally 
determined and the values indicated in table 6.7 are calculated using the calibration 
curves. In this way LOD and LOQ were calculated according to the following 
equations: 
𝐿𝑂𝐷 =  
3 × 𝑆𝐷
𝑠𝑙𝑜𝑝𝑒
 
𝐿𝑂𝑄 =  
10 × 𝑆𝐷
𝑠𝑙𝑜𝑝𝑒
 
Where, SD is the standard deviation of the data set. 
Due to time constraints and the large number of samples requiring analysis some of the 
analysed compounds only have 2 repeats. This was accepted because generally the 
calibration curves gave very good correlations, R
2
, values and so n=2 was judged to be 
sufficiently reliable for the experiments. 
 
Table 6.7 Limit of detection and limit of quantification calculated for each compound. 
 Compound 
 MCUU MCDU MCUS MCDS DCUU DCUS TCUU TCUS HCUS OCUS 
LOD 
(g/mL) 
4.7 11.7 4.7 5.3 2.4 0.4 2.5 2.1 2.2 0.5 
LOQ 
(g/mL) 
15.8 39.1 15.7 17.6 7.9 1.5 8.4 6.9 7.3 1.7 
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There is good correlation for every analysed compound. The LC/MS method allows the 
quantification of the analytes via LC and MS; some of the analysed compounds (smaller 
molecules) were not UV active and the calibration curves were obtained measuring the 
EIC areas of the protonated or/and the sodiated forms. Table 6.8 shows the detected 
mass vs the molecular weight of each compound. 
 
Table 6.8 Calculated molecular weight (Mw) and detected mass units (EIC). 
 Compound 
 MCUU MCDU MCUS MCDS DCUU DCUS TCUU TCUS HCUS OCUS 
Mw 127.06 127.06 129.08 129.08 198.10 200.24 378.43 382.46 564.68 746.91 
EIC 
(Da) 
128.07 
150.06 
128.07 
150.06 
130.08 
152.07 
130.09 
152.07 
182.09 
201.24 
223.11 
379.20 383.24 565.34 747.45 
 
Compound DCUU differed to the behaviour of the other compounds and an analysis of 
the possible fragments was done to understand the EIC of 182.09. A difference of 17 
mass units corresponds to the loss of the hydroxyl group of the carboxylic acid (Figure 
6.16). Fragmentation was also observed for the tetramers, hexamer and octamer; in 
which case all the area of the fragments was taken in account. Though the type of 
ionisation used (ESI) is adequate for large biological molecules, the temperature of the 
ionising source may have an influence in fragmentation. 
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Figure 6.16 Proposed fragmentation for compound DCUU. 
 
Using the calibration curves obtained for the analytes, the “solubility” of the analyte in 
the SC (Sasc), the partition coefficient between SC and water (Kscw) – presented as Log 
Pscw, (P = Kscw) – and the aqueous solubility (S) of each compound were determined and 
are listed in Table 6.9. 
Table 6.9 Partition coefficient and solubility for the set of selected compounds. 
 Compound 
 MCUU MCDU MCUS MCDS DCUU DCUS TCUU TCUS HCUS OCUS 
SascSD 
(g/mg SC) 
2970 1502 424 1310 51 182 181 151 172 221 
SSD 
(mg/mL) 
1006 836 121 343 304 527 151 71 112 71 
Log Pscw -1.99 -2.06 -1.80 -1.90 -3.06 -2.74 -2.26 -2.07 -2.19 -1.83 
 
The solubility decreases with the increase of the molecular size, with the monomers 
being the most soluble compounds followed by the dimer and tetramers. TCUS, HCUS 
and OCUS have no marked difference in their solubility. HCUS is slightly higher (11 
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mg/mL) than the other two (both with 7 mg/mL). The Sasc shows interesting behaviour 
along the saturated series, i.e., it decreases from monomer to dimer, with the same value 
for the tetramer and increases as the size of the peptide grows showing there is a non-
obvious nor linear relationship between molecular weight and 
hydrophilicity/hydrophobicity. 
 
6.3 CONCLUSIONS 
Two quantification methods were tested: TNBSA and LC/MS. TNBSA, though giving 
good linearity, proved to be slow in execution time and gave unreliable results and it 
had the disadvantage of requiring derivatisation. The LC/MS method revealed more 
reliable results and lower execution time. 
The aqueous solubility of the enantiomers MCUU (100 mg/mL) and MCDU (83 
mg/mL) is significantly different and the same conclusion is drawn for enantiomers 
MCUS (12 mg/mL) and MCDS (34 mg/mL). The cis up configuration has higher S for 
the unsaturated monomer, but it behaves in the opposite manner in the saturated 
monomer. The same trend is observed for the partition coefficient (Kscw), i.e., a higher 
uptake for the cis up unsaturated monomer and the opposite trend for the saturated 
monomer. 
Chapter 7 provides further critique of these data and aims to provide insight on the 
structure /activity relationships of the analysed compounds. 
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7. GENERAL DISCUSSION AND SUGGESTIONS 
This Chapter is divided in four Sections. Section 7.1 and 7.2 present relationships 
between the compounds’ properties, Section 7.3 gives the Chapter’s conclusions and 
Section 7.4 suggests future work in the field. 
7.1 RELATIONSHIP OF THE PHYSICAL PROPERTIES FOR THE ALL DATA SET 
Chapters 3, 4, 5 and 6 report and analyse data in a “separate” manner. However, it is the 
purpose of this project to try to observe trends in the collected data. The following 
sections will present data in totality. Figure 7.1 presents the melting point variation with 
the molecular weight and the molecular structure as enantiomerically pure compounds 
or as a mixture of two or more of the possible isomers. 
 
Figure 7.1 Influence of the structure and  molecular weight in the melting point. 
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The melting point of the mixture of enantiomers/diastereomers (blue bar) is generally 
different from their isolated isomers (enantiomer/diastereomer). There is no clear simple 
relationship between configurations, i.e., the cis down configuration (red bar) is not 
always the enantiomer/diastereomer with higher or lower melting point than the cis up 
configuration isomer (green bar). The melting point as a function of the molecular 
weight for the mixture of compounds and their enantiomerically pure isomers is 
depicted in Figures 7.2-4. 
 
Figure 7.2 Relationship between mp and Mw for the library of compounds as a mixture of 
enantiomers/diastereomers. 
 
The melting point of a mixture of enantiomers/diastereomers can be interpreted as the 
measure of the melting point of an impure sample; compounds MMU, MMS, MMH, 
DMU, DMS and DMH are a mixture of two enantiomers (monomeric series) and 
diastereomers (dimeric series); TMU, TMS and TMH are a mixture of four 
diastereomers. The cis down series of compounds (Figure 7.3) presents a linear trend for 
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lower Mw’s (< 300 Da) but it changes for “heavier” molecules. The elaborated 
polynomial relationship in Figure 7.3 has an inflection ~600 Da with no experimental 
data and a poor correlation (the polynomial relationship has the sole purpose of trying to 
fit the data to a mathematical equation and express its complexity). 
 
Figure 7.3 Relationship between mp and Mw for the library of compounds with cis down configuration. 
 
The cis up series of compounds (Figure 7.4) also presents a complex relationship 
between the melting point and Mw. Up to ~500 Da, the relationship presents a slight 
decrease of the melting point with the increase of the molecular weight. 
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Figure 7.4 Relationship between mp and Mw for the library of compounds with cis up configuration. 
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Figure 7.5 Variation of 𝑵𝒘 with Mw of different isomers. 
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Figure 7.6 Number of water molecules per molecule of compound vs D/A for compounds as a mixture of 
enantiomers/diastereomers. 
 
 
Figure 7.7 Number of water molecules per molecule of compound vs D/A for enantiomerically pure 
compounds with cis down configuration. 
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Figure 7.8 Number of water molecules per molecule of compound vs D/A for enantiomerically pure 
compounds with cis up configuration. 
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7.2 RELATIONSHIP OF THE PHYSICAL PROPERTIES FOR THE SELECTED 
COMPOUNDS 
The selection of compounds allows a qualitative analysis on the influence of the 
physical properties measured in this project as well as using properties that are predicted 
using known software packages. The influence of chirality will be analysed when 
possible or relevant. 
Figure 7.9 illustrates 𝑁𝑤 as a function of D/A for the selected compounds, where it is 
possible to see a linear dependence of the variables for some of the compounds (blue 
diamonds). This linearity is not straight forward though, there is an increase of the 
molecular weight, but the configuration of the cyclic amino acid varies. Three of the 
outliers (red diamonds) belong to the same series of compounds (saturated series), this 
series will be evaluated separately later. 
Comparing the effect of different spatial arrangements, Figure 7.10 shows the influence 
of chirality for two pairs of enantiomers with the same D/A relationship (MCDU, 
MCUU, MCDS and MCUS) and approximately the same molecular weight (127 and 
129 Da). 
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Figure 7.9 Number of water molecules per molecule of compound vs D/A for the selected compounds. 
 
 
Figure 7.10 Aqueous solubility and uptake into the SC as a function of Nw for compounds with the same 
D/A relationship. 
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The two compounds that present a 𝑁𝑤 of 2 (MCDU and MCDS) have very different 
behaviour in terms of aqueous solubility and uptake into the SC. MCDU (72 mg/mL) is 
3 fold more soluble in water than MCDS (24 mg/mL) but their uptake into the SC is 
approximately of the same order, i.e., 150 g/mL and 131 g/mL, respectively. The 
behaviour of their enantiomers is even more dissonant. This can be seen as a reflection 
of chirality and also as a reflection of the structural change as they differ in a 
saturated/unsaturated bond. Figure 7.11 depicts the remining compounds analysed and it 
is evident that the trend is different from that previously observed. The solubility (blue 
diamonds) does tend to increase with the increase of 𝑁𝑤 but the uptake (red diamonds) 
of these compounds suggests independence from 𝑁𝑤 
 
 
Figure 7.11 Solubility and uptake into the SC as a function of 𝑵𝒘 for compounds with different D/A 
relationship. 
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Figure 7.12 shows the solubility and uptake as a function of the D/A relationship. For 
compounds with the same D/A relationship, the solubility and uptake differ 
significantly. As before, while discussing figure 7.10, four monomers have the same 
D/A (5) relationship as do two dimers (D/A = 8) and two tetramers (D/A = 14). These 
compounds are two sets of enantiomers (monomers) and two different compounds of 
the dimers and tetramers (saturated and unsaturated); the influence of the structural 
differences reduces as the size of the molecules increase. Analysing molecular size, it 
seems to dilute its influence on solubility and uptake as the molecules grow as they 
progress to the same value. Following this last observation, Figure 7.13 illustrates 
uptake as a function of aqueous solubility, where it can be seen that the solubility and 
the uptake are directly related, and one increase with the other (red diamond was 
considered an outlier). Figure 7.14 shows the same relationship but this time for the 
saturated series with cis up configuration, from monomer to octamer. The trend line 
observed is inconclusive (R
2
 0.43) though generally it reverses, i.e., the compound with 
the higher solubility (DCUS) is the one with the lower uptake but it is not the 
compound with the lower or higher molecular weight. In fact, DCUS and TCUS are the 
compounds with the higher number of bound water (7), TCUS has almost twice the Mw 
of DCUS, half the solubility in water and three times the uptake; inferring that solubility 
and uptake are strongly related to spatial arrangement. 
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Figure 7.12 Solubility and uptake as a function of D/A for the selected compounds. 
 
 
Figure 7.13 Uptake as a function of the solubility. 
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Figure 7.14 Uptake as a function of the solubility for the cis up configuration of the saturated series. 
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Table 7.1 LogP and LogS obtained experimentally and via algorithms. 
 Chemdraw ALogPS Chemicalize Experimental 
 
LogP 
(Broto’s 
Method) 
CLogP LogS ALogP LogS LogP LogS LogPasc LogS 
MCUU -1.36 -2.58 -0.49 -2.51 0.12 -2.36 1.71 -1.99 2.00 
MCDU -1.36 -2.58 -0.49 -2.51 0.12 -2.36 1.71 -2.06 1.86 
MCUS -0.64 -2.30 -0.59 -2.45 0.22 -2.16 1.83 -1.80 1.03 
MCDS -0.64 -2.30 -0.59 -2.45 0.22 -2.16 1.83 -1.90 1.37 
DCUU -2.37 -2.56 -0.73 -2.23 -0.84 -2.90 1.14 -3.06 1.72 
DCUS -1.65 -2.28 -0.82 -2.07 -0.84 -2.69 1.26 -2.74 1.48 
TCUU -4.34 -2.62 -2.03 -0.63 -2.80 -3.49 -0.38 -2.26 0.85 
TCUS -1.65 -2.06 -2.21 -1.06 2.25 -3.08 -0.14 -2.07 1.16 
HCUS -0.86 -1.83 -3.60 -1.71 -3.41 -3.47 -1.12 -2.19 1.03 
OCUS * -1.61 -4.99 -1.98 -3.82 -3.85 -1.64 -1.85 0.81 
* The method did not predict a value for this molecule 
The LogP prediction algorithms that best correlate with the experimental (pig SC/water 
LogP) data are LogP Chemicalize for monomers and dimers and ALogP and ClogP 
from Chemdraw for molecules with higher molecular weight, though neither predicts 
chirality effects.The LogS prediction is best fitted by LogS from Chemicalize. 
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Figure 7.15 Comparison of predicted and experimentally obtained values of LogP. 
 
 
Figure 7.16 Comparison of predicted and experimentally obtained values of LogS. 
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7.3 CONCLUSIONS 
The melting point of a mixture of enantiomers/diastereomers and its enantiomerically 
pure forms differ with no noticeable trend. This difference is at times greater than 20 ºC 
but it is not always the cis up or cis down configuration is the one with the higher or 
lower melting point. This has an influence on the solubility of the different enantiomers. 
There is a linear relationship between 𝑁𝑤 and D/A with no relation to chirality, i.e., the 
linearity is independent from the configuration. This trend holds for lower molecular 
weight compounds, but as the molecular size increases then the 𝑁𝑤 absorbed tends to 
zero. However, the hydroxylated series starts to bind to water as the molecular weight 
increases suggesting that the internal arrangement and the side chain motifs of the 
molecules have great influence on their ability to hydrogen bond to water (and hence 
alters in their hydrophilicity/lipophilicity. 
The solubility and the uptake of the analysed compounds have a linear relationship with 
𝑁𝑤 for molecules with lower Mw, but this relationship changes for larger molecules. 
The solubility, though lower, is directly related to the number of bound water molecules 
and the uptake shows 𝑁𝑤 independence. 
There is a linear and proportional correlation between solubility and uptake, this 
relationship is disturbed by the structural differences of the enantiomers/diastereomers, 
as the saturated series demonstrates. For this series (cis up), solubility and uptake are 
indirectly correlated. 
LogP Chemicalize is the best theoretical prediction algorithm for smaller molecules and 
ALogP and ClogP from Chemdraw are more appropriate for molecules with higher 
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molecular weight. Chirality effects are not contemplated by the software used. On the 
other hand LogS prediction is roughly fitted by LogS from Chemicalize. 
The physical properties have an influence in the solubility and uptake, their relationship 
is not always linear and other properties have to be taken in account. Chirality clearly 
plays a role since such molecules, with the same molecular weight, have different 
melting point, solubility and uptake. 
In summary, the project began by designing a series of monomers that could be 
assembled into larger structures, to investigate the influence of chirality on molecular 
uptake into stratum corneum. In parallel the monomers were designed to have different 
hydrogen bonding capabilities which was expected to confer the ability to bind to water. 
In general terms, the addition of hydrogen bonding capabilities presented internal 
hydrogen bonding opportunities as the molecular weight was increased from monomer 
to dimer. The assemblies, or foldamers, clearly confounded the simple initial hypothesis 
and prevented simple hydrogen bond site-water binding correlations. The internal 
structures also confounded simple relationships between chirality and uptake (or other 
properties) since simple chemical representations of structures are not based in the 
reality of the molecular assembly – as shown by the X-ray diffraction results. One 
further key lesson is apparent. A large library of molecules was synthesised – an 
extensive series of monomers (e.g. unsaturated, saturated and hydroxylated) and these 
then built into their own series of “macromolecules” (monomer, dimer, tetramer, 
hexamer, octamer). From the critique above, some trends could be described within a 
subset of the data – for example trends in the monomers or trends across a 
macromolecule series, or trends in a particular cis up or down series. However, 
considering the data in total, such trends are not apparent in all series or classes and 
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indeed trends from one series reverse in another. This illustrates the importance of not 
selecting a narrow range of materials and the extrapolating findings more broadly; had a 
single series, for example the saturated ones, been used throughout but they could have 
erroneously then been extrapolated to other chemical series. 
 
7.4 FUTURE WORK 
From this project, a number of directions could be followed. Below is a list of some 
potential future work that could be further investigated. 
 Firstly, the work could continue with diffusion studies of the selected 
compounds using Franz Cell equipment to provide a clearer insight on the 
dynamics of these compounds in a permeation process and would dissipate 
doughts about the SC permeability. 
 Test the selected compounds in excised human skin. This would be firstly 
uptake studies into isolated sheets of human epidermal membranes to evaluate if 
human skin is chirally selective for these molecules. Molecules that enter the 
tissue could then be tested as permeation enhancers. An initial hypothesis was 
that the molecules would bind to water and so could have permeation enhancing 
properties. 
 As an extension to the above, it would be feasible to conjugate the selected 
compounds with a drug and evaluate the influence of the conjugation on 
physical properties and uptake into SC. 
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 A more complete study would involve complete testing of all compounds 
synthesised, spatially the hydroxylated series. The small molecular weight 
hydroxylated compounds do not bind to water and the present study suggests no 
obvious relationship between 𝑁𝑤 and uptake but it does suggest a linear 
relationship between solubility and uptake. 
 A more powerful package for molecular dynamics would be advisable to predict 
𝑁𝑤 that theoretically bind to each compound and rationalise the design of new 
candidates. 
 Explore the foldameric potential of the synthesised compounds varying 
concentration, temperature, pH and solvent systems in order to relate their 
characteristic folding to permeation. 
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